<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-NER-TCA</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Niger (le): Aide cibl&#xE9;e aux pays</narrative>
   <narrative xml:lang="EN">Niger (the): Targeted country assistance</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Plans d&#x2019;assistance technique cibl&#xE9;e aux pays L&#x2019;assistance technique cibl&#xE9;e aux pays (TCA) est octroy&#xE9;e sous forme de ressources destin&#xE9;es aux partenaires pr&#xE9;sents dans les pays. La TCA est un &#xE9;l&#xE9;ment du cadre d&#x2019;engagement avec les partenaires (PEF) de Gavi. Le plan de TCA d&#x2019;un pays est &#xE9;tablie selon les besoins exprim&#xE9;s du dit pays lors de l&#x2019;&#xE9;valuation conjointe. Un plan comprend une liste d&#x2019;activit&#xE9;s, d&#x2019;&#xE9;tapes cl&#xE9;s, et un budget pour une ann&#xE9;e dite.  L&#x2019;assistance technique est un soutien non financier fourni par des sp&#xE9;cialistes. Elle peut rev&#xEA;tir plusieurs formes : partage d&#x2019;information et de savoir-faire, formation et services-conseils.

L&#x2019;assistance technique fournie dans le cadre du PEF est appel&#xE9;e aide cibl&#xE9;e aux pays. Ce type de soutien vise principalement &#xE0; payer le personnel bas&#xE9; en permanence dans les bureaux pays des partenaires. Il repose sur la demande et les besoins identifi&#xE9;s par les pays eux-m&#xEA;mes.</narrative>
   <narrative xml:lang="EN">Targeted country assistance (TCA) are resources provided to in-country partners under Gavi&#x2019;s partners&#x2019; engagement framework (PEF). A country&#x2019;s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.Technical assistance is non-financial support provided by specialists. It can take the form of sharing information and expertise, training and consulting services.

The technical assistance provided through PEF is called targeted country assistance (TCA). This type of support mainly consists of staff permanently based in partners&#x2019; country offices. It is based on the demand and needs identified by the countries themselves.</narrative>
  </description>
  <participating-org role="4">
   <narrative xml:lang="EN">CDC Foundation</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">Expertise France</narrative>
  </participating-org>
  <participating-org role="4">
   <narrative xml:lang="EN">GIE Vaccilog</narrative>
  </participating-org>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-44001" role="4" type="40">
   <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
  </participating-org>
  <participating-org role="4" type="70">
   <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Niger (the)</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
  </participating-org>
  <participating-org ref="XI-GRID-grid.5510.1" role="4" type="80">
   <narrative xml:lang="EN">University of Oslo</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-928" role="4" type="40">
   <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2019-01-01" type="1"></activity-date>
  <activity-date iso-date="2019-01-01" type="2"></activity-date>
  <activity-date iso-date="2022-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="NE" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="NE" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Niamey</narrative>
   </name>
   <administrative code="NE" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>13.5125 2.11178</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TCA" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Targeted country assistance</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">1917052</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3691792</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">3006127</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2022-03-30">517666</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="NERPEF-TCA-CDC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">12000</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">313147</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">97845</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">51745</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">122978</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">7842</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">853789</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2019">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-01-01"></transaction-date>
   <value currency="USD" value-date="2019-01-01">457706</value>
   <description>
    <narrative xml:lang="EN">2019 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">314661</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">139874</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">98565</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-IBRD2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">200000</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">351269</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-SAMBOU2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">27457</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">27644</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1382196</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-VACCILOG2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">70774</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2020">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">1079352</value>
   <description>
    <narrative xml:lang="EN">2020 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">367763</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CHITOU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">170410</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">275686</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">452450</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-SAMBOU2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">59101</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNI OF OSLO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">30476</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">945252</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-VACCILOG2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">12</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2021">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-01-01"></transaction-date>
   <value currency="USD" value-date="2021-01-01">704976</value>
   <description>
    <narrative xml:lang="EN">2021 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-CDC FOUND2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">87625</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-EXPERTISE FRANCE2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">0</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-JSI2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">14668</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-UNIC2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">236315</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="NERPEF-TCA-WHO2022">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2022-01-01"></transaction-date>
   <value currency="USD" value-date="2022-01-01">179057</value>
   <description>
    <narrative xml:lang="EN">2022 Operational budget for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000858">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">9000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000748">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-03"></transaction-date>
   <value currency="USD" value-date="2019-12-03">3000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC (Centers for Disease Control and Prevention)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Centers for Disease Control and Prevention</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000859">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">234860</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000675">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-02"></transaction-date>
   <value currency="USD" value-date="2019-12-02">78287</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001735">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-29"></transaction-date>
   <value currency="USD" value-date="2020-04-29">314661</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001204">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-23"></transaction-date>
   <value currency="USD" value-date="2021-03-23">104887</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002631">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-08"></transaction-date>
   <value currency="USD" value-date="2021-06-08">262876</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CDC FOUND (CDC Foundation)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900002697">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">15925</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002606">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">3445</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">26353</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900004170">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-08-31"></transaction-date>
   <value currency="USD" value-date="2019-08-31">19463</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900007319">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-20"></transaction-date>
   <value currency="USD" value-date="2019-09-20">9535</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000913">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">10336</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000911">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">3912</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000912">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">8604</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002816">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">5578</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002817">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">8098</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-07-07"></transaction-date>
   <value currency="USD" value-date="2020-07-07">8977</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003067">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9260</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003065">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9289</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003066">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-29"></transaction-date>
   <value currency="USD" value-date="2020-09-29">9959</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-1248</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-1414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-821</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-8628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1248</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">1414</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">821</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">8628</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000402">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-10"></transaction-date>
   <value currency="USD" value-date="2021-03-10">9366</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000406">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">8331</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000407">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000404">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9319</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000405">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-19"></transaction-date>
   <value currency="USD" value-date="2021-03-19">9400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000403">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-22"></transaction-date>
   <value currency="USD" value-date="2021-03-22">9120</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004683">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">7650</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004685">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">8432</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004686">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">8825</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004684">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-28"></transaction-date>
   <value currency="USD" value-date="2021-09-28">9040</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005689">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-02"></transaction-date>
   <value currency="USD" value-date="2021-11-02">8775</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100005688">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-02"></transaction-date>
   <value currency="USD" value-date="2021-11-02">9007</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007525">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-15"></transaction-date>
   <value currency="USD" value-date="2021-12-15">5250</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007557">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">1400</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007558">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">4900</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100007559">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-16"></transaction-date>
   <value currency="USD" value-date="2021-12-16">7700</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-CHITOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000752">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000751">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-05"></transaction-date>
   <value currency="USD" value-date="2019-12-05">9689</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001176">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">40997</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005513">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">20399</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000814">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-29"></transaction-date>
   <value currency="USD" value-date="2021-04-29">6574</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000815">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-10"></transaction-date>
   <value currency="USD" value-date="2021-05-10">21608</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003858">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-17"></transaction-date>
   <value currency="USD" value-date="2021-08-17">5965</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004939">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-10-05"></transaction-date>
   <value currency="USD" value-date="2021-10-05">16688</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">98173</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-EXPERTISE FRANCE (Expertise France)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">Expertise France</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001342">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-06"></transaction-date>
   <value currency="USD" value-date="2020-04-06">200000</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-IBRD (International Bank for Reconstruction and Development (IBRD))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-44001" type="40">
    <narrative xml:lang="EN">International Bank for Reconstruction and Development (IBRD)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001004">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">47085</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001166">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-30"></transaction-date>
   <value currency="USD" value-date="2019-06-30">-4024</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900001306">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-07-31"></transaction-date>
   <value currency="USD" value-date="2019-07-31">-84416</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000552">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-26"></transaction-date>
   <value currency="USD" value-date="2019-11-26">76808</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000332">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-01"></transaction-date>
   <value currency="USD" value-date="2019-12-01">45887</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001252">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700000432">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-01"></transaction-date>
   <value currency="USD" value-date="2020-01-01">-16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000181">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-30"></transaction-date>
   <value currency="USD" value-date="2020-01-30">16798</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100003005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-16"></transaction-date>
   <value currency="USD" value-date="2020-12-16">85198</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-25624</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-49603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005505">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">25624</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">49603</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000078">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-01-14"></transaction-date>
   <value currency="USD" value-date="2021-01-14">24841</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001428">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">7294</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001428">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">85198</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000266">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-04"></transaction-date>
   <value currency="USD" value-date="2021-05-04">48923</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001922">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-27"></transaction-date>
   <value currency="USD" value-date="2021-09-27">41082</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006718">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">111336</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006717">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">41082</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100006715">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-03"></transaction-date>
   <value currency="USD" value-date="2021-12-03">49599</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">42627</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100007321">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-13"></transaction-date>
   <value currency="USD" value-date="2021-12-13">5837</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-JSI (JSI Research &amp; Training Inst)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="70">
    <narrative xml:lang="EN">JSI Research &amp; Training Inst</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000556">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">0</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000553">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">1554</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000554">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-26"></transaction-date>
   <value currency="USD" value-date="2020-02-26">345</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001258">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-31"></transaction-date>
   <value currency="USD" value-date="2020-03-31">1403</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001674">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">1546</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002495">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-22"></transaction-date>
   <value currency="USD" value-date="2020-06-22">135</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002074">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-06-25"></transaction-date>
   <value currency="USD" value-date="2020-06-25">247</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002008">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-08-13"></transaction-date>
   <value currency="USD" value-date="2020-08-13">1607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002494">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-07"></transaction-date>
   <value currency="USD" value-date="2020-09-07">1607</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003977">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-09-30"></transaction-date>
   <value currency="USD" value-date="2020-09-30">1668</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004071">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-10-08"></transaction-date>
   <value currency="USD" value-date="2020-10-08">778</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004421">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-03"></transaction-date>
   <value currency="USD" value-date="2020-11-03">1668</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004672">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-17"></transaction-date>
   <value currency="USD" value-date="2020-11-17">1690</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004673">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-17"></transaction-date>
   <value currency="USD" value-date="2020-11-17">395</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004969">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-03"></transaction-date>
   <value currency="USD" value-date="2020-12-03">1704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004970">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-03"></transaction-date>
   <value currency="USD" value-date="2020-12-03">1731</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-2698</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">2698</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6081</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000174">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-16"></transaction-date>
   <value currency="USD" value-date="2021-02-16">1734</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001124">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1541</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001125">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1704</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001126">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-18"></transaction-date>
   <value currency="USD" value-date="2021-03-18">1707</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100000598">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-30"></transaction-date>
   <value currency="USD" value-date="2021-04-30">1730</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100001916">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-05-03"></transaction-date>
   <value currency="USD" value-date="2021-05-03">1716</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003039">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">1695</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003061">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">1695</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100002521">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-06"></transaction-date>
   <value currency="USD" value-date="2021-07-06">956</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003717">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">1691</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003715">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">2237</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100003718">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-08-10"></transaction-date>
   <value currency="USD" value-date="2021-08-10">953</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100004592">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">2233</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006154">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-11-29"></transaction-date>
   <value currency="USD" value-date="2021-11-29">2118</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006885">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">2138</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="5100006883">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-07"></transaction-date>
   <value currency="USD" value-date="2021-12-07">4262</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-SAMBOU</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
  </transaction>
  <transaction ref="700000318">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-19"></transaction-date>
   <value currency="USD" value-date="2019-11-19">6938</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700001283">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-468</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000949">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-18"></transaction-date>
   <value currency="USD" value-date="2020-03-18">733</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001193">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-29"></transaction-date>
   <value currency="USD" value-date="2020-03-29">14911</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004212">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">2374</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000005">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">-6476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000007">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-31"></transaction-date>
   <value currency="USD" value-date="2020-12-31">6476</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000297">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-02-03"></transaction-date>
   <value currency="USD" value-date="2021-02-03">3150</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004265">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-07"></transaction-date>
   <value currency="USD" value-date="2021-09-07">3225</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004623">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-09-23"></transaction-date>
   <value currency="USD" value-date="2021-09-23">375</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700006603">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">4688</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNI OF OSLO (University of Oslo)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XI-GRID-grid.5510.1" type="80">
    <narrative xml:lang="EN">University of Oslo</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000860">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">800427</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000229">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000867">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-03-17"></transaction-date>
   <value currency="USD" value-date="2020-03-17">106724</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001481">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-14"></transaction-date>
   <value currency="USD" value-date="2020-04-14">708921</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">53362</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005692">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">513189</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001377">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-03-30"></transaction-date>
   <value currency="USD" value-date="2021-03-30">236307</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002681">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">708945</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-UNIC (United Nations Children&apos;s Fund (UNICEF))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">United Nations Children&apos;s Fund (UNICEF)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100004581">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-11-10"></transaction-date>
   <value currency="USD" value-date="2020-11-10">9401</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005105">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">22193</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005104">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-07"></transaction-date>
   <value currency="USD" value-date="2020-12-07">33457</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005312">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-14"></transaction-date>
   <value currency="USD" value-date="2020-12-14">3717</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-VACCILOG (GIE Vaccilog)</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org>
    <narrative xml:lang="EN">GIE Vaccilog</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="9900000861">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-03-31"></transaction-date>
   <value currency="USD" value-date="2019-03-31">416096</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100000231">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-02-04"></transaction-date>
   <value currency="USD" value-date="2020-02-04">41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001657">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">503412</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001655">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-04-28"></transaction-date>
   <value currency="USD" value-date="2020-04-28">55480</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">-41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="700005028">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-01"></transaction-date>
   <value currency="USD" value-date="2020-12-01">41610</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100005691">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-21"></transaction-date>
   <value currency="USD" value-date="2020-12-21">478851</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100001826">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-04-27"></transaction-date>
   <value currency="USD" value-date="2021-04-27">83902</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="5100002722">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-06-10"></transaction-date>
   <value currency="USD" value-date="2021-06-10">537172</value>
   <description>
    <narrative xml:lang="EN">Disbursement for PEF-TCA-WHO (World Health Organisation (WHO))</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-928" type="40">
    <narrative xml:lang="EN">World Health Organisation (WHO)</narrative>
   </receiver-org>
  </transaction>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/role-expanded-partners-under-pef-guidance-note">
   <title>
    <narrative xml:lang="EN">Partners&#x2019; engagement framework (PEF)</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Guidance on the role of expanded partners in the provision of targeted country assistance</narrative>
   </description>
   <category code="A04"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/directives-concernant-le-processus-mis-en-place-au-titre-de-laide">
   <title>
    <narrative xml:lang="EN">Directives concernant le processus mis en place au titre de l&#x2019;aide cibl&#xE9;e aux pays dans le cadre du PEF</narrative>
   </title>
   <category code="A04"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2017-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2017 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2017-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2018-french">
   <title>
    <narrative xml:lang="EN">Targeted country assistance plan Niger 2018 [French]</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="FR"></language>
   <document-date iso-date="2018-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/fr/actualites/librarie-de-documents/targeted-country-assistance-plan-niger-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2019">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2019</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2019-12-31"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2020">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2020</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2020-07-13"></document-date>
  </document-link>
  <document-link format="APPLICATION/PDF" url="https://www.gavi.org/news/document-library/targeted-country-assistance-plan-niger-2021">
   <title>
    <narrative xml:lang="EN">Targeted Country Assistance Plan Niger 2021</narrative>
   </title>
   <category code="A02"></category>
   <category code="A05"></category>
   <language code="EN"></language>
   <document-date iso-date="2021-05-31"></document-date>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/programmes-et-impact/types-de-soutien/pef">
   <title>
    <narrative xml:lang="EN">Cadre d&apos;engagement avec les partenaires</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">A travers le cadre d&#x2019;engagement avec les partenaires, les partenaires de l&#x2019;Alliance du Vaccin soutiennent les activit&#xE9;s de vaccination au niveau national</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/types-support/pef/targeted-country-assistance">
   <title>
    <narrative xml:lang="EN">About targeted country assistance</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Gavi&#x2019;s targeted country assistance aims to share our partners&#x2019; specialist skills with the countries we support</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/fr/types-de-soutien/pef/aide-ciblee-aux-pays">
   <title>
    <narrative xml:lang="EN">&#xC0; propos de l&#x2019;aide cibl&#xE9;e aux pays</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">L&#x2019;aide cibl&#xE9;e aux pays de Gavi vise &#xE0; partager les comp&#xE9;tences sp&#xE9;cialis&#xE9;es de nos partenaires avec les pays que nous soutenons</narrative>
   </description>
   <category code="A12"></category>
   <language code="FR"></language>
  </document-link>
  <document-link format="TEXT/HTML" url="https://www.gavi.org/programmes-impact/types-support/pef">
   <title>
    <narrative xml:lang="EN">Partners&apos; engagement framework</narrative>
   </title>
   <description>
    <narrative xml:lang="EN">Through the partners&#x2019; engagement framework, Vaccine Alliance partners support countries&#x2019; immunisation activities</narrative>
   </description>
   <category code="A12"></category>
   <language code="EN"></language>
  </document-link>
  <related-activity ref="47122-NER" type="1"></related-activity>
  <conditions attached="1">
   <condition type="2">
    <narrative xml:lang="EN">Conditions are detailed in the Partners&#x2019; engagement framework</narrative>
    <narrative xml:lang="FR">Les conditions sont d&#xE9;taill&#xE9;es dans le cadre d&apos;engagement des partenaires</narrative>
   </condition>
  </conditions>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EVM composite score of 80%
2. Improvement in the level of cIP implementation by 70%.
3. A report on assessment of status of scaling up of Push plus (targeted at least &gt;50% of the states implementing push plus)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation and monitoring of EVM, cIPs and ISC2 recommendations.
2. Provide technical support for system re-design and CCEOP implementation. 3. Support NLWG to strenghen capacity and coordination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. All preparation for an EVM had been concluded including training or onboarding in January 2020 but yet to commence assessment due to COVID-19 outbreaks and COVID-19 vaccination currently ongoing. Coming in August, 2020. 2. WHO is supporting the ongoing CEOP implementation. 3.Country has completed first tranche of CCEOP and has started the 2nd tranche of CEOP. 4. States are at different stages of implementation of cIP (see attachment for details). 5. System re-design plan in 3 hubs in Lagos, Kano &amp; Abuja. So far approval was given for Lagos Hub. 6. WHO deployed an officer as Logistician who is providing technical support to NLWG.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation and monitoring of EVM, cIPs and ISC2 recommendations.
2. Provide technical support for system re-design and CCEOP implementation. 3. Support NLWG to strenghen capacity and coordination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. All preparation for an EVM had been concluded including training or onboarding in January 2020 but yet to commence assessment due to COVID-19 outbreaks and COVID-19 vaccination currently ongoing. Coming in August, 2020. 2. WHO is supporting the ongoing CEOP implementation. 3.Country has completed first tranche of CCEOP and has started the 2nd tranche of CEOP. 4. States are at different stages of implementation of cIP (see attachment for details). 5. System re-design plan in 3 hubs in Lagos, Kano &amp; Abuja. So far approval was given for Lagos Hub. 6. WHO deployed an officer as Logistician who is providing technical support to NLWG.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Data Analysis reports on RISS, DHIS2

2) updated OIRIS implementation dashboards

3) RI-LQAS data reports</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Ensure that the Data Management Team of NERICC are technically guided to provide data management and analysis
2. Support the development and implementation of operational plans to meet objectives of the of the Data Quality Improvement Plans (DQIP)
3. Provide technical support in the review and analysis of RI Supportive Supervision, RI-LQAS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. 2 WHO officers are assigned to NERICC data team to provide technical guide in data management. One of the officers which is a data quality improvement plan officer also supports the development and implementation of DQIP. 2. NERICC has a DQIP which is being implemented but not closely monitored and so there is plan to incorportate the indicators onto NERICC dashboard. 3. The 2 WHO officers in Data Team supports NERICC to conduct monthly analysis of RI data from DHIS2 and SMS and also preparation of PAPA/LQAS preliminary finding/report from the analysis (WHO is the leading agency on PAPA/LQAS).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Ensure that the Data Management Team of NERICC are technically guided to provide data management and analysis
2. Support the development and implementation of operational plans to meet objectives of the of the Data Quality Improvement Plans (DQIP)
3. Provide technical support in the review and analysis of RI Supportive Supervision, RI-LQAS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. 2 WHO officers are assigned to NERICC data team to provide technical guide in data management. One of the officers which is a data quality improvement plan officer also supports the development and implementation of DQIP. 2. NERICC has a DQIP which is being implemented but not closely monitored and so there is plan to incorportate the indicators onto NERICC dashboard. 3. The 2 WHO officers in Data Team supports NERICC to conduct monthly analysis of RI data from DHIS2 and SMS and also preparation of PAPA/LQAS preliminary finding/report from the analysis (WHO is the leading agency on PAPA/LQAS).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 80% of States with Penta3 coverage of 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support, coordination and partnership for the implementation of NSIPSS focusing on contributions to strategic technical decisions of the Technical Management Team of:
- NERICC (RED/OIRIS), 
- New Vaccine Introduction
- Accelerated Disease Control interventions, and 
- NGI TAG
- VPD surveillance, 
aiming at strengthening and improving routine immunisation and PHC

2. Support the coordination and conduct of JA and other partnership reviews">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Provided technical support in the development of concept note on the evaluation of OIRIS Strategies. 2. Provided technical support in strategic meetings at NPHCDA and NG_TAG where decisions were taken on new vaccines as COVID-19, IPV2, Rota vaccine and HPV. 3. Supported the cordination of Multi-Stakeholders Dialogue in November, 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support, coordination and partnership for the implementation of NSIPSS focusing on contributions to strategic technical decisions of the Technical Management Team of:
- NERICC (RED/OIRIS), 
- New Vaccine Introduction
- Accelerated Disease Control interventions, and 
- NGI TAG
- VPD surveillance, 
aiming at strengthening and improving routine immunisation and PHC

2. Support the coordination and conduct of JA and other partnership reviews">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Provided technical support in the development of concept note on the evaluation of OIRIS Strategies. 2. Provided technical support in strategic meetings at NPHCDA and NG_TAG where decisions were taken on new vaccines as COVID-19, IPV2, Rota vaccine and HPV. 3. Supported the cordination of Multi-Stakeholders Dialogue in November, 2020</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Operational manuals for IPV2, Rota, COVID-19 developed.
  2. Concept note for COVID-19 Impact Assemment.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Development of training and operational manuals for new vaccine introduction (IPV2, Rota, HPV). 
 2. Develop a protocol for the conduct COVID-19 vaccine introduction impact assessment. 
 3.Develop regular feedback on updates of VPD surveillance 
 4. Develop an integrated strategies for using SIAs to improve Routine Immunisation
 5. Monitor impact of vaccines introduced and scaled up (measles, yellow fever, meningitis etc)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported the development of IPV2 training manual which will soon be printed for training in July. Rota and HPV manuals are yet to be developed because the country had not received Gavi approval yet. 2. COVID-19 vaccine introduction is current ongoing and so it impact assessment is yet to be conducted, however the development of the impact assessment protocol will soon commenced. 3. A section on how to improve routine immunization using SIA has been incorporated into the SIA Guideline. 4. PIE for MCV2 and MenA introduction is yet to be carried out due to COVID-19 outbreaks and COVID-19 vaccine rollout. There is plan to have the evaluation before the year runs out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Guidelines for integrating RI in SIA interventions developed
 2. Protocol for COVID-19 impact assessment finalised</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Development of training and operational manuals for new vaccine introduction (IPV2, Rota, HPV). 
 2. Develop a protocol for the conduct COVID-19 vaccine introduction impact assessment. 
 3.Develop regular feedback on updates of VPD surveillance 
 4. Develop an integrated strategies for using SIAs to improve Routine Immunisation
 5. Monitor impact of vaccines introduced and scaled up (measles, yellow fever, meningitis etc)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Training manual for IPV2 introduction developed and used for training of health workers. Training materials for Rota and HPV are yet to be developed as Gavi has not given approval for introduction yet. 2. Month VPD Surveillance shared with government and partners. 3. Supported Polio EOC to develop protocol for routine immunization intensification during OBR and integration of RI and NPSIA activities such as yellow fever &amp; Men. A. Yet to develop protocol for COVID-19 vaccination Impact. This has been rolled over to 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recruitment completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">2021 TCA grant not received and recruitment not started.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Finance personnel from the 18 priorities are trained in HACT modality and fiduciary risk control</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Finance officer not recruited and activity not implemented. This has been reflected new milestone.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial management strategy developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Finance officer not recruited and activity not implemented.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NPHCDA and SPHCDA finance staff from 6 prioriy states trained in HACT modalities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Finance specialist is not recruited yet. This activity to be carried out the specialist.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Physical stock counting (PSC) exercise completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="10. Physical Stock Counting Exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Insourced physical stock counts was conducted at national, zonal, state level monthly from February to May. Following up with weekly stock data reported via ODK and comparison with physical stock done during the period. The outsourced nationwide one-off physical stock count was not conducted and now planning to reprogram the funding for the activity.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recruitment of TA to support 3 Hub operationalisation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Lagos hub construction contract has just been awarded and site yet to be clear. Abuja upgrade is at the level of design review finalization. Procurement process of of Large cold rooms started. As part of the operationalization the human resource requirement, workflows and system design assessment will be conducted in Q3 and 4</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Policy &amp; Regulatory Environment</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">4 r&#xE9;nions du GTCV organis&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour renforcer le secr&#xE9;tariat du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">4 reunions organis&#xE9;es dont 2 en 2020 et 2 en 2021 ayant permis &#xE0; emettre les avis sur l&apos;introduction des vaccins contre la COVID-19, nOPV2 et la deuxieme dose du VPI</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour renforcer le secr&#xE9;tariat du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">4 reunions organis&#xE9;es dont 2 en 2020 et 2 en 2021 ayant permis &#xE0; emettre les avis sur l&apos;introduction des vaccins contre la COVID-19, nOPV2 et la deuxieme dose du VPI</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) YF lab training scheduled
2) All states transitioned to SORMAS; post transition evaluations completed
3) National surveillance and OB investigation and response training for measles and YF completed
4) Draft guidelines and SOPs for measles RDT implementation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To reduce the number of outbreaks in the country, it is critical that surveillance and lab testing capacity is optimal. The US CDC will continue to support NCDC in the development of a national disease surveillance system, lab network, outbreak response plans, and diagnostic testing for measles, rubella and yellow fever to include: 1) Conduct lab training for the testing of measles, rubella, and yellow fever 2) Finalize surveillance and outbreak response guidance 3) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever, 4) Support implementation of SORMAS surveillance system 5) Support outbreak investigations with NCDC staff by training state and local level staff 6) Introduce measles rapid diagnostic testing">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Activities are either completed or delayed due to travel restrictions related to COVID19 and will be implemented once the restrictions are lifted. (1) The lab training for the testing of MRYF will be conducted next year, 2022. (2) Surveillance and outbreak response guidance is developed (3) Curriculum development is ongoing. (4) The system for the SORMAS surveillance is ongoing, a few more states are yet to implement (5) The outbreak investigation materials have been developed andimplementation will be done in line with government plans. (6) Measles rapid diagnostic testing not yet introduced as we await supplies.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Finalize and distribute surveillance and outbreak response guidance 
2) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever
3) Support VPD data transition to SORMASacross all states, with at least one quarterly review completed
4) Draft SOPs for measles and YF outbreak investigation and response</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="To reduce the number of outbreaks in the country, it is critical that surveillance and lab testing capacity is optimal. The US CDC will continue to support NCDC in the development of a national disease surveillance system, lab network, outbreak response plans, and diagnostic testing for measles, rubella and yellow fever to include: 1) Conduct lab training for the testing of measles, rubella, and yellow fever 2) Finalize surveillance and outbreak response guidance 3) Develop curriculum and support national and subnational surveillance and outbreak response training for measles and yellow fever, 4) Support implementation of SORMAS surveillance system 5) Support outbreak investigations with NCDC staff by training state and local level staff 6) Introduce measles rapid diagnostic testing">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;1) Surveillance and OBR guidance are pending final review/approval by the Director General of the Nigeria Centres for Disease Control; will be distributed once received.
2) Development of curiculum and training for MR and YF surveillance and outbreak response is delayed, pending final approval of the guidance, and will be developed/conducted as soon as possible once the guidance is approved.
3) Training for SORMAS VPD data transmission has been completed, following a minor delay. Temporary staff selected to support the transition are in place: one at each LGA (774) and two at each of teh six regional labs (12). Transition activities are ongoing and on track. The first quarterly review is not yet due, but is on track to be conducted.
4) SOPs for MR and YF investigation and response are in early draft form, following minor Covid-related delays. Work on this activity is ongoing.&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evidence based CE sustainability framework developed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Assess, revitalize and document implementation of community engagement strategy in 8 priority States. 2. Develop CE sustainability framework and mechanism, outlining key strategies for integration to inform CE roll out in targeted States.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Community engagement activities revitalized in 6 implementation States and lessons learned documented to inform CE roll out in remaining targeted States. 
2. Community engagement registers for community mobilizers and LGA Heads harmonised among other key primary health care activities and incorporated for operationalization in targeted States.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Tools and guidance for generating social and behavioural data adapted and developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support on appropriate use of communication approaches for social development, aimed at individual, community behaviour change, collective action and policy advice. 2. Support review and development of tools for generating social and behavioral data to guide appropriate communication approaches.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Community engagement strategy and plan for priority States developed and preparatory activities for roll out conducted. 2. Rapid information needs assessment tools developed and utilized to generate evidence to tailor communication activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% increase in awareness of immunization through community based channels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program, SIAs and new vaccine introduction. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach adopted to strengthen demand of routine immunization, SIAs and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Detailed social and behavior communication plans developed in 37 States for specific interventions on RI, SIAs and COVID-19 vaccine introduction. 
2. Three Communication Task Groups (SIAs, RI, and COVID-19 vaccine introduction) coordinated regularly at National level to support stakeholder-centric approaches on demand generation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach to strengthen demand of routine immunization, and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Detailed social and behaviour communication plans developed for specific interventions across the 37 States al different levels of implementation for RI, SIAs and COVID-19 vaccine introduction. 2. Communication task groups for SIAs, RI, and COVID-19 vaccine introduction coordinated regularly to support stakeholder-centric approaches on demand generation.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program. 2. Support coordination of communication task groups for inclusive and consultative stakeholder-centric approach to strengthen demand of routine immunization, and new vaccines.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Provide technical support and guidance in the formulation and management of programme communication strategies and plans of action for social and behavioural change in support of routine immunization program.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Line listing used for action</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical support provided on Community engagement strategy and reporting in priority 6 implementing States. 2. Technical support provided on CE quality data reporting, to inform linelisting and defaulter tracking activities.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. TA to support Community engagement strategy and conduct line-listing of newborns and eligible children in every settlement">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="4. TA to support Community engagement strategy and conduct line-listing of newborns and eligible children in every settlement">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Communication plan of action developed and utilized to guide implementation of demand generation activities. Regular ACSM TWG meetings coordinated for inclusive decision making.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health worker BCC strategy rolled out at subnational levels.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support to planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers at various implementation levels e.g, IPCI. 2. Provide technical support in development and design of health worker BCC package and toolkit to guide communication interventions with caregivers..">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical support provided on conceptualization and operationalization of human centered approaches to reach zero dose communities in targeted 12 States. 2. Technical support provided on interpersonl communication for health workers at different levels of implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integrated communication packages for resouces persons developed and adapted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical support provided to CHIPS activities, including harmonising CHIPS registers to incorporate key activities on routine immunization. 2. Key messages for community resource persons such as town announces developed and key messages on AEFI for use by frontline workers on IPC developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">22 DS ont r&#xE9;alis&#xE9; des Assemblees Villageoises de leurs CSI avec liste nominative enterinee par la chefferie traditionnelle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">10 DS (Madaoua, Boboye, Tahoua, Bouza, Takeita, N?Gourti, Aderbissanat, Abala, T&#xE9;ra, Dungass) ont r&#xE9;alis&#xE9; des Assembl&#xE9;es Villageoises de leurs CSI.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Nombre de Plateformes, d&apos;OSC et de Radios Communautaires suivies et encadrees</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les Organisations de la Societe Civile ainsi que les Radios Communautaires dans la qualite des interventions au profit des communautes, en vaccination (Categorie 5 - Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">3 r&#xE9;seaux de radios Communautaires (Radcom, RedaCom et Groupe Hirondelle) briefes sur la vaccination de routine et la communication lors des campagnes</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les Organisations de la Societe Civile ainsi que les Radios Communautaires dans la qualite des interventions au profit des communautes, en vaccination (Categorie 5 - Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">3 r&#xE9;seaux de radios Communautaires (Radcom, RedaCom et Groupe Hirondelle) briefes sur la vaccination de routine et la communication lors des campagnes</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rota vaccine introduced</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7. Communication support in the  implementation SIAs (Men A, Measles and Yellow Fever campaigns and New Vaccines Introduction (MCV2) in the northern states and rota vaccine introduction nationwide.  Supports disease outbreak response and supervision of  state-level community engagement for Routine Immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">?	NPSIA communication activities for campaigns conducted and MCV 2 introduction in Northern States done in targeted period.
?	Rota vaccine introduction postponed by the Country.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="7. Communication support in the  implementation SIAs (Men A, Measles and Yellow Fever campaigns and New Vaccines Introduction (MCV2) in the northern states and rota vaccine introduction nationwide.  Supports disease outbreak response and supervision of  state-level community engagement for Routine Immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">?	NPSIA communication activities for campaigns conducted and MCV 2 introduction in Northern States done in targeted period.
?	Rota vaccine introduction postponed by the Country.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le plan strat&#xE9;gique de communication 2017-2021 est r&#xE9;vis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le developpement de la Demande de la vaccination dans l&apos;encadrement du niveau central et d&#xE9;centralis&#xE9;, dans le developpement et la mise en oeuvre des directives et procedures en communication pour la vaccination">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Atelier d&apos;evaluation de la mise en oeuvre de la Strategie de Communication pour la vaccination realisee, avec points d&apos;orientation pour la Revue Externe du PEV avant developpement du PPAc prochain et la nouvelle Strategie de Communication pour la Vaccination</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">CE Strategy rolled out in priority States.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Community engagement activities revitalized in 6 implementation States and lessons learned documented to inform CE roll out in remaining targeted States. 
2. Community engagement registers for community mobilizers and LGA Heads harmonized among other key primary health care activities and incorporated for operationalization in targeted States.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Support CE Strategy and plan, M&amp;E activities roll out and establishment of CE structures in targeted States. 2. Support quality CE Data collation, M&amp;E and reporting in implementation States.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">CE roll out in 4 States postponed to September 2021. Current CE roll out activities being conducted in Zamfara State</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">11 DS ont r&#xE9;alis&#xE9; des Assembl&#xE9;es Villageoises de leurs CSI avec liste nominative enterinee par la chefferie traditionnelle</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">11 DS (Birni Konni ; Maradi Ville, Niamey 5, Tahoua Commune, Madarounfa, Dosso, Abalak, Goure, Malbaza, Tessaoua, G. Roumdji) ont r&#xE9;alis&#xE9; des Assembl&#xE9;es Villageoises de leurs CSI.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer 33 Districts Sanitaires &#xE0; organiser les Assembl&#xE9;s Villageoises pour le renouvellement des COSAN">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Cartographie des Assemblees Villageoises attendue de la DOS par la DI, pour les CSI a couvrir</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical support on integrated community based interventions provided in implementing States.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical support provided to CHIPS activities, including harmonizing CHIPS registers to incorporate key activities on routine immunization. 2. Key messages for community resource persons such as town announces developed and key messages on AEFI for use by frontline workers on IPC developed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to implementation of an integrated CHIPS program, social mobilization and monitoring in implementing States. 2. Support the development and design of integrated communication packages for community resource persons and frontline health workers.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Demand generation Data Collection Tools for use by community resource persons integrated with CHIPS components. Community resource persons still to be trained and aligned on integration for use. Capacity building of community resource persons dependent on CE roll out in 4 targeted States.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Lessons learned on CE implementation in current States implementing CE documented.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Assess, revitalize and document implementation of community engagement strategy in 8 priority States. 2. Develop CE sustainability framework and mechanism, outlining key strategies for integration to inform CE roll out in targeted States.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Documentation of lessons learned on implementation of CE activities in 6 States conducted, and findings utilized to inform roll out of CE in Zamfara and remaining States where roll out is still to be done</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les acteurs impliques dans la vaccination sont formes sur les risques de communication et d&apos;appropriation communautaire et utilise les outils developes.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI, les DRSP et les DS pour assurer un engagement communautaire efficace  (Categorie 5 -Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Formation r&#xE9;alis&#xE9;e pour l?ensemble des Communicateurs de District sur la communication de Risque. A former aussi&#xA0;: les autres membres de l?ECD/District</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI, les DRSP et les DS pour assurer un engagement communautaire efficace  (Categorie 5 -Classification activites JSP)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Formation r&#xE9;alis&#xE9;e pour l?ensemble des Communicateurs de District sur la communication de Risque. A former aussi&#xA0;: les autres membres de l?ECD/District</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Health worker BCC strategy, costed implementation plan and M,E, and reporting plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support to planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers at various implementation levels e.g, IPCI. 2. Provide technical support in development and design of health worker BCC package and toolkit to guide communication interventions with caregivers..">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Health workers capacitated on demand generation key strategies to improve IPCI with scenarios incorporated in training materials. Training materials on demand generation to RIOs developed and refresher training conducted. HCD approaches conceptualized for operationalization. Health worker BCC toolkit still to be developed and designed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La formation des 3 pools a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux 3 pools de formation des OSC sur les Directives du PEV, la Recherche des perdus de vue et l&apos;engagement communautaire dans 33 Districts Sanitaires Prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La formation des 3 pools a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e. 6 OSC (2 OSC par DS) ont &#xE9;t&#xE9; capacit&#xE9;s sur la promotion de la vaccination en vue de mener les activit&#xE9;s de plaidoyer, d&apos;information, de sensibilisation, de recherche des enfants perdus de vue et de mobilisation communautaire pour un changement de comportement social sur la promotion du Renforcement du Syst&#xE8;me de Sant&#xE9; et la vaccination dans les 33 DS prioritaires. En plus, une journ&#xE9;e d?information sur la promotion de la vaccination &#xE0; l?endroit des leaders a &#xE9;t&#xE9; organis&#xE9;e au niveau de 31/33 districts &#xE0; l&apos;exception de deux(2) districts (Tillia et Ngourti) pour raison d?ins&#xE9;curit&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des agents communautaires menent des activit&#xE9;s de suivi communautaire des enfants de 0-23 mois et de d&#xE9;claration des naissances dans les 33 districts sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la mise en place des registres communautaires pour le suivi communautaire de la vaccination et autres activit&#xE9;s de sant&#xE9; ainsi que la d&#xE9;claration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les registres communautaires int&#xE9;grant les activit&#xE9;s de vaccination, de nutrition, d&apos;enregistrement des naissances et de prise en charge de la diarrh&#xE9;e ont &#xE9;t&#xE9; valid&#xE9;s avec la participation des toutes les parties prenantes (Direction des Immunisations, Direction de la Sant&#xE9; Communautaire, Direction des Statistiques, de l&apos; Etat Civil, de la Nutrition). les registres communautaires sont en cours de reproduction. 82 formateurs du Ministres de la sant&#xE9;, des r&#xE9;gions et des districts ont &#xE9;t&#xE9; form&#xE9;s sur le registre communautaire. Par ailleurs le module registre communautaire a &#xE9;t&#xE9; int&#xE9;gr&#xE9; dans le paquet complet du relais par la Direction de la Sant&#xE9; Communautaire. Une formation des relais a &#xE9;t&#xE9; organis&#xE9;e dans les districts sanitaires pilotes de Malbaza et de Niamey 4. Aussi, une digitalisation &#xE0; travers le Kobo collect est en cours &#xE0; Niamey 4.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des agents communautaires sont form&#xE9;s sur le suivi communautaire de la vaccination des enfants de 0-23 mois et pour la d&#xE9;claration des naissances &#xE0; travers des registres communautaires dans les 33 districts prioritaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la mise en place des registres communautaires pour le suivi communautaire de la vaccination et autres activit&#xE9;s de sant&#xE9; ainsi que la d&#xE9;claration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les registres communautaires sont disponibles pour les deux districts pilotes de Boboze et Malbaza avec financement UNICEF, la reproduction pour les 31 autres districts et la formation des acteurs (superviseurs, ECD , Chefs CSI) sont programm&#xE9;es sur financement RSS3</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evidence based communication plans in priority states developed and adapted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support on appropriate use of communication approaches for social development, aimed at individual, community behaviour change, collective action and policy advice. 2. Support review and development of tools for generating social and behavioral data to guide appropriate communication approaches.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Review of CSO mapping tools in progress. Immunization IEC materials such as flipcharts and rapid assessment tools reviewed and updated</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Modules de formation pour les OSC disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux 3 pools de formation des OSC sur les Directives du PEV, la Recherche des perdus de vue et l&apos;engagement communautaire dans 33 Districts Sanitaires Prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Districts ayant des regroupements des OSC identifies
Modules de formation des OSC sur la promotion de la vaccination realises
Planification des formations des OSC faites avec le ROASEN sur les 33 DS prioritaires&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La revue du PEV volet communication est finalis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer le developpement de la Demande de la vaccination dans l&apos;encadrement du niveau central et d&#xE9;centralis&#xE9;, dans le developpement et la mise en oeuvre des directives et procedures en communication pour la vaccination">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Rapport pour la revue du PEV 2021 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation de la revue externe du PEV en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Cette activit&#xE9; est reprogramm&#xE9;e pour le premier semestre 2022, compte tenu de la priorisation de la vaccination contre la COVID-19 et des activit&#xE9;s de riposte aux autres &#xE9;pid&#xE9;mies survenues dans le pays au cours de cette ann&#xE9;e (cVDPV2, rougeole, chol&#xE9;ra).
Aussi, le pays a souhait&#xE9; que la revue externe puisse prendre en compte les performances de l&apos;ann&#xE9;e 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un dashboard pour le monitoring et &#xE9;valuation des activit&#xE9;s de vaccination &#xE9;labor&#xE9; et diffus&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en place d&apos;un syst&#xE8;me de monitoring des activit&#xE9;s de vaccination des populations sp&#xE9;cifiques et des enfants zero doses et insuffisement vaccin&#xE9;s dans les 14 districts prioritaires des 04 regions (Agadez, Dosso, Tillabery et Zinder)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Draft du monitoring des activit&#xE9;s de vaccination est en cours de finalisation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 50% des activit&#xE9;s prevues dans le PAA du PEV et microplans des districts sont r&#xE9;alis&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre, le suivi et l&apos;&#xE9;valuation des plans programmatiques du PEV y compris l&apos;appui &#xE0; l&apos;organisation de deux revues (&#xE0; mi parcours et annuellle) du PAA du PEV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La revue &#xE0; mi-parcours du PAA PEV a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e en Juillet 2021, et une proportion de 45% (20/45) d&apos;activit&#xE9;s avait &#xE9;t&#xE9; r&#xE9;alis&#xE9;es. 
Les TDRs, le budget et l&apos;agenda de la revue annuelle ont &#xE9;t&#xE9; &#xE9;labor&#xE9;s; le m&#xE9;mo et la note conceptuelle approuv&#xE9;s par l&apos;OMS, et les fonds mis &#xE0; disposition du Minist&#xE8;re de Ia Sant&#xE9; pour la mise en oeuvre pr&#xE9;vue du 13 au 16 D&#xE9;cembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des activit&#xE9;s mises en ?uvre et renseign&#xE9;es &#xE0; travers le dashboard</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en place d&apos;un syst&#xE8;me de monitoring des activit&#xE9;s de vaccination des populations sp&#xE9;cifiques et des enfants zero doses et insuffisement vaccin&#xE9;s dans les 14 districts prioritaires des 04 regions (Agadez, Dosso, Tillabery et Zinder)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le Dashboard a &#xE9;t&#xE9; &#xE9;labor&#xE9; sous la forme d&apos;un outil de monitoring des donn&#xE9;es d&apos;identification des ZD et EIV, mais aussi des r&#xE9;sultats issus de la mise en ?uvre des activit&#xE9;s de rattrapage de ces enfants. 
Cet outil a &#xE9;t&#xE9; utilisa par toutes r&#xE9;gions pour faciliter le reporting des r&#xE9;sultats issus de la mise en oeuvre des activit&#xE9;s planifi&#xE9;es apr&#xE8;s l&apos;exercice de cartographie des ZD et EIV fait en Septembre 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">TDRs et la note conceptuelle des revues PAA sont disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre, le suivi et l&apos;&#xE9;valuation des plans programmatiques du PEV y compris l&apos;appui &#xE0; l&apos;organisation de deux revues (&#xE0; mi parcours et annuellle) du PAA du PEV">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">TDRs disponibles, premiere revue &#xE0; mi-parcours prevue du 6-9 Juillet 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recrutement des consultants (international et national) pour appuyer la revue externe du PEV finalis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation de la revue externe du PEV en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; and generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and stregthen case-based surveillance for VPD program monitoring, early detection of meningitis epidemics and equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens by PCR and culture, and reinforce quality assurance programs to ensure laboratory proficiency for the molecular detection at the national level, and bacterial culture proficiency subnationally; 2) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2) to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Despite the ongoing COVID-19 pandemic, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Niger as a strategic country at high risk for meningitis disease and epidemics. Significant progress has been made to standardize meningococcal case investigation, confirmation, and data management in Niger. Thus far in 2021, surveillance system health was monitored, and technical assistance provided remotely through five monthly MenAfriNet Surveillance and Data Management Working Group teleconferences. During the 2021 epidemic season, Niger shared meningitis surveillance data weekly to inform epidemic situation monitoring and epidemic response. Between January-June, Niger had 5 districts in alert, two epidemics, with meningococcus C as the dominant serogroup. With successful application to WHO ICG for meningococcal vaccine, we completed two reactive campaigns with menC conjugate vaccine (Menactra). Niger expanded case-based surveillance nationally in 2020, but struggled to collect case-based data from new districts. To improve the timeliness of case-based surveillance data, STELab 2.0 multi-disease data management and specimen tracking system completed a successful pilot in 5 districts in December 2020, and will be rolled out nationally in Q3 2021. STELab 2.0 is an integrated multi-disease system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. The ongoing COVID-19 response has necessitated prioritization of field activities at the country level. Field validation of case-based meningitis surveillance data had to be postponed until Q3 2021 and will be completed concurrently with STELab rollout; validated data will be analyzed and Summary MenAfriNet Surveillance Reports will be published next quarter. In July 2021, Niger will participate in a regional MenAfriNet data analysis training using the R package in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Assessment of materials conducted and tools adapted as needed for in-country needs. Materials included in planning for phased MCV2 introduction.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging findings from a targeted EPI program assessment in 3 states planned for January 2019, we will provide technical support for the planned introduction of MCV2 in Nigeria in 2019. This will include operations research to identify and mitigate barriers to uptake of second year of life (2YL) services (e.g. MCV2), and recording/reporting of vaccines doses delivered in 2YL; development and roll-out of training materials for 2YL, with emphasis on use of MCV2 as an opportunity to catch-up children on vaccinations that were missed during the first year of life; communications messaging to increase awareness and demand for MCV2">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The MCV2 introduction is complete with a supported roll out, uptake and supervision. The 2YL OR will now be used to support catch up vaccination uptake, including new vaccine introductions that include catch up activities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">? Harmonized HSS workplan developed ? Quarterly report on implementation status of NERICC workplan developed and shared with Gavi ? Joint Appraisal Review successfully conducted ? High-level review of Accountability Framework results conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="? Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM ? Provide critical technical support (as may be required) on all Gavi-funded interventions ? Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS ? Monitor and track progress on the accountability framework ? Provide support to the NVSTT in the development of requisite documents for new vaccines introductions ? Support the NPSIA team in the development and submission of required documents for planned campaigns ? Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM ? Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required ? Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks ? Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings ? Report proceedings of PMT meetings to GAVI ? Ensure proper storage and management of CCEOP documents and data ? Support development and timely submission of relevant data and documents from PMT to Gavi as may be required ? Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks ? Support the PMT to identify sites ready for CCE installation ? Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions ? Monitor and report the progress of Key performance indicators ? Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors ? Work with the PMT to ensure commitments from the states to the project ? Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE ? Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE ? Support PMT to monitor and track CCE distribution, installation and commissioning ? Lead the development of templates for tracking various Key performance indicators ? Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Detailed progress description contained in attached report</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Harmonized HSS workplan developed
?	Quarterly report on implementation status of NERICC workplan developed and shared with Gavi
?	Joint Appraisal Review successfully conducted
?	High-level review of Accountability Framework results conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM 
?	Provide critical technical support (as may be required) on all Gavi-funded interventions 
?	Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS 
?	Monitor and track progress on the accountability framework 
?	Provide support to the NVSTT in the development of requisite documents for new vaccines introductions 
?	Support the NPSIA team in the development and submission of required documents for planned campaigns 
?	Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM 
?	Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required 
?	Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks
?	Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings
?	Report proceedings of PMT meetings to GAVI 
?	Ensure proper storage and management of CCEOP documents and data 
?	Support development and timely submission of relevant data and documents from PMT to Gavi as may be required 
?	Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks
?	Support the PMT to identify sites ready for CCE installation
?	Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions 
?	Monitor and report the progress of Key performance indicators
?	Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors 
?	Work with the PMT to ensure commitments from the states to the project 
?	Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE
?	Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE
?	Support PMT to monitor and track CCE distribution, installation and commissioning   
?	Lead the development of templates for tracking various Key performance indicators  
?	Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Detailed progress description contained in attached report</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Work closely with the Gavi SCM, the office of the ED, NPHCDA and other directors and staff of the NPHCDA to ensure timely delivery of any tasks, as guided by the SCM 
?	Provide critical technical support (as may be required) on all Gavi-funded interventions 
?	Support the development and costing of annual/quarterly operational plans in line with the HSS proposal and NSIPSS 
?	Monitor and track progress on the accountability framework 
?	Provide support to the NVSTT in the development of requisite documents for new vaccines introductions 
?	Support the NPSIA team in the development and submission of required documents for planned campaigns 
?	Support implementation of key NERICC and National Logistics Working Group (NLWG) priority activities, as approved by the SCM 
?	Support development and timely submission of relevant data and documents from NPHCDA to Gavi as may be required 
?	Monthly reporting to Gavi and proactive reporting on specific issues and/or identified risks
?	Ensure proper facilitation of PMT meetings and follow-up on action points and decisions made during the meetings
?	Report proceedings of PMT meetings to GAVI 
?	Ensure proper storage and management of CCEOP documents and data 
?	Support development and timely submission of relevant data and documents from PMT to Gavi as may be required 
?	Monthly review of PMT workplan and proactive reporting on specific issues and/or identified risks
?	Support the PMT to identify sites ready for CCE installation
?	Support the PMT to monitor custom clearances of CCE and map bottlenecks for interventions 
?	Monitor and report the progress of Key performance indicators
?	Provide critical technical assistance to the PMT to develop the CCE deployment plan and facilitate the submission of operational deployment plan to UNICEF SD and vendors 
?	Work with the PMT to ensure commitments from the states to the project 
?	Develop stickers and support the PMT to brand CCE with stickers and allocation of serial numbers to CCE
?	Collaborate with CCE distribution vendors to facilitate a training workshop for Zonal and State cold chain officers and technicians on the maintenance of CCE
?	Support PMT to monitor and track CCE distribution, installation and commissioning   
?	Lead the development of templates for tracking various Key performance indicators  
?	Track and report the activities of the SLWG/SPMTs in accordance with the state ToRs">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Harmonized workplan developed but not yet approved due to ongoing discussions on Nigerian zero-dose strategy. Minor delays also observed across many other activities due to less focus on RI work, resulting from all the teams being pulled into COVID-19 vaccination roll-out support. A report of support provided for the past months is attached.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Financial reports of utilization of Gavi funds across Gavi-supported programmes, including state budget, submitted every quarter (or as required)
?	Report on execution of activities and funds including the absorption rate per budget item
?	Request for reprogramming or reallocation submitted to Gavi in a timely manner
?	Timely submission of request for funding to WHO and UNICEF
?	Harmonization of HSS and NERICC workplans conducted 
?	Required budgets for NERICC, NLWG, Non-Polio SIAs and other programmes developed, agreed with WHO and UNICEF finance teams and submitted on time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Proactively monitor the execution of activities and utilization of Gavi funds by the RI and SIA teams, for NPHCDA and partners and provide weekly reports to the Gavi SCM and NPHCDA leadership
?	Support NERICC and other teams (where necessary) in the development of appropriate workplans and budgets for Gavi-funded activities
?	Track utilization of Gavi funds for the intended purposes and flag any potential issues related to execution of Gavi funds to Gavi teams.
?	Provide strategic efforts towards harmonisation, integration, when feasible, and ensure complementarities across the multiple programmes and/or projects funded by Gavi and by other partners.
?	Support identification and implementation of synergistic approaches that will deliver maximum impact and value for money in the roll-out of health system strengthening plans
?	Strengthen cross-communication and collaboration among Gavi-funded organizations (WHO, UNICEF, US-CDC, etc)
?	Provide systematic support in optimization of planned activities to eliminate/minimize wastage of resources
?	Proactively flag any delays in implementation or release of funds and provide options to address the bottlenecks and improve the absorption of funds.
?	Support NERICC and the NPSIA teams to report on execution of activities, Gavi grants and fund utilization and absorption to the Core Group, the Inter Agency Coordinating Committee (ICC) and the Gavi Secretariat.
?	Support the development of state-specific plans for improving RI and PHC, in line with the NSIPSS as well as support states to develop LGA-specific plans to improve RI and PHCMonthly reporting to Gavi and proactive reporting on specific issues and/or identified risks">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The team continues to provide critical financial management support to NPHCDA EPI team around budget developments, tracking, reporting, etc and ensuring alignment with Gavi requirements. Details of supported activities from March-June 2021 are as provided in the attached report.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">- Assessment of EOCs conducted (1st step towards standardization)
- Findings and recommendations on how to ensure the EOCs are leveraged for health system strengthening (SERICC, SEMCHIC, etc) presented to the Core Group and NCDC</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the design and implementation of an approach to promote the integration and optimal functionality of Polio EOCs and Public EOCs to support SERICCs, SEMCHICs and other PHC operations across states
- Define standards for PH EOC
- Assess all EOCs including polio EOCs for standardization
- Support harmonization and integration of all PH and polio EOCs
- Support standardization of all PH EOCs across Nigeria
- Design framework for integrated functionality of EOCs, SERICC, SEMCHIC and other PHC operations in the state">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Due to the recent change in leadership of the Natioanl Centre for Disease Control (NCDC), the incoming leadership and team have been settling in and have not been able to make out sufficient time to engage on this project. We however expect things to speed significantly by January 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#NAME?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the design and implementation of an approach to promote the integration and optimal functionality of Polio EOCs and Public EOCs to support SERICCs, SEMCHICs and other PHC operations across states
- Define standards for PH EOC
- Assess all EOCs including polio EOCs for standardization
- Support harmonization and integration of all PH and polio EOCs
- Support standardization of all PH EOCs across Nigeria
- Design framework for integrated functionality of EOCs, SERICC, SEMCHIC and other PHC operations in the state">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Some progress has been made for this milestone. A draft approach has been developed and being socialized with the NPHCDA and NCDC focal points for Polio EOC transition and Public Health EOC work respectively</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Funds released for Q3 &amp; Q4 2021 Vaccines procurement 
?	All planned immunisation funding sensitization workshops for National Assembly, MOPB and MoF completed.
?	Adequate budgetary allocation for vaccines in the approved 2022 FGoN budget
?	All high-level meetings /events for the 2022 Gavi High Level visit confirmed
?	Annual review of 2021 vaccines and device forecast</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the implementation of the financial commitment as laid out in the transition plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">For the period June 2021 ? November 2021, the Clinton Health Access Initiative (CHAI), under a GAVI-funded grant provided Technical Assistance (TA) at the National level to the Federal Government of Nigeria to support the implementation of the financial commitments outlined in the country?s financial commitment letter to GAVI. CHAI provided TA to the National Primary Healthcare Development Agency (NPHCDA), Ministry of Health (MoH), Ministry of Finance, Budget, and Planning (MoFBP), and the Budget Office of the Federation (BO) &amp; National Assembly (NASS).
During this period, CHAI worked with the NPHCDA, UNICEF and key stakeholders to conduct vaccines forecasting and budgeting for 2022 and determine projected requirements for 2022 - 2024. CHAI also facilitated the submission of vaccines funding requirements into the FGoN?s 2022 ? 2024 Medium Term Expenditure Framework by the MoFBP with expected government investment of about $269m for 2022 vaccines procurement. 
Additionally, to facilitate the timely release of funds for vaccines CHAI facilitated the following - 
-	The development and approval of a memo from NPHCDA to MoFBP requesting for the release of ?16.08bn ($40Mn) from the Service Wide Vote in the 2021 Budget for Q1/Q2 vaccines to ensure that the country meets its co-financing obligations.
-	The development and approval of a memo from NPHCDA to MoFBP requesting for the release of ?17.2bn (42Mn) from the Service Wide Vote in the 2021 Budget for Q3/Q4 vaccines to ensure that the country meets its co-financing obligations.
-	The development of the 2022 ? 2024 Vaccines Financing outlook and Monthly updated Vaccines Financing tracker to aid visibility and tracking of Vaccines Financing at the NPHCDA. The NPHCDA will incorporate components of the Vaccines Financing outlook document into the 2022 Vaccines Financing Plan.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Conducted training and mentoring of NPHCDA staff on vaccines and financial forecasting
?	2022 State-specific and national vaccines and devices forecast for 36 states + FCT with other health commodities concluded
?	2021 ? 2024 Vaccines Finance outlook documents developed
?	2022 vaccine procurement schedule submitted and reviewed with MoBP and MoF
?	Funds released for Q1 &amp; Q2 2021 vaccines 
?	First line charge preliminary analysis conducted, developed and disseminated advocacy tools</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical assistance for the implementation of the financial commitment as laid out in the transition plan">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Evidence driven
and efficiently
coordinated
campaigns and
introductions
2. Data collected,
collated, reviewed and triangulated
before, during and
after campaigns.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for
supplemental immunisation
activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for
supplemental immunisation
activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documentation of the final implementation results of the DRS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data Review System">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">In collaboration with the WHO, JSI contributed to a 4-day workshop from May 6 ? May 10 on data triangulation related to COVID-19 vaccination. JSI co-facilitated the analysis of data through providing TA. 
The workshop highlighted areas for a more systematic and routine process for data triangulation. Additionally, the MOH used data triangulation to inform the country&apos;s decision to send COVID-19 vaccines to Cote d&apos;Ivoire and to readjust the in-country strategy. 
JSI has transferred capacity to the MoH EPI team so that they are able to continue data triangulation efforts.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Data Review System">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">In collaboration with the WHO, JSI contributed to a 4-day workshop from May 6 ? May 10 on data triangulation related to COVID-19 vaccination. JSI co-facilitated the analysis of data through providing TA. 
The workshop highlighted areas for a more systematic and routine process for data triangulation. Additionally, the MOH used data triangulation to inform the country&apos;s decision to send COVID-19 vaccines to Cote d&apos;Ivoire and to readjust the in-country strategy. 
JSI has transferred capacity to the MoH EPI team so that they are able to continue data triangulation efforts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Identification of participants for logistics training</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Recruit, identify and advocate for the participation of at least 25 EPI agents in logistics training">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">JSI has prepared the TORs for the logistics trainings that will be led by Logivac (as has been done in previous years) and identified EPI agents to participate in the logistics training. JSI is working closely with EPI on setting a date for this training.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Supportive supervision visits conducted in one region</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">JSI participated in one supportive supervision visit in Maradi and Tahoua regions between September 16 and October 3, 2021, as part of the preparations for ultra-cold chain (UCC) equipment for the Pfizer vaccine.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data review team meetings conducted monthly</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the functionality of data review team at national level">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Official data review meetings are currently being conducted every three months, due to competing priorities related to COVID-19. However, WHO has requested for data review meetings to be on a monthly basis, and the country is shifting to monthly meetings. Additionally, data is reviewed by a smaller team on a regular basis, bi-weekly or monthly. Results of this small team analysis is shared at the quarterly meetings and will be incorporated into the monthly meetings.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Consistent weekly reporting of meningitis cases and testing of CSF obtained from participating districts; and generation of weekly meningitis surveillance bulletins/reports for MOH and key partners to monitor trends in meningitis disease and early detection of epidemics.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preperation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">COVID-19 has impacted public health programs in Nigeria and put direct international technical assistance on hold. However, CDC through leadership of MenAfriNet, continues to provide remote technical assistance through monthly regional and bilateral teleconferences during the 2021 meningitis epidemic season. In 2021, Nigeria participated in MenAfriNet Surveillance &amp; Data Management Work Group meetings, and shared meningitis surveillance data weekly to inform epidemic situation monitoring--between January-June 2021, Nigeria reported 127 cases, one LGA in Alert, but experienced no meningococcal epidemics. An evaluation of the national meningitis surveillance (SORMAS) variables was completed in Q4 2020 in support of WHO/country plans for implementation of a regional DHIS2 meningitis case based surveillance module which is planned for 2021-22. Nigeria attended The Annual Meeting of Meningitis Belt countries hosted virtually by Chad on 8-9 December 2020 and completed their epidemic preparedness plan as a part of side-meetings to the plenary meeting.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preperation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">COVID-19 has impacted public health programs in Nigeria and put direct international technical assistance on hold. However, CDC through leadership of MenAfriNet, continues to provide remote technical assistance through monthly regional and bilateral teleconferences during the 2021 meningitis epidemic season. In 2021, Nigeria participated in MenAfriNet Surveillance &amp; Data Management Work Group meetings, and shared meningitis surveillance data weekly to inform epidemic situation monitoring--between January-June 2021, Nigeria reported 127 cases, one LGA in Alert, but experienced no meningococcal epidemics. An evaluation of the national meningitis surveillance (SORMAS) variables was completed in Q4 2020 in support of WHO/country plans for implementation of a regional DHIS2 meningitis case based surveillance module which is planned for 2021-22. Nigeria attended The Annual Meeting of Meningitis Belt countries hosted virtually by Chad on 8-9 December 2020 and completed their epidemic preparedness plan as a part of side-meetings to the plenary meeting.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Despite the ongoing COVID-19 pandemic, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Niger as a strategic country at high risk for meningitis disease and epidemics. Significant progress has been made to standardize meningococcal case investigation, confirmation, and data management in Niger. Thus far in 2021, surveillance system health was monitored, and technical assistance provided remotely through five monthly MenAfriNet Surveillance and Data Management Working Group teleconferences. During the 2021 epidemic season, Niger shared meningitis surveillance data weekly to inform epidemic situation monitoring and epidemic response. Between January-June, Niger had 5 districts in alert, two epidemics, with meningococcus C as the dominant serogroup. With successful application to WHO ICG for meningococcal vaccine, we completed two reactive campaigns with menC conjugate vaccine (Menactra). Niger expanded case-based surveillance nationally in 2020, but struggled to collect case-based data from new districts. To improve the timeliness of case-based surveillance data, STELab 2.0 multi-disease data management and specimen tracking system completed a successful pilot in 5 districts in December 2020, and will be rolled out nationally in Q3 2021. STELab 2.0 is an integrated multi-disease system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. The ongoing COVID-19 response has necessitated prioritization of field activities at the country level, and field validation of case based meningitis surveillance data had to be postponed until Q3 2021 and will be completed concurrently with STELab rollout; validated data will be analyzed and Summary MenAfriNet Surveillance Reports will be published next quarter. In July 2021, Niger will participate in a regional MenAfriNet data analysis training using the R package in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring, early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Despite the ongoing COVID-19 pandemic, CDC through leadership of MenAfriNet, strengthened case-based surveillance in Niger as a strategic country at high risk for meningitis disease and epidemics. Significant progress has been made to standardize meningococcal case investigation, confirmation, and data management in Niger. Thus far in 2021, surveillance system health was monitored, and technical assistance provided remotely through five monthly MenAfriNet Surveillance and Data Management Working Group teleconferences. During the 2021 epidemic season, Niger shared meningitis surveillance data weekly to inform epidemic situation monitoring and epidemic response. Between January-June, Niger had 5 districts in alert, two epidemics, with meningococcus C as the dominant serogroup. With successful application to WHO ICG for meningococcal vaccine, we completed two reactive campaigns with menC conjugate vaccine (Menactra). Niger expanded case-based surveillance nationally in 2020, but struggled to collect case-based data from new districts. To improve the timeliness of case-based surveillance data, STELab 2.0 multi-disease data management and specimen tracking system completed a successful pilot in 5 districts in December 2020, and will be rolled out nationally in Q3 2021. STELab 2.0 is an integrated multi-disease system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. The ongoing COVID-19 response has necessitated prioritization of field activities at the country level, and field validation of case based meningitis surveillance data had to be postponed until Q3 2021 and will be completed concurrently with STELab rollout; validated data will be analyzed and Summary MenAfriNet Surveillance Reports will be published next quarter. In July 2021, Niger will participate in a regional MenAfriNet data analysis training using the R package in Burkina Faso.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of 2 national and &gt;4 regional labs on detection of bacterial meningitis using the latest effective technology; Implement in-country quality programs to ensure lab proficiency. Complete analysis &gt;90% of specimens collected between Jan-Aug 2020;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">In-country trainings on meningitis diagnosis using culture, gram stain and cytology, and specimen management were conducted for 17 laboratory technicians from regional and district laboratories. Specimen testing has been completed and supervisory visits will be conducted in Sept-Oct 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete training of national and 8 state referal labs on detection of bacterial meningitis using the latest effective technology; Implement in-country quality programs to ensure lab testing proficiency within the lab network; Complete analysis of &gt;90% of specimens collected between Jan-Aug 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Nigeria held a laboratory training workshop with 8 laboratories in high risk states (Gombe, Sokoto, Kebbi, Jigawa, Zamfara, Adamawa, Niger, and Katsina). Training courses included quality management systems, biosafety requirements, specimen handling, culture media preparations, and antimicrobial susceptiblity testing. Pre/post training test scores showed improvement for all participants. Supervisory visits have been planned for 9 states and completed for 6 states (Katsina, Taraba, Kebbi, Benue, Ondo and Rivers). The remaining 3 supervisory visits (Nasarawa, Osun and Abuja) are scheduled to occur in early July 2021 and a final report will be provided. Specimen testing completed. UPDATED REPORT FOR PEF TF 21.1.2 (Unable to update since already submitted): Supervisory visits have been planned for 9 states and completed for 6 states (Katsina, Taraba, Kebbi, Benue, Ondo and Rivers). The remaining 3 supervisory visits (Nasarawa, Osun and Abuja) are scheduled to occur in early July 2021 and a final report will be provided. Specimen testing has been completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Antimicrobial susceptibility testing of CSF specimens complete; whole genome sequencing of CSF specimens complete</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens has started and characterization will continue during the coming months.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens complete</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens has started and characterization will continue during the coming months.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens has started and characterization will continue during the coming months.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Strengthen and continue PCR-based serotyping for pneumococcus and bacterial meningitis surveillance into the established population based surveillance platform in Niger by 1) continuing to provide laboratory and epidemiologic technical assistance at CERMES; 2) building capacity for antimicrobial susceptibility testing; 3) familiarizing laboratorians with whole genome sequencing; 4) characterizing pneumococcal carriage serotypes circulating pre-PCV">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Serotyping of pneumococcal carriage specimens remains ongoing, with delays due to continued COVID-19 situation as a competing priority in-country.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits to at least 5 sites; Complete analysis &gt;90% of specimens collected in 2020</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. In-country trainings on meningitis diagnosis using culture, gram stain and cytology, and specimen management were conducted for 17 laboratory technicians from regional and district laboratories. Culture capacity was further reinforced in three regional laboratories. Supervisory visits are expected to complete by Dec 2021 as well as specimen testing and analysis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. In-country trainings on meningitis diagnosis using culture, gram stain and cytology, and specimen management were conducted for 17 laboratory technicians from regional and district laboratories. Culture capacity was further reinforced in three regional laboratories. Supervisory visits are expected to complete by Dec 2021 as well as specimen testing and analysis.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for VPD surveillance program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens; 2) reinforce quality control programs to ensure laboratory proficiency within the nation wide laboratory system; 3) Improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. Supervisory visits are expected to complete by December 2021, and specimen testing/analysis in country have been completed (&gt;90%).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete trainings on data management and analysis processes;Complete supervision visits at least 5 sites; Complete analysis &gt;90% of specimens collected in 2020.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. Nigeria held a laboratory training workshop with 8 laboratories in high risk states (Gombe, Sokoto, Kebbi, Jigawa, Zamfara, Adamawa, Niger, and Katsina). Training courses included quality management systems, biosafety requirements, specimen handling, culture media preparations, and antimicrobial susceptibility testing. Pre/post training test scores showed improvement for all participants. Supervisory visits are tentatively scheduled for June and a report will be provided following the visits. Nigeria is on track to complete the testing and analysis of specimens.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems, vaccine preventable diseases surveillance and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide technical support and trainings to strengthen the detection of bacterial meningitis pathogens for meningitis surveillance; 2) reinforce quality control programs and supervision visits to ensure laboratory proficiency within the national lab network; 3) improve lab data management, analysis, and reporting practices.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trainings on data management and analysis were completed in June 2020. Nigeria held a laboratory training workshop with 8 laboratories in high risk states (Gombe, Sokoto, Kebbi, Jigawa, Zamfara, Adamawa, Niger, and Katsina). Training courses included quality management systems, biosafety requirements, specimen handling, culture media preparations, and antimicrobial susceptibility testing. Pre/post training test scores showed improvement for all participants. Supervisory visits are tentatively scheduled for June and a report will be provided following the visits. Nigeria is on track to complete the testing and analysis of specimens.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% improvement in the proportion of LGAs having &gt;80% children appropriately immunized for age in NERRIC Focus states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">67 LGAs across in 11 NERICC States supported on RI intensification and integrated outreach services shows significant improvement in children appropriately immunized by age. January,2022 LQAS report will show % improvement on children appropriately immunized by age.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% improvement in the proportion of LGAs having  &gt;80% children appropriately immunized for age in NERRIC Focus states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Intended improvement couldn&apos;t be achieved because of Covid pandemic.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide day-to-day technical support to the NERICC and oversights to the sub national levels on routine immunization.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Intended improvement couldn&apos;t be achieved because of Covid pandemic.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">JSI participated in Project Management Team meetings</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Actively support all aspects of cold chain management and planning for the CCEOP">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">JSI is actively supporting all aspects of cold chain management, as part of the National Logistics Working Group (NLWG) which also serves as the PMT. Some of the cold chain decisions made during NLWG meetings include the selection of Haier HCD110 refrigerators and working with Haier to adjust the design due to an issue with manufacturing.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Plan for cold room mapping and transport monitoring developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the DI for temperature monitoring during transport and cold room mapping in national/regional levels">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Through another JSI project, M-RITE has procured LogTag devices according to WHO product specifications to expand and implement temperature mapping activities within the walk-in cold rooms (WICRs), as the current devices available in-country are no longer functioning. These devices were received in Niger on October 21, 2021. JSI expects to conduct temperature mapping within walk-in cold rooms in three of the regions of Niger in Q4 2021. The Terms of Reference (TORs) for national-level temperature mapping have been drafted, and JSI will be joined by one person from the Niger Ministry of Public Health (MoH)/Expanded Programme on Immunization (EPI) during this exercise. The temperature mapping exercise will start in Niamey &amp; Tillaberi, then Dosso in December 2021. 
Transport mapping is on-going through use of the Parsyl device. JSI introduced it to one region (Dosso) to use during transportation as well as in WICR for on-going monitoring. It has been well received by the regional immunization officer, as well as by national level supply chain managers who have access to the real-time data being collected.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 80% of the 18 low performing states receiving real time support and onsite supervision from National Teams
2. 60% of 19 medium to high perform states sensitised on OIRIS and NERICC approach</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support to the PM to Coordinate and Monitor Quality Implementation of OIRIS strategies 18 low performing and 19 medium and high performing states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. A WHO officer has been assigned as Deputy Program Manager (DPM) Operations and another WHO officer as Technical Assistant to the PM NERICC. 2. WHO provides lead through these two officers in the monitoring the quality of implementation of OIRIS strategy through the collation of field reports from national supervisors. 3. There is an ongoing effort to evaluate OIRIS strategies which is lead by the NERICC DPM Operations.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support to the PM to Coordinate and Monitor Quality Implementation of OIRIS strategies 18 low performing and 19 medium and high performing states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. A WHO officer has been assigned as Deputy Program Manager (DPM) Operations and another WHO officer as Technical Assistant to the PM NERICC. 2. WHO provides lead through these two officers in the monitoring the quality of implementation of OIRIS strategy through the collation of field reports from national supervisors. 3. There is an ongoing effort to evaluate OIRIS strategies which is lead by the NERICC DPM Operations.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) at least 80% of service delivery strategies implemented

3) NToT reports on capacity building</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to the Service Delivery Team in NERICC to guide the development and assessment of operational plans of states
2. Manage the conduct of RI-LQAS  dictated by NERICC and facilitating compilation of relevant reports
3. Support the implementation of training interventions to build the capacity of lower level staff on immunisation">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Provided technical suport to the service delivery working group of NERICC to support states to develop quality operational plan for 2021 through OIRIS visit to the states. 2. Provided technical support in the training of trainers and surveyors that conducted quarter 4, 2020 RI-LGAS/PAPA. 3. Provided technical support for the training of trainers and vaccination team for COVID-19 vaccine in quarter 2, 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support to the Service Delivery Team in NERICC to guide the development and assessment of operational plans of states
2. Manage the conduct of RI-LQAS  dictated by NERICC and facilitating compilation of relevant reports
3. Support the implementation of training interventions to build the capacity of lower level staff on immunisation">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Provided technical suport to the service delivery working group of NERICC to support states to develop quality operational plan for 2021 through OIRIS visit to the states. 2. Provided technical support in the training of trainers and surveyors that conducted quarter 4, 2020 RI-LGAS/PAPA. 3. Provided technical support for the training of trainers and vaccination team for COVID-19 vaccine in quarter 2, 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;activit&#xE9; est mise en oeuvre grace &#xE0; un appui de proximit&#xE9; &#xE0; travers les consultants recrut&#xE9;s &#xE0; ce sujet</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre les strat&#xE9;gies de vaccination en zones d&#xE9;sertiques et d&apos;ins&#xE9;curit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Agadez, Tillab&#xE9;ry, Zinder (Aderbissenat, Arlit, Ingall, Abala, Ayerou, T&#xE9;ra, Bankilar&#xE9;, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en oeuvre a demarr&#xE9; grace &#xE0; l&apos;appui de proximit&#xE9; des consultants OMS</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Agadez, Tillab&#xE9;ry, Zinder (Aderbissenat, Arlit, Ingall, Abala, Ayerou, T&#xE9;ra, Bankilar&#xE9;, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en oeuvre a demarr&#xE9; grace &#xE0; l&apos;appui de proximit&#xE9; des consultants OMS</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts urbains et semi-urbains identif&#xE9;s ont mis en eouvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre de la strat&#xE9;gie urbaine au niveau des r&#xE9;gions de Dosso et Zinder (3 districts urbains et semi urbains Magaria, Gaya, Dosso)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s mise en oeuvre dans tous les districts cibl&#xE9;s malgr&#xE9; la vaccination contre la COVID-19 en cours.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en oeuvre de la strat&#xE9;gie urbaine au niveau des r&#xE9;gions de Dosso et Zinder (3 districts urbains et semi urbains Magaria, Gaya, Dosso)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s mise en oeuvre dans tous les districts cibl&#xE9;s malgr&#xE9; la vaccination contre la COVID-19 en cours.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 3 districts ont mis en oeuvres la strategie de vaccination avec l&apos;elaboration de cartographie de population nomade en collaboration de l?equipe cadre du district et personnels des centres de sant&#xE9; int&#xE9;gr&#xE9;s, service de l?Elevage, agents du service du plan, de l?Environnement , les Chefs coutumiers, les Maires des zones concern&#xE9;es
Cette cartographie a permis par exemple dans le distrcit de Gour&#xE9; de d&#xE9;nombrer 11 centres de sant&#xE9; int&#xE9;gr&#xE9;s qui re&#xE7;oivent les populations nomades dans 77 localit&#xE9;s. Les distances qui s&#xE9;parent ces populations nomades aux centres de sant&#xE9; de rattachement varient de 2 &#xE0; 45 km reparties dans tous les sens. 
- 578 enfants ag&#xE9;s de 0-11 mois ont &#xE9;t&#xE9; estim&#xE9;s parmi les populations nomades,
60 personnes repr&#xE9;santant des leadres des populations nomades ont &#xE9;t&#xE9; identifi&#xE9;es avec leurs num&#xE9;ros de contact. Ces leaders serviront des interm&#xE9;diaires pour informer et regrouper les populations lors de passage du personnel de sant&#xE9; pour la vaccination des enfants cible du PEV;
- 7 puits pastoraux o&#xF9; les populations nomades se regroupent ont &#xE9;t&#xE9; recens&#xE9;s,
- 5 coulloirs de passage ont &#xE9;t&#xE9; recens&#xE9;s.
ce travail a permis la R&#xE9;alisation de 7307 sessions de vaccination en fixe en 2021 contre 5 201 en 2020 ,1359 en 2021 sorties en avanc&#xE9;e contre 1114 en 2020 et 451 en 2021 sorties en strat&#xE9;gie mobile en 2021 contre 334 en 2020.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Zinder et Dosso (Gour&#xE9;, Boboye et Takeita)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 3 districts ont mis en oeuvres la strategie de vaccination avec l&apos;elaboration de cartographie de population nomade en collaboration de l?equipe cadre du district et personnels des centres de sant&#xE9; int&#xE9;gr&#xE9;s, service de l?Elevage, agents du service du plan, de l?Environnement , les Chefs coutumiers, les Maires des zones concern&#xE9;es
Cette cartographie a permis par exemple dans le distrcit de Gour&#xE9; de d&#xE9;nombrer 11 centres de sant&#xE9; int&#xE9;gr&#xE9;s qui re&#xE7;oivent les populations nomades dans 77 localit&#xE9;s. Les distances qui s&#xE9;parent ces populations nomades aux centres de sant&#xE9; de rattachement varient de 2 &#xE0; 45 km reparties dans tous les sens. 
- 578 enfants ag&#xE9;s de 0-11 mois ont &#xE9;t&#xE9; estim&#xE9;s parmi les populations nomades,
60 personnes repr&#xE9;santant des leadres des populations nomades ont &#xE9;t&#xE9; identifi&#xE9;es avec leurs num&#xE9;ros de contact. Ces leaders serviront des interm&#xE9;diaires pour informer et regrouper les populations lors de passage du personnel de sant&#xE9; pour la vaccination des enfants cible du PEV;
- 7 puits pastoraux o&#xF9; les populations nomades se regroupent ont &#xE9;t&#xE9; recens&#xE9;s,
- 5 coulloirs de passage ont &#xE9;t&#xE9; recens&#xE9;s.
ce travail a permis la R&#xE9;alisation de 7307 sessions de vaccination en fixe en 2021 contre 5 201 en 2020 ,1359 en 2021 sorties en avanc&#xE9;e contre 1114 en 2020 et 451 en 2021 sorties en strat&#xE9;gie mobile en 2021 contre 334 en 2020.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 35% increase number of LGA 18 priority states , with accpetable LQAS results at &gt;80%
2. 80% of States with Penta3 coverage of 80%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide State specific Technical and Operational support for the management and coordination of SERICCs to improve RI peformance in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">WHO has a National Immunization Officer in each of these 8 Gavi focus states. They are deputy program managers and they support with management and coordination of SERICC activities that will improve routine immunization performance in the states.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide State specific Technical and Operational support for the management and coordination of SERICCs to improve RI peformance in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">WHO has a National Immunization Officer in each of these 8 Gavi focus states. They are deputy program managers and they support with management and coordination of SERICC activities that will improve routine immunization performance in the states.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts ont mis en ?uvre les activites de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; dans la mise en oeuvre des activites innovantes de vaccination dans les 19 districts sanitaires prioritaires de responsablit&#xE9; de l&apos;UNICEF couverts par les 4 bureaux de zone UNICEF">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre des activit&#xE9;s de vaccination. Les consultants d&#xE9;ploy&#xE9;s dans les 8 r&#xE9;gions couvrant les 19 districts apportent un appui technique continue dans l&apos;organisation des activit&#xE9;s de vaccination de routine et de masse. 11 districts sur les 19 h&#xE9;bergent plus de 5% des enfants z&#xE9;ro dose comparativement &#xE0; 9 districts . 
Globalement , on note une r&#xE9;gression de 20% du nombre d?enfants z&#xE9;ro doses en fin septembre 2021 comparativement &#xE0; la m&#xEA;me p&#xE9;riode de 2020. 74% des districts sanitaires ont connu une r&#xE9;gression du nombre d?enfants z&#xE9;ros doses comparativement &#xE0; 2020. Cette r&#xE9;gression varie de 7% &#xE0; Malbaza &#xE0; 100% &#xE0; Tahoua Commune. 
On note respectivement une r&#xE9;gression de 100% dans la zone d&#xE9;sertique 89% dans les zones nomades, 67% dans les zones d?ins&#xE9;curit&#xE9; et p&#xE9;ri-urbaines.
Aussi, l&apos;UNICEF apporte un financement compl&#xE9;mentaire dans la mise en ?uvre des activit&#xE9;s des vaccination ax&#xE9;es sur l?&#xE9;quit&#xE9; dans les districts de Dakoro, Abalak, N?Gourti, Main&#xE9; Soroa.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts ont &#xE9;labor&#xE9; des Plans d&apos;Action Annuel (PAA) prenant en compte les activites de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; dans la mise en oeuvre des activites innovantes de vaccination dans les 19 districts sanitaires prioritaires de responsablit&#xE9; de l&apos;UNICEF couverts par les 4 bureaux de zone UNICEF">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;appui technique a &#xE9;t&#xE9; apport&#xE9; aux 19 districts pour l&apos;&#xE9;laboration de leurs plans d&apos;action en s&apos;assurant que ces plans contiennent les activit&#xE9;s financ&#xE9;es par l&apos;UNICEF. Un appui technique et financier est apport&#xE9; ( stat&#xE9;gies avanc&#xE9;es , mobiles, supervision, reunion d&apos;evaluation des donn&#xE9;es au niveau DRSP, districts et CSI)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mission d&apos;appui de bureau r&#xE9;gional (WCARO) &#xE0; l&apos;examen du budget r&#xE9;alis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Soutenir l&apos;examen du budget annuel et pluriannuel d&apos;achat des vaccins, y compris, l&apos;&#xE9;laboration d&apos;un mod&#xE8;le de budg&#xE9;tisation normalis&#xE9;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les Termes de reference et le recrutement du consultant ont &#xE9;t&#xE9; finalis&#xE9;s avec l&apos;appui de WCARO et Supply Division. Le consultant a re&#xE7;u l&apos;offre pour commencer en debut Juillet 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mission d&apos;appui du bureau r&#xE9;gional (WCARO) &#xE0; la r&#xE9;vision de la cartographie r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la r&#xE9;vision de la cartographie du processus de budg&#xE9;tisation des achats de vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Mission d&apos;appui du bureau r&#xE9;gional (WCARO) &#xE0; la r&#xE9;vision de la cartographie financi&#xE8;re a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training/capacity-building activities to strengthen immunization costing/ planning/budgeting conducted. NPHCDA and SPHCDA finance staff from 4/8 Gavi priority states trained in HACT modalities.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started because the finance specialist not recruited.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">4/8 states started implementing Gavi accountability framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started because the finance specialist not recruited.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training materials developed, training plan prepared, and budget secured.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited and the capacity building activities not conducted.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Build the capacity of state finance officers on immunization costing, planning, udgeting in the 8 Gavi priority states.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited yet. This activity to be carried out by the specialist.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">States teams oriented on Gavi accountability framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started because the finance specialist not recruited.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalization of the Gavi accountability framework in 8 priority states">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited yet. This activity to be carried out by the specialist.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les ECD des 33 districts prioritaires ont benefici&#xE9; d&apos;une mise &#xE0; niveau sur l&apos;analyse des donn&#xE9;es et le monitorage pour action selon le modele de Tanahashi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">21 Equipes cadres de districts sur les 33 ont b&#xE9;n&#xE9;fici&#xE9; d&apos;une formation sur le monitorage des donn&#xE9;es pour action selon le mod&#xE8;le de Tanahashi. Le processus se poursuit pour la formation des 12 districts restants.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">10 cadres de la DI ont b&#xE9;n&#xE9;fici&#xE9; d&apos;une formation sur le monitorage pour action selon le mod&#xE8;le de Tanahashi</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Activit&#xE9; reprogramm&#xE9;e au 3e trimestre 2021</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique aux r&#xE9;gions et 33 districts prioritaires au monitorage mensuel des donn&#xE9;es pour action selon le modele de Tanahashi">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le processus se poursuit avec la Direction des Statistiques pour la formation des cadres de la DI</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts prioritaires et 8 r&#xE9;gions ont r&#xE9;alis&#xE9; le LQAS/DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Contribuer &#xE0; la mise en ?uvre du LQAS/DQS dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L?activit&#xE9; est pr&#xE9;vue en d&#xE9;cembre par la Direction des Immunisations. Les TDR sont en cours d?&#xE9;laboration</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Implementation/Coverage &amp; Equity</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The states are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? .OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility. and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? .OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility. and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility. and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="16. Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, conducting successful NPSIAs, and introducing new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility. and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts prioritaires  ont mis en ?uvre leur microplan PEV ACD/CEA et les paquets d&apos;intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 27  ECD des districts prioritaires (Region de Maradi, Zinder, Diffa, Agadez et Tahoua) dans l&apos;elaboration  des micro plans PEV sur la base du guide ACD/CEA et  dans la mise en ?uvre des paquets d&apos;intervention dans les 33 districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Deux ateliers de formation des 68 formateurs de districts sur l&apos;approche ACE/Equit&#xE9; ont eu lieu du 18 au 24 mai 2021 simultanement &#xE0; Maradi et Tillaberi. La prochaine &#xE9;tape est la tenue des ateliers au niveau des districts (la compilation des informations des districts dans l&apos;outil d&apos;analyse des goulots d&apos;&#xE9;tranglement est en cours avec pour deadline de transmission le 01 Juillet 2021).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 27  ECD des districts prioritaires (Region de Maradi, Zinder, Diffa, Agadez et Tahoua) dans l&apos;elaboration  des micro plans PEV sur la base du guide ACD/CEA et  dans la mise en ?uvre des paquets d&apos;intervention dans les 33 districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Deux ateliers de formation des 68 formateurs de districts sur l&apos;approche ACE/Equit&#xE9; ont eu lieu du 18 au 24 mai 2021 simultanement &#xE0; Maradi et Tillaberi. La prochaine &#xE9;tape est la tenue des ateliers au niveau des districts (la compilation des informations des districts dans l&apos;outil d&apos;analyse des goulots d&apos;&#xE9;tranglement est en cours avec pour deadline de transmission le 01 Juillet 2021).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro, Abalak, Bermo, Malbaza, Tessaoua, G. Roumdji, Madaoua, Tahoua, Bouza)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en ?uvre de la strat&#xE9;gie nomade est effective dans les 9 districts &#xE0; travers les strat&#xE9;gies avanc&#xE9;e et mobile. Ces districts ont r&#xE9;alis&#xE9; la cartographie des mouvements des nomades selon les p&#xE9;riodes de l?ann&#xE9;e et les &#xE9;venements socio-culturels. Les activit&#xE9;s de microplanification semestrielle pour l&apos;identification et l&apos;adressage de differents goulots sont en cours. Ces activit&#xE9;s ont &#xE9;t&#xE9; financ&#xE9;es par le Fond Commun RSS3 au 1er trimestre.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro, Abalak, Bermo, Malbaza, Tessaoua, G. Roumdji, Madaoua, Tahoua, Bouza)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en ?uvre de la strat&#xE9;gie nomade est effective dans les 9 districts &#xE0; travers les strat&#xE9;gies avanc&#xE9;e et mobile. Ces districts ont r&#xE9;alis&#xE9; la cartographie des mouvements des nomades selon les p&#xE9;riodes de l?ann&#xE9;e et les &#xE9;venements socio-culturels. Les activit&#xE9;s de microplanification semestrielle pour l&apos;identification et l&apos;adressage de differents goulots sont en cours. Ces activit&#xE9;s ont &#xE9;t&#xE9; financ&#xE9;es par le Fond Commun RSS3 au 1er trimestre.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts identifi&#xE9;s ont mis en ?uvre les strat&#xE9;gies de vaccination en zones d&#xE9;sertiques et d&apos;ins&#xE9;curit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Diffa et Tahoua(Bosso, N&apos;gourti, Main&#xE9; Soroa et Tilia)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 4 districts mettent en ?uvre les activit&#xE9;s de vaccination dans les zones d&apos;ins&#xE9;curit&#xE9; et desertique en collaboration avec les autorit&#xE9;s adminitratives et militaires sur financement du Fond Commun/RSS3 et de l&apos;UNICEF</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre des strategies en zones d&#xE9;sertique et d&apos;ins&#xE9;curit&#xE9; dans 3 DS situ&#xE9;s dans les r&#xE9;gions de Diffa et Tahoua(Bosso, N&apos;gourti, Main&#xE9; Soroa et Tilia)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 4 districts mettent en ?uvre les activit&#xE9;s de vaccination dans les zones d&apos;ins&#xE9;curit&#xE9; et desertique en collaboration avec les autorit&#xE9;s adminitratives et militaires sur financement du Fond Commun/RSS3 et de l&apos;UNICEF</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des districts urbains et semi-urbains identif&#xE9;s ont mis en eouvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les r&#xE9;gions de Niamey, Maradi et Tahoua (6 districts urbains et semi urbains B.Konni ; Maradi Ville, Niamey 5, Niamey 3, Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 6 districts ont mis en ?uvre la strat&#xE9;gie urbaine de vaccination gr&#xE2;ce au financement du Fond commun /RSS3</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les r&#xE9;gions de Niamey, Maradi et Tahoua (6 districts urbains et semi urbains B.Konni ; Maradi Ville, Niamey 5, Niamey 3, Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 6 districts ont mis en ?uvre la strat&#xE9;gie urbaine de vaccination gr&#xE2;ce au financement du Fond commun /RSS3</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">72 districts ont &#xE9;labor&#xE9; et mis en oeuvreles activites de vaccination pour ameliorer la couverture vaccinale</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la planification, la mise en oeuvre et le suivi des activites  de vaccination tant au niveau national qu&apos;au niveau regional et district pour augmenter la couverture vaccinale tant en milieu urbain qu&apos;en milieu rural">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 72 districts ont mis en ?uvre les activit&#xE9;s de vaccination en strat&#xE9;gie fixe, avanc&#xE9;e, mobile pour am&#xE9;liorer la couverture vaccinale : La CV administrative du Penta 3 a &#xE9;t&#xE9; maintenue au dessus de 90% en decembre 2020, Le nombre des DS avec plus de 80% d&apos;enfants vaccin&#xE9;s en Penta 3 est pass&#xE9; de 55 en Juin 2020 &#xE0; 58 en Decembre 2020, avec un taux d&apos;abandon passant de 7 &#xE0; 6 %, le VAR 2 passant de 66% &#xE0; 67%. La couverture Td 2+ est pass&#xE9;e de 75% en juin 2020 &#xE0; 88% en decembre 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la planification, la mise en oeuvre et le suivi des activites  de vaccination tant au niveau national qu&apos;au niveau regional et district pour augmenter la couverture vaccinale tant en milieu urbain qu&apos;en milieu rural">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 72 districts ont mis en ?uvre les activit&#xE9;s de vaccination en strat&#xE9;gie fixe, avanc&#xE9;e, mobile pour am&#xE9;liorer la couverture vaccinale : La CV administrative du Penta 3 a &#xE9;t&#xE9; maintenue au dessus de 90% en decembre 2020, Le nombre des DS avec plus de 80% d&apos;enfants vaccin&#xE9;s en Penta 3 est pass&#xE9; de 55 en Juin 2020 &#xE0; 58 en Decembre 2020, avec un taux d&apos;abandon passant de 7 &#xE0; 6 %, le VAR 2 passant de 66% &#xE0; 67%. La couverture Td 2+ est pass&#xE9;e de 75% en juin 2020 &#xE0; 88% en decembre 2020</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply chain</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project management team estalished and workplan available. ToR for Cold room and infrastructure procurement completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the construction and outfitting of Abuja Mega hub project implementation at National Strategic Cold Store">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Project management team established
2. PMT workplan developed 
3. ToR for cold room and infrastructure work is being finalized to be completed within June 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Project Operational Deployment Plan (ODP) developed for 6,346 CCEs and 30% installation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the deployment of Cold Chain Equipment and implementation of CCEOP project as well as facilitating the inventory management system">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Project operational plan (ODP) developed for 6,346 CCEs and shared with UNICEF SD.
2. As at 18 June, 57% (3,607out of 6,346) unit of CCE have been installed from tranche 2 across all States plus the FCT</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of national, zonal an state cold stores and 60% of CCEs at LGA and HF level have functional RTM</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the coordination of Remote Temperature Monitoring (RTM) system and facilitate capacity to review and provide regular feedback">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. The functionality rate has been increased from almost zero to over 50% during this reporting. However, by end of 2021 new generation RTMS will be received in country and deployment wil be completed within Q1 2022 making 100% functionality. 
2. 100% CCEOP CCE comes with RTMDs and all are RTMDs are functional. This makes approx 70% functionality at LGA and HF level stores. 
3. HSS reprogramming is being requested to procure 5,000 temperature monitoring devices for LGA and HF lecel.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of target states have updated CCE management documents
 (e.g. CCE inventory, or Cold Chain Expansion and
 Rehabilitation Plan, CCE maintenance plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor the CCEOP implementation, track performance of maintainance units and facilitate development and implementation of maintainance and rehabilitation plans">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. The team updates inventory and replacement plan quarterly for 36 states plus FCT. This has helped to readjust the deployment plan where necessary. 
2. 36 out of 37 States has established the state maintence units. One state has incuded the budget line for CCE maintenance in annual plan. Others are yet to be pursued on this.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des r&#xE9;gions organisent des reunions d&apos;analyse des donn&#xE9;es de gestion de vaccins et des ECF</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 8 r&#xE9;gions et 72 districts dans la mise en ?uvre du CCEOP, le suivi de la gestion des &#xE9;quipements de la chaine de froid et des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">100% (8) r&#xE9;gions ont r&#xE9;alis&#xE9; des analyses mensuelles des donn&#xE9;es de gestion des vaccins et des &#xE9;quipements de la cha&#xEE;ne du froid avec production des rapports d&apos;analyse de SMT, analyse des temperatures avec le syst&#xE8;me de surveillance &#xE0; distance (Beyond).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of states under the zone supported to implement workplan and updated supply chain guidance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical liaisons between the NLWG and SLWGs, within zonal catchment areas, and support alignment and implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">12 Zonal Liaison officers from NLWG have been appointed to coordinate with the zones, supply chain</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les ressources humaines dedi&#xE9;es &#xE0; la cha&#xEE;ne d&apos;approvisionnement sont form&#xE9;es dans l&apos;utilisation du tableau de bord de la gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la Direction des Immunisations dans l&apos;am&#xE9;lioration de la disponibiit&#xE9;, la qualit&#xE9; et l&apos;utilisation des donn&#xE9;es de gestion de l&apos;information logistique (vaccins et &#xE9;quipements de la chaine du froid)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">33 personnes (15 cadres de la Direction Nationale des Immunisations, 7 consultants de l&apos;UNICEF, 3 staff UNICEF et les 8 coordonnateurs r&#xE9;gionaux des immunisations) sont form&#xE9;es et utilisent le tableau de bord.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% installation completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical support for the deployment of Cold Chain Equipment and implementation of CCEOP project as well as facilitating the inventory management system">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">4,000 out of 6,346 (62%) installation of CCEs completed during reporting period. 
1. Supported project management team to successfully implement the project. 
2. Pursued high level engagement for the country joint investment. CJI of US$23m yet to be deposited to procure and deply balance 2,300 CCEs.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les plans de d&#xE9;ploiement operationnels du CCEOP 2 et de l&apos;ann&#xE9;e 5 du CCEOP 1 sont &#xE9;labor&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et les 8 r&#xE9;gions dans la mise en ?uvre du CCEOP, et le suivi de la gestion des &#xE9;quipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">494 &#xE9;quipements du CCEOP ont &#xE9;t&#xE9; r&#xE9;ceptionn&#xE9;s sur les 611 attendus avec une forte implication de l&apos;&#xE9;quipe UNICEF dans le d&#xE9;douanement. Le premier lot est en cours de distribution et d&apos;installation dans les sites identifi&#xE9;s &#xE0; cet effet. Aussi, l&apos;UNICEF a assur&#xE9; un suivi rigoureux dans la correction du d&#xE9;faut de fabrication en lien avec une d&#xE9;fection de la tuyauterie constat&#xE9; sur 310 r&#xE9;frig&#xE9;rateurs HTC-110.
Les 117 &#xE9;quipements restants sont attendus d&apos;ici la fin Novembre 2021. 
L&apos;ODP a &#xE9;t&#xE9; actualis&#xE9; avec les nouvelles acquisitions ce qui portera la couverture des points de prestations en ECF Homologu&#xE9;s de 53% &#xE0; 75%. 
11 consultants logisticiens couvrant les 8 r&#xE9;gions dont 8 sous financement TCA Gavi (4 CCEOP, 4 COVID 19) ont contribu&#xE9; dans le suivi mensuel du fonctionnement des ECF avec prise d&apos;action correctrices.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">internal workflows for the hubs developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">A committee on system design and 3 hub operationalization was established comprising of NPHCDA and UNICEF. Concept note for the commencement of the analyisis for the operationalisation of the Hub was developed. Letter of request for the commencement of the engagement for the operationalisation and analysis and plans to be sent by NPHCDA</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40% of the action points from the coordination meeting implemented in atleast 50% of the states in the zone</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strenghening of ZLWG/SLWG and facilitate coordination efforts with other relevant fora to achieve supply chain synergy at subnational level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">About 70% of the planned ZLWG meetings were conducted, about 55% of the action points implemented. Frequency of SLWGs meeting has increased by about 10% due to the rollout of COVID-19 vaccine. About 60% of the planned CCO meetings were conducted</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Revised target coverage, population and other assumptions developed and 2022 forecasting exercise conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Facilitate conduct of nationwide physical stock count exercise, supporting the entrenchment of quarterly PSC and Conduct of annual state specific vaccines and devices forecasting exercise in line with revised coverage and targets; support conduct of vaccine audit exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Because of the competing priorities, this activity was not conducted and the stock count as reported via ODK from 37 states, 774 LGAs, 6 zonal stores and national store was used for the 2022 forecast. There is need to reprogram the funds for this activity to the operationalisation of 3 hub and other supply chain strengthening activities</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">eLMIS solution selected and developed. Training for the roll out conducted Sites for field test identified</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Country has selected open LMIS starting with COVID-19 Modules. Technical requirement established, training for users finalised and has started piloting it</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training for eLMIS users facilitated in the 100% of the states in the zone</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Facilitate rollout of e-LMIS at subnational levels and support monitoring of accuracy, timeliness and completeness of reporting">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Country has selected open LMIS starting with COVID-19 Modules. Technical requirement established, training for users finalised and has started piloting it.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">country&apos;s EVM environment set up reviewed, Site selection conducted and assesment created, assessor refresher orientation conducted. 2 system design assesment completed in targetted states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In line with GAVI Immunization Supply Chain Steering Committee (iSC2) mission recommendation, provide Technical Support for the conduct of quarterly targeted and nationwide EVMAs, Development and monitoring of cIPs, facilitating system design activities, and implementation of iSC2 recommendations">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">EVM 2.0 parameters reviewed on the Nigeria&apos;s platform. Quarterly cIP updated with 80.70% level of implementation of at national level. Targeted for NSCS created to conducted end of the month. Refresher training on EVMA not conducted due to COVID-19 vaccine roll out. System design assessment completed in 8 states of Niger, Zamfara, Gombe, Kebbi, Katsina, Taraba, Bayelsa and Jigawa (80% of the 10 states targeted) with stakeholders workshops, landscape assessment, baseline scenario and prioritization completed. States of Kano and Lagos are at the stage of landscape scenario and data collection.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Recommendations from the FtV finalised and action plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Follow the vaccine activity finalized in 12 states. Recommendations are being finalized as part of the overall report. Action plan to be developed following the finalization and dissimilation</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">FtV- immunization supply chain audit concluded and recommendations shared. However, action plan to implement the recommendations yet to be developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.PSC RFQs and vendors selection finalised, PSC data and reports available.2. Mock audit exercise conducted 3.Forecast for 2021 reviewed and adjusted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Facilitate conduct of nationwide physical stock count exercise, supporting the entrenchment of quarterly PSC and Conduct of annual state specific vaccines and devices forecasting exercise in line with revised coverage and targets; support conduct of vaccine audit exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Insourced physical stock counts was conducted at national, zonal, state level monthly from February to May. Following up with weekly stock data reported via ODK and comparison with physical stock done during the period. The outsourced nationwide one-off physical stock count was not conducted and now planning to reprogram the funding for the activity.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">L&apos;&#xE9;tude de faisabilit&#xE9; d&apos;eLMIS est r&#xE9;alis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la Direction des Immunisations dans l&apos;am&#xE9;lioration de la disponibiit&#xE9;, la qualit&#xE9; et l&apos;utilisation des donn&#xE9;es de gestion de l&apos;information logistique (vaccins et &#xE9;quipements de la chaine du froid)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;&#xE9;tude de faisabilit&#xE9; d&apos;eLMIS est r&#xE9;alis&#xE9;e, une analyse exhaustive des solutions sur le march&#xE9; a &#xE9;t&#xE9; faite et le choix a &#xE9;t&#xE9; port&#xE9; sur la nouvelle g&#xE9;n&#xE9;ration du SMT d&#xE9;velopp&#xE9;e par Supply Division UNICEF.
Une demande officielle du pays afin d&apos;&#xEA;tre &#xE9;ligible pour la phase pilote a &#xE9;t&#xE9; adress&#xE9;e au bureau pays de l&apos;UNICEF Niger. Cette requ&#xEA;te est le pr&#xE9;alable &#xE0; une discussion de faisabilit&#xE9; avec Supply Division pour l&apos;utilisation du nouveau SMT &#xE0; partir de janvier 2022.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un inventaire des ECF est mis &#xE0; jour</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 8 r&#xE9;gions et 72 districts dans la mise en ?uvre du CCEOP, le suivi de la gestion des &#xE9;quipements de la chaine de froid et des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise &#xE0; jour de l&apos;inventaire des ECF des 8 r&#xE9;gions et 72 districts est effectif et un suivi de la maintenance des &#xE9;quipements en panne est r&#xE9;alis&#xE9;. L&apos;UNICEF a financ&#xE9; la maintenance des &#xE9;quipements des r&#xE9;gions de Maradi, Tahoua et Agadez. Aussi, l&apos;analyse mensuelle de la gestion des vaccins avec l&apos;appui des consultants CCEOP est effective.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La revue de la composante logistique et chaine d&apos;approvisionnement a finalis&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La non atteinte de ce r&#xE9;sultat est en lien avec le report de la revue PEV initialement pr&#xE9;vue en 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les TDR du consultant pour la revue externe du PEV composante logistque sont finalis&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La non atteinte de ce r&#xE9;sultat est en lien avec le report de la revue PEV initialement pr&#xE9;vue en 2021. Par cons&#xE9;quent , le recrutement n&apos;est pas effectif.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la revue externe du PEV pour la composante logistique et cha&#xEE;ne d&apos;approvisionnement des vaccins">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La revue du PEV est planifi&#xE9;e dans le PAA de la DI mais connait un retard dans les pr&#xE9;paratifs en lien avec un chevauchement de l&apos;intensification de la vaccination contre la COVID-19, les ripostes contre l&apos;&#xE9;pidemie de polio de source vaccinale</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">72 districts utilisent l&apos;Outil &quot;Stock report&quot; pour la visibilit&#xE9; du niveau des stocks des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La visibilit&#xE9; des donn&#xE9;es des stock des districts a &#xE9;t&#xE9; assur&#xE9;e gr&#xE2;ce &#xE0; l&apos;outil Niger Vaccine Stock mis en place et le tableau de bord de la chaine d&apos;approvisionnement. Ceci a permis un suivi &#xE0; temps r&#xE9;el des stock afin d&apos;assurer la continuit&#xE9; de la vaccination. La disponibilit&#xE9; de ce syst&#xE8;me a permis des red&#xE9;ploiements entre differentes r&#xE9;gions et district. 
A titre d&apos;exemples, en fin octobre 2021 le BCG a &#xE9;t&#xE9; d&#xE9;ploy&#xE9; de Niamey &#xE0; Dosso et Diffa, la PCV-13 de Tillaberi &#xE0; Dosso. Les analyses r&#xE9;guli&#xE8;res de triangulation des donn&#xE9;es de vaccination d&apos;avec les stocks de vaccins sont r&#xE9;alis&#xE9;es avec l&apos;appui des consultants.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Human resource requirement and plan for deployment available including roles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Lagos hub construction contract has just been awarded and site yet to be clear. Abuja upgrade is at the level of design review finalization. Procurement process of of Large cold rooms started. As part of the operationalization the human resource requirement, workflows and system design assessment will be conducted in Q3 and 4</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support operationalisation of the 3 Hub project including process mapping, human resource allocation and capacity (people), workflows integration and synergies (systems) leveraging appropriate technologies (eLMIS and its integration with the HMIS and or N SCIP tool) as per GAVI iSC2 mission recommendation">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The 3 hubs project yet to be completed. The discussion and coordination have started to develop the operationalization plan.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du plan d&apos;am&#xE9;lioration de la GEV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le taux de r&#xE9;alisation du plan d&apos;am&#xE9;lioration est pass&#xE9; de juin &#xE0; novembre de 35% &#xE0; 47% des activit&#xE9;s mises en ?uvre dans les 6 composantes de la cha&#xEE;ne d&apos;approvisionnement des vaccins. Cette avanc&#xE9;e significative est due en partie &#xE0; la mise en place du comit&#xE9; de suivi des acquisitions et &#xE0; la r&#xE9;ception effective des acquisitions programm&#xE9;es dans le RSS3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">8 r&#xE9;gions tiennent des r&#xE9;unions mensuelles d&apos;analyse des donn&#xE9;es de gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les analyses mensuelles de gestion des donn&#xE9;es de vaccination triangul&#xE9;es avec la gestion des vaccins (SMT, DVDMT, Registre des stocks) sont r&#xE9;alis&#xE9;es et partag&#xE9;es &#xE0; tous les niveaux. Ces analyses ont permis de corriger les incoh&#xE9;rences identifi&#xE9;es dans les donn&#xE9;es.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les mesures de d&#xE9;douanement des &#xE9;quipements des ann&#xE9;es 3 et 4 sont mises en place</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et les 8 r&#xE9;gions dans la mise en ?uvre du CCEOP, et le suivi de la gestion des &#xE9;quipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les commandes pour les ann&#xE9;es 3 et 4 sont confirm&#xE9;es pour les livraisons au deuxieme semestre 2021. Un appui a &#xE9;t&#xE9; apport&#xE9; &#xE0; la DI pour l&apos;obtention d&apos;une exon&#xE9;ration des droits et taxes en douane (N&#xB0;000225/MF/DGD/DREP du 19 fevrier 2021) afin de garantir le dedouanement des &#xE9;quipements.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Logistics plans and NDVP finalsed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging on the CCEOP and 3 Hubs system/Abuja NSCS upgrade, support the capacity requirement estimation and prioritization for readiness towards introduction of new vaccines such as Rota; including the implementation of logistics plan.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Logistics plans and NDVP for the introduction of COVID-19 vaccines finalized. Abuja NSCS upgrade designed is being finalized, Cold chain requirement estimation in view of the new vaccines determined. Plans to procure additional cold chain equipment in line with COVAX CCE support is finalized. Procurement of 3 units of 175 CM3 WICR as part of NSCS Abuja upgrade has reached advance stage</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% of sites generated for Q2 in zone assesed and reports generated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Faciltate quarterly effective Vaccine Management Assessments for subnational stores (zonal and state); supporting zones and states to develop, implement and monitor cIPs">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Mock EVMA not conducted. However, cIP is being monitored and about 89% of the cIP activities were achieved at national level. Preparation for nationwide EVMA is ongoing and expected to happen in December 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">NLWG convened 3 times per week and demonstrated to be meeting regularly in past [6] months</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the development, implementation, monitoring and evaluation of NLWG strategic priorities and initiatives as detailed in the annualised work plan; Support the strengthening of NLWG and ZLWGs and facilitate the integration of the broader PHC supply chain coordination efforts.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">National Logistics Working Group was finalized and being implemented. 3 times a week meeting is being conducted with one expanded NLWG incorporating state officers to improve coordination. Action points are being tracked for implementation. Zonal liaison for zonal logistics working groups are appointed from the NLWG. Monthly CCOs meeting are being conducted. 28, 26, 23 states have conducted CCO coordination meeting in July, August and September respectively.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Strategic planning documentation for Q1 nationwide EVMA and cIP,supported
 and submitted to NLWG</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Faciltate quarterly effective Vaccine Management Assessments for subnational stores (zonal and state); supporting zones and states to develop, implement and monitor cIPs">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Nigeria&apos;s EVM 2.0 environment is set up and reviewed regularly. Mock assessment for NSCS created to conducted end of the month. Refresher training on EVMA not conducted due to COVID-19 vaccine roll out. Planning meeting for the conduct of nationwide EVMA conducted, timelines and budget reviewed. Assessment expected to be conducted in August 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% of the sites targeted for CCEOP have validated Operational Deployment Plan (ODP)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Monitor the CCEOP implementation, track performance of maintainance units and facilitate development and implementation of maintainance and rehabilitation plans">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Operational deployment plan for all targeted 6,346 sites (100%) were discussed with all the beneficiary states PMT/ SLWG and validated. The installations were randomly inspected during the supportive supervisions and any irregularity were reported.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">20% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du plan d&apos;am&#xE9;lioration de la GEV">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Sur 55 activit&#xE9;s programm&#xE9;es : 35% des activit&#xE9;s sont r&#xE9;alis&#xE9;es (19) , 29% en cours (16) et 36% non r&#xE9;alis&#xE9;es (20)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EVM Assement completed and submitted to MoH, including
 supporting analysis of VfM and zero-dose considerations (as applicable)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In line with GAVI Immunization Supply Chain Steering Committee (iSC2) mission recommendation, provide Technical Support for the conduct of quarterly targeted and nationwide EVMAs, Development and monitoring of cIPs, facilitating system design activities, and implementation of iSC2 recommendations">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">System design assessment in 10 states finalised, implementation plans being finalised. Preparation towards nationwide EVMA is being finalised, cIP implementation is 89%.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunization supply chain annual workplan and budgets including interventions to reach last mile/ zero dose children in place.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the development, implementation, monitoring and evaluation of NLWG strategic priorities and initiatives as detailed in the annualised work plan; Support the strengthening of NLWG and ZLWGs and facilitate the integration of the broader PHC supply chain coordination efforts.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Technical support provided and immunization supply chain costed annual workplan available reflecting the iSC priorities. Support provided for the development of subnational immunization supply chain costed workplans through ZLWG and SLWG as well. NLWG, ZLWGs and SLWGs are meeting regularly in the past six month to operationalize workplans. Areas for zero dose intervention identified, vaccine delivery modalities to the implementing facilities are determined, cold chain availability was mapped in the zero dose affected areas in favor of coverage and equity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunization supply chain annual workplan and budgets including interventions to reach last mile/ zero dose children adapted for zonal and state levels</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Technical liaisons between the NLWG and SLWGs, within zonal catchment areas, and support alignment and implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Technical support provided and immunization supply chain costed annual workplan available reflecting the iSC priorities. Support provided for the development of subnational immunization supply chain costed workplans through ZLWG and SLWG as well. NLWG, ZLWGs and SLWGs are meeting regularly in the past six month to operationalize workplans. Areas for zero dose intervention identified, vaccine delivery modalities to the implementing facilities are determined, cold chain availability was mapped in the zero dose affected areas in favor of coverage and equity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Action plan for the implementation of vaccine audit exercise available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the implementation of FtV and vaccine audit exercise recommendations to improve vaccine accountability">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The FtV audit concluded. However, final reports being reviewed, preliminary outcomes has been used to inform some adjustment on the documentation of the vaccine distribution and issuance. The action plan for the implementation of audit recommendation has been delayed due to Covid-19 vaccination prioritization.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Contract awarded and 40% project works completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the construction and outfitting of Abuja Mega hub project implementation at National Strategic Cold Store">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The contract award process is in progress, can be awarded before end of Nov 2021. 
The Hub infrastructures had to be redesigned which was not considered. RFP process took longer than expected. By Jan 2022, it is expected that major upgrade works will be completed and ready for the installation of 3 x 175 cbm WICRs</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">iSC roadmap finalized and 2022 annualized NLWG work plan developed and submitted to NPHCDA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalization of 10 year iSC road map following the completion of the iSC policies">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Final draft is ready for NLWG validation. Workshop was planned in Q3 2021. However, because of high priority on Covid-19 vaccinations, it has been deferred in 2022. Dates to be determined.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Finalization of 10 year iSC road map following the completion of the iSC policies">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The draft road map is being finalized. A lockdown workshop has been planned in September 2021 to finalize the document.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">eLMIS requirement collection for the country finalised, funding source available</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">This activity is behind schedule as the selection of the new LMIS has just been finalized and scoping and requirement gathering just finalized. List of the health facilities is being finalized and plan for the implementation starting with COVID-19 vaccine stocks is being discussed. However, there is continuous support to the weekly stock reporting via the ODK, conduct of weekly stock data report review and monthly physical stock count across the 36 states+ FCT.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support in the development of business and technical requirement for development and deployment of eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">This milestone has been achieved. The eLMIS is being rolled out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% of the planned meeting between ZLWG and SLWGs conducted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the strenghening of ZLWG/SLWG and facilitate coordination efforts with other relevant fora to achieve supply chain synergy at subnational level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Virtual meetings have been held between ZLWG and SLWG. Different percentage of the planned meetings held in 6 Zones. In the Zones where meeting between complete team of ZLWG and SLWG couldn&apos;t hold, ZLWG representative members attended the SLWG meetings and provided the feedback. In aggregate 60-80% of planned meetings were held. Action points are tracked and followed up. Each zone conducted minimum of 60-80% of the planned ZLWG meeting with some extended with participation of members of ZLWGs. Conduct of supportive supervision by the zonal supply chain consultants to supervise states and mentor SLWGs</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Technical guidance based on the countries experience in the new vaccine (COVID-19) deployment adjusted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Leveraging on the CCEOP and 3 Hubs system/Abuja NSCS upgrade, support the capacity requirement estimation and prioritization for readiness towards introduction of new vaccines such as Rota; including the implementation of logistics plan.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;1. The Cold chain storage capacity has been expanded for Pfizer vaccine. 93 units ULTF have been deployed and 23 in process.
2. 31 WICRs are being developed to national, zonal and state level stores to expand the capacity required to Covid-19 vaccines and other RI vaccines - Rota, HPV..
&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">33 districts r&#xE9;alisent des revues de validation et d&apos;analyse des donn&#xE9;es de la vaccination  prenant en compte la triangulation avec les donn&#xE9;es de gestion des vaccins</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La triangulation des donn&#xE9;es est faite trimestriellement au niveau des r&#xE9;gions et mensuellement au niveau des districts avec l&apos;appui des consultants et partag&#xE9;s avec les DRSP et M&#xE9;decins chefs de district</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la gestion des donn&#xE9;es de stocks de vaccin et la triangulation avec les donn&#xE9;es de couvertures vaccinales">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La triangulation des donn&#xE9;es est faite trimestriellement au niveau des r&#xE9;gions et mensuellement au niveau des districts avec l&apos;appui des consultants et partag&#xE9;s avec les DRSP et M&#xE9;decins chefs de district</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC Foundation : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Complete epidemic preparedness plan and Attend the Annual Meeting of Meningitis Belt countries</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">An evaluation of the national meningitis surveillance (SORMAS) variables was completed in Q4 2020 in support of WHO/country plans for implementation of a regional DHIS2 meningitis case based surveillance module which was planned for 2021-22. Bilateral meetings were held in September and planned for December 2021 with Nigeria CDC to discuss potential integration of SORMAS case based meningitis data in the regional MenAfriNet Surveillance Bulletin in advance of DHIS2 implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of data management system efficiency and integration status</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems; 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">An evaluation of the national meningitis surveillance (SORMAS) variables was completed in Q4 2020 in support of WHO/country plans for implementation of a regional DHIS2 meningitis case-based surveillance module which was planned for 2021-22. Bilateral meetings are planned for July 2021 with Nigeria CDC to discuss potential integration of SORMAS case based meningitis data in the regional MenAfriNet Surveillance Bulletin in advance of DHIS2 implementation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate lab testing flows for meningitis within national laboratory network; 

Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">CDC is working with in-country partners on operational plans to implement activities and establish timelines. A questionnaire is being developed for proposed assessment on specimen management and testing flows. Standardized programs with a focus on laboratory quality measures are being developed to ensure lab quality and proficiency.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluate specimen management and lab testing flows for meningitis within national laboratory network; 

Develop a standardized program to ensure lab quality and proficiency</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">CDC is working with in-country partners on operational plans to implement activities and establish timelines. A questionnaire is being developed for proposed assessment on specimen management and testing flows. Standardized programs with a focus on laboratory quality measures are being developed to ensure lab quality and proficiency.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at the national lab and at least 1 regional lab that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Lab trainings on meningitis diagnostics will be completed by the end of November 2021 for the Tillaberi, Dosso, and Diffa regions. A total of 58 participants is expected, 24 at Tillaberi (10 from regional and 14 from district labs), 18 at Dosso (10 from regional and 8 from district labs) and 16 at Diffa (10 from regional and 6 from district labs).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Generation of routine meningitis surveillance performance feedback summaries to guide national monitoring and evaluation, with a target of &gt;90% of participating districts reporting data monthly and &gt;80% of suspected meningitis cases have a specimen collected</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Niger expanded case based surveillance nationally, but struggled to collect case based data from new districts in 2020. An evaluation of data management and specimen transport system completeness and timeliness was completed in Q3 2021. To improve the timeliness of case based surveillance data, STELab 2.0 multi-disease data management and specimen tracking system is in the process of being rolled out nationally in Q4 2021-Q1 2022. STELab 2.0 is an African developed, integrated multi-disease system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. Following implementation, STELab will be integrated with DHIS2 for regional data merging.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Evaluation of data management and specimen transport system efficiency and integration status, roll-out of updated data management and specimen tracking system nationwide</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Niger under a One TA plan, CDC/DBD proposes the following activities to leverage and strengthen case-based surveillance for multi-disease VPD program monitoring and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) provide epidemiological support and tools to ensure efficient data/specimen collection, management, and country-level analysis to accurately assess the burden of bacterial meningitis in the context of vaccine implementation and integration into broader health information systems (i..e DHIS2); 2) integrate with other national disease priorities to ensure data triangulation between immunization and disease surveillance; 3) reinforce the country&apos;s capacity for epidemic detection and response. Efforts will be harmonized and coordinated with other regional/global activities and partners (i.e. MenAfriNet, WHO ICG Vaccine Stockpile), 4) technical support for preparation and participation in Annual Meeting of Meningitis Belt Countries">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Niger expanded case-based surveillance nationally, but struggled to collect case based data from new districts in 2020. An evaluation of data management and specimen transport system completeness and timeliness will be completed in Q3 2021. To improve the timeliness of case based surveillance data, STELab 2.0 multi-disease data management and specimen tracking system will be rolled out nationally in Q3 2021. STELab 2.0 is an African developed, integrated multi-disease system with case-based reporting modules for Meningococcal Disease, Pneumococcal disease, Hib, Cholera, SARI, Dengue, measles, rubella, polio, Yellow Fever, and COVID-19. Following implementation, STELab will be integrated with DHIS2 for regional data merging.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Support lab testing at national and state labs (8 priority state labs at least) that have been trained for the detection and characterization of bacterial meningitis and specimen referral;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="In collaboration with Nigeria under OneTA plan, CDC/DBD proposes the following activities to strengthen laboratory systems for vaccine preventable diseases surveillance including epidemic prone meningitis disease, and early detection of disease epidemics to guide equitable deployment of emergency meningococcal stockpile vaccines: 1) Continue to support laboratory based surveillance for rapid/timely detection and characterization of bacterial meningitis pathogens at national and regional levels; 2) strengthen nation-wide lab network through reinforcing proper specimen management and lab testing flows; 3) implement effective measures to improve laboratory quality, proficiency and data quality. 4) provide technical support for preparation and participation of annual meningitis meetings and other meetings">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The remaining supervisory visits planned for May-July 2021 to state laboratories who had been trained in March 2020 (Rivers, Taraba, Kebbi, Benue, Ondo, Katsina, Nasarawa, Zamfara, and Osun) were finally completed. Trainings were held in November 2021 on the identification of bacterial meningitis pathogens with 10 states within the meningitis belt (Katsina, Oyo, Ebonyi, Imo, Enugu, Anambra, Kaduna and F.C.T.). Supportive supervisory visits scheduled to be conducted in 9 states (Oyo, Katsina, Imo, Enugu, Anambra, Ebonyi, Kogi, Abuja, and Adamawa) in November-December 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft du PDS 2022-2026 disponible; Draft avanc&#xE9; du PPAc 2022-2026 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Compte tenu de l&apos;agenda du Ministere de la sant&#xE9;, le processus d&apos;&#xE9;l&#xE9;boration du PDS a demarr&#xE9; avec un retard, les comit&#xE9;s technique et de piltoage ont ete mis en place en septembre 2021, &#xE0; ce jour , le comit&#xE9; technique est &#xE0; la phase d&apos;analyse situationnelle.
Pour le PPAc le pays attend encore les nouvelles directives du bureau regional pour declancher le processus du developpement du noveau PPAC</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft du PDS 2022-2026 disponible;
Draft avanc&#xE9; du PPAc 2022-2026 disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L;&#xE9;l&#xE9;boration du PNDS et du PPAc 2022-2026 est pr&#xE9;vue en Novembre 2021 compte tenue de la vacination contre la COVID-19 en cours et en attendant les nouvelles du directives du niveau global et regional sur le PPAC</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;&#xE9;laboration des documents programmatiques (PPAc 2022-2026, PDS 2022-2026, strat&#xE9;gie de financement pour tendre vers la CSU)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L;&#xE9;l&#xE9;boration du PNDS et du PPAc 2022-2026 est pr&#xE9;vue en Novembre 2021 compte tenue de la vacination contre la COVID-19 en cours et en attendant les nouvelles du directives du niveau global et regional sur le PPAC</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Activit&#xE9;s retenues dans la JSP pour l&apos;an 1 &#xE9;valu&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le retard du &#xE0; la vaccination contre la COVID-19 est en cours au pays qui prend le temps des experts de la DI</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le retard du &#xE0; la vaccination contre la COVID-19 est en cours au pays qui prend le temps des experts de la DI</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appui &#xE0; l&apos;&#xE9;valuation et l?extension du PPAc, l&apos;&#xE9;laboration, la validation et la vulgarisation de la strat&#xE9;gie nomade et le suivi de la mise en ?uvre de la Justification de Soutien au Programme 2020-2022">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les activit&#xE9;s retenues dans le JSP pour l&apos;an sont ont ete evalu&#xE9; lors d&apos;une reunion du CCIA extraordinaire du 1 octobre 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial updates on grants utilisation in line with established standards</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide programme support on financial management">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">WHO designated an officer in Program Management Unit to support NERICC in management of TCA funds, VIGs, development of activity budgets, payment for activities and monitoring utilization of Gavi funds at national and state level.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide programme support on financial management">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">WHO designated an officer in Program Management Unit to support NERICC in management of TCA funds, VIGs, development of activity budgets, payment for activities and monitoring utilization of Gavi funds at national and state level.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Health Information Systems (Data)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Training materials developed and used by 90% of trained personnel for SIAs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation of accelerated disease control activities focusing on Measles, Yellow Fever and MNTE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Conducted Integrated Measles and MenA campaign 5-18 December 2020 in North Central States. 2. Conducted an integrated PCCS for Measles, MenA &amp; Yellow Fever campaign in January 2021 . 3. Pre-validation asssment for South-South September/October 2020. Conducted several MNTE campaigns (see attachment for details).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide Technical Support for the implementation of accelerated disease control activities focusing on Measles, Yellow Fever and MNTE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Conducted Integrated Measles and MenA campaign 5-18 December 2020 in North Central States. 2. Conducted an integrated PCCS for Measles, MenA &amp; Yellow Fever campaign in January 2021 . 3. Pre-validation asssment for South-South September/October 2020. Conducted several MNTE campaigns (see attachment for details).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Report on SMS systems server evaluation</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical and operational support for the conduct of quarterly LQAs and Routine Data Analysis at NERICC.
2 .Support Real time AEFI reporting
3. Conduct JRF estimates for states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO is the leading agency in the conduct of PAPA/LQAS (revision of concept note, planning, training of trainers, recruitment of surveyors, monitoring , data cleaning, analysis and feedback of results). 2. WHO is supporting real time reporting of AEFI on Med Safety App while the traditional reprting is still ongoing. Yet to conduct JRF estimates for states.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical and operational support for the conduct of quarterly LQAs and Routine Data Analysis at NERICC.
2 .Support Real time AEFI reporting
3. Conduct JRF estimates for states">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO is the leading agency in the conduct of PAPA/LQAS (revision of concept note, planning, training of trainers, recruitment of surveyors, monitoring , data cleaning, analysis and feedback of results). 2. WHO is supporting real time reporting of AEFI on Med Safety App while the traditional reprting is still ongoing. Yet to conduct JRF estimates for states.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Draft rapport d&apos;&#xE9;valuation disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance techniques pour l&apos;&#xE9;valuation finale de la feuille de route DHIS2 Niger 2019-2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les TDRs sont d&#xE9;sormais valid&#xE9;s par les parties prenantes notamment la Direction des Statistiques. Ils ont &#xE9;t&#xE9; partag&#xE9;s avec AFRO afin de lancer le recrutement du consultant international. Ce dernier participera au recrutement du consultant national charg&#xE9; de l&apos;appuyer.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance techniques pour l&apos;&#xE9;valuation finale de la feuille de route DHIS2 Niger 2019-2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les TDRs sont d&#xE9;sormais valid&#xE9;s par les parties prenantes notamment la Direction des Statistiques. Ils ont &#xE9;t&#xE9; partag&#xE9;s avec AFRO afin de lancer le recrutement du consultant international. Ce dernier participera au recrutement du consultant national charg&#xE9; de l&apos;appuyer.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">R&#xE9;sultats d&apos;au moins une (1) recherche op&#xE9;rationnelle publi&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le resultat de la recherche operationnelle sur la fievre jaune dans la region de Zinder est disponible</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les fonds TCA sont arriv&#xE9;s en Juin 2021 ce qui n&apos;a pas permis de publier &#xE0; temps les resultats de la recherche en plus du recrutement un consultant</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de recherches op&#xE9;rationnelles sur les Maladies Evitables par la Vaccination en partenariat avec la DSRE, le CERMES et le CDC">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les fonds TCA sont arriv&#xE9;s en Juin 2021 ce qui n&apos;a pas permis de publier &#xE0; temps les resultats de la recherche en plus du recrutement un consultant</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. HRH assessment protocol developed 2. HRS assessment implemented in 2 states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Not done due to other competing priorities. It is still planned to be conducted before the year runs out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 50% of recommendation of HRH assessment implemented in selected states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Not started</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Not started</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Integration microplanning guides and tools adapted/developed based on the national REW/RED guide</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. support priority states, wards and LGAs to provide integrated EPI and PHC services
 3.1 Develop an integration guide and tools
 3.2 Support the microplanning process
 3.3 Support integrated services.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">3. support priority states, wards and LGAs to provide integrated EPI and PHC services 3.1 Develop an integration guide and tools 3.2 Support the microplanning process 3.3 Support integrated services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% districts prioritaires ont mis en ?uvre leur microplan PEV ACD/CEA et les paquets d&apos;intervention</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 19 ECD des 33 districts prioritaires dans l&apos;&#xE9;laboration des micro plans PEV sur la base du guide ACD/CEA et dans la mise en ?uvre des paquets d&apos;intervention dans les districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">4 districts sur les 19, soit 21%, ont b&#xE9;n&#xE9;fici&#xE9; de l&apos;appui technique et financier de l&apos;UNICEF pour l&apos;&#xE9;laboration des microplans ax&#xE9;e sur l?analyse des goulots. 
L&apos;&#xE9;laboration des microplans ax&#xE9;s sur l&apos;analyse des goulots dans les 15 autres districts restants est en cours et prendra fin en d&#xE9;cembre 2021. Pour rappel un conflit de calendrier en lien avec la vaccination contre la COVID-19, l&apos;organisation des ripostes vaccinales contre la polio de souche vaccinale ont perturb&#xE9; le chronogramme de mise en ?uvre.
Les quatre districts sanitaires ont b&#xE9;n&#xE9;fici&#xE9; d&apos;un financement compl&#xE9;mentaire de l&apos;UNICEF pour la mise en ?uvre de leurs microplans.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">19 districts prioritaires disposent d&apos;un microplan PEV ax&#xE9; sur l&apos;&#xE9;quit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique de proximit&#xE9; pour accompagner 19 ECD des 33 districts prioritaires dans l&apos;&#xE9;laboration des micro plans PEV sur la base du guide ACD/CEA et dans la mise en ?uvre des paquets d&apos;intervention dans les districts sanitaires prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Deux ateliers de formation des 68 formateurs de districts sur l&apos;approche ACE/Equit&#xE9; ont eu lieu du 18 au 24 mai 2021 simultanement &#xE0; Maradi et Tillaberi. La prochaine &#xE9;tape est la tenue des ateliers au niveau des districts (la compilation des informations des districts dans l&apos;outil d&apos;analyse des goulots d&apos;&#xE9;tranglement est en cours avec pour deadline de transmission le 01 Juillet 2021).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les documents du dialogue multipartite sont en cours de collecte</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et la DEP dans l&apos;organisation du Dialogue Multipartite avec Gavi en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le dialogue multipartite n&apos;a pas encore &#xE9;t&#xE9; annonc&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Un dialogue multipartite est organis&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI et la DEP dans l&apos;organisation du Dialogue Multipartite avec Gavi en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les pr&#xE9;paratifs du dialogue multipartite sont en cours et une proposition d&apos;atelier est pr&#xE9;vu &#xE0; cet effet. Cependant les documents d&apos;analyse sont en cours de finalisation.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Roadmap for improved integration of EPI with other PHC services</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. support priority states, wards and LGAs to provide integrated EPI and PHC services
 3.1 Develop an integration guide and tools
 3.2 Support the microplanning process
 3.3 Support integrated services.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Nigeria is one of the countries with high number of unvaccinated/zero dose children and the government and partners have been working on identifying states and LGAs with high number of unvaccinated children/zero doses. UNICEF analyzed the immunization data at state and LGA level and identified 90 LGAs with high number of zero dose children and supporting those LGAs in improving access and utilization of immunization and other services. UNICEF started the supply in July 2021 and the number of children vaccinated improved from July to September 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">EPI reviews and Multi-Stakeholder Dialogue are well managed ensuring availability of relevant data to track progress.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support in the national level leadership, management and coordination of the immunization program 
 1.1. Contribute to the national level planning, management and coordination meetings including TWGs, ICC, Core group, NERICC, NPSIAs, etc
 1.2. Participate in the regular monitoring and evaluation of the immunization program including OIRIS visits, review meetings, new vaccines introductions, SIAs monitoring, MSD, etc">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Technical support provided to the national level in leadership, management and coordination. Actively participated in the national coordination meetings including TWG, Core group, NERICC and other coordination meetings. Actively participated in the theory of change discussion and reaching the missed communities and zero dose children. The EPI reviews and MSD will be conducted during the 2nd half of the year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">National routine immunization coverage survey Implemented-MICS/NICS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support in the conduct of the immunization coverage survey, equity assessment and identification of missed communities 
 2.1 Support the conduct of MICS/NICS
 2.2 Support equity assessment in priority areas 
 2.3 support poor performing LGAs in developing an integrated micro plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The national immunization coverage survey (MICS/NICS) is ongoing , all preparatory activities have been conducted and data collection will be started soon. The preliminary result will be ready by the end of the year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Equity assessment performed in identified urban slum areas</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support in the conduct of the immunization coverage survey, equity assessment and identification of missed communities 
 2.1 Support the conduct of MICS/NICS
 2.2 Support equity assessment in priority areas 
 2.3 support poor performing LGAs in developing an integrated micro plan">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">UNICEF conducted an immunization and coverage and equity assessment, the assessment was conducted at national level and in selected 6 states and includes both quantitive and qualitative data collection and analysis. The report will be ready by the end of November 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Action plans to implement recommendations of MSD and EPI reviews developed and implemented</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical support in the national level leadership, management and coordination of the immunization program 
 1.1. Contribute to the national level planning, management and coordination meetings including TWGs, ICC, Core group, NERICC, NPSIAs, etc
 1.2. Participate in the regular monitoring and evaluation of the immunization program including OIRIS visits, review meetings, new vaccines introductions, SIAs monitoring, MSD, etc">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Unicef supports the national level planning, monitoring and coordination, including participating in the core group, NERICC and other coordination forums. The Nigerian government and partners conducted internal evaluation of the immunization program. Based on the evaluation a three years strategic plan was developed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - General</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des agents communautaires  menent des activites de suivi communautaire des enfants de 0-23 mois et de declaration des naissances dans les 33 districts sanitaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la  mise en place des registres communautaires pour le suivi communuataire de la vaccination et  autres activites de sante ainsi que la declaration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les registres communautaires sont disponibles pour les deux districts pilotes de Boboze et Malbaza avec financement UNICEF, la reproduction pour les 31 autres districts et la formation des acteurs (superviseurs, ECD , Chefs CSI) sont programm&#xE9;es sur financement RSS3</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI en collaboration avec l&apos;Etat civil dans la  mise en place des registres communautaires pour le suivi communuataire de la vaccination et  autres activites de sante ainsi que la declaration des naissances dans 33 districts sanitaires prioritaires retenus dans la JSP.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les registres communautaires sont disponibles pour les deux districts pilotes de Boboze et Malbaza avec financement UNICEF, la reproduction pour les 31 autres districts et la formation des acteurs (superviseurs, ECD , Chefs CSI) sont programm&#xE9;es sur financement RSS3</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All priority LGAs supported in developing annual workplan , identification of missed communities, zero dose children and implementation strategy,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to Lagos State in all LGAs in the NSIPSS implmentation and improving RI coverage, identification of missed communities,urban slums, zero dose children, conducting successful NPSIAs, and introducition of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">- Lagos State RIWG operationalized the developed annual work plan on RI and other PHC services. Supported the development of 2022 AOP on RI and PHC Services. 11 LGAs identified as prioritized LGAs for zero dose children &amp; missed communities in Lagos States. Supported 3 rounds of LGAs in 11 prioritized LGAs in August,November and December,2021 1189 HCWs acquired knowledge on development of REW/REC REW micro-plan for zero dose children and missed communities. and 152 HFs from 11 supported LGAs developed REW/REC mico-plan. 341,738 children immunized with penta1 in 2021 as against 321,045 in 2020 of same period. Resulted in 20,693 reduction of zero dose children as compared with 2020. IPV2vaccine was introduced in JulyAugust,2021in Lagos State. 1,574 HCWs acquired knowledge on IPV2 introduction and 1,840 training manuals and other materials/data tools were distributed to the HCWs and HFs. 91,225 children immunized with IPV2 vaccines from August to October,2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All priority states supported in developing annual workplan , identification of missed communities, zero dose children and implementation strategy,</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, identification of missed communities and zero dose children,conducting successful NPSIAs, and introduction of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">- Lagos State RIWG operationalized the developed annual work plan on RI and other PHC services. Supported the development of 2022 AOP on RI and PHC Services. 11 LGAs identified as prioritized LGAs for zero dose children &amp; missed communities in Lagos States. Supported 3 rounds of LGAs in 11 prioritized LGAs in August,November and December,2021 1189 HCWs acquired knowledge on development of REW/REC REW micro-plan for zero dose children and missed communities. and 152 HFs from 11 supported LGAs developed REW/REC mico-plan. 341,738 children immunized with penta1 in 2021 as against 321,045 in 2020 of same period. Resulted in 20,693 reduction of zero dose children as compared with 2020. IPV2vaccine was introduced in JulyAugust,2021in Lagos State. 1,574 HCWs acquired knowledge on IPV2 introduction and 1,840 training manuals and other materials/data tools were distributed to the HCWs and HFs. 91,225 children immunized with IPV2 vaccines from August to October,2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1 NERIC and states supported in the development of annual work plan on identification and mapping of zero dose children, 1.2. Barriers of missed communities to access immunisation services identified and prioritised 1.3 .REW micro-plan developed and suitable approached to reach missed communities identified and endorsed.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical Support to NERICC and states on ithe development of annual work plan,OIRIS implementation strategy and new vaccines introduction. 1.1 Provide technical support to Gavi supported eight (8) states on identification and mapping of zero dose children, missed communities and implementation of strategies to reduce number of zero dose and reached missed children. 1.2 Provide support to priority states on the development of REW microplans and implementation of RI intensification in uban slums and missed/underserve communities.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. NERICC and states annual work plan developed for 2021 
1.2 LQAS and DHIS2 data triangulated and LGAs with zero dose/unimmunized and barriers identified and prioritized.. 1.3 REW Micro-plan developed in 31LGAs( 1,600 HFs) in five states and strategy developed by HCWs to reach missed communities.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.1 Capacity of health workers built on conduct of integrated RI intenfication to missed communities ( Uban slums,under servce communities and zero dose children ). 1.2 Integrated routine immunization intensification conducted in the identified missed communites including under served communities in the identified LGAs. 1.3 OIRIS activity conducted and supervised in priority states/LGAs/HFs</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide technical Support to NERICC and states on ithe development of annual work plan,OIRIS implementation strategy and new vaccines introduction. 1.1 Provide technical support to Gavi supported eight (8) states on identification and mapping of zero dose children, missed communities and implementation of strategies to reduce number of zero dose and reached missed children. 1.2 Provide support to priority states on the development of REW microplans and implementation of RI intensification in uban slums and missed/underserve communities.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1.0 NERICC,36 states &amp;FCT SERICC/SRIWG operationalized the developed annual work plan 2021 and supported the development of Annual Operation plan for 2022 from the 36 states and FCT. 1.0.1. Prioritized145 LGAs across the 36 states &amp; FCT for zero dose/missed communities immunization. 1.0.2. 90 LGAs across 13 states supported PIRI for zero dose children and missed communities. Reduced zero dose children by 5% as compared to 2020 1.0.3.Supported OIRIS Assessment held in six states in the 18 NERICC states, OIRIS methodology revised in the 36 states &amp; FCT with 148 participants and 777 RIOs knowledge updated on optimized RI session&apos;s data analysis and RISS . 1.0.4. Supported two (2) days National virtual TOT for national and sub-national staff on IPV2 introduction in 36 states and FCT. 4,267 participants acquired acknowledge on IPV2 introduction. 64,916 IPV2 introduction training manual developed &amp; distributed to the 36 states &amp; FCT . Total of 762,815 children immunized with IPV2 from August to October,2021 1.1 . 18 LGAs in 4 Gavi supported states developed REW micro-plan and implemented RI intensification for zero dose children. 1.2. 3,804 heath facilities in 102 LGAs developed comprehensive REW-micro-plan for zero dose children and missed communities and implemented RI intensification . 1.3;Supported development of NSPISS,2.0 to the 36 states and Annual Operational plan for 36 states, and FCT developed</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">60% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro,,Abalak, Bermo,Malbaza,Tessaoua, G. Roumdji,Madaoua, Tahoua D&#xE9;partement,,Bouza,)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">100% des 9 districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade. Sur la base des cartographies des mouvements des nomades et les &#xE9;v&#xE9;nements socio-culturels, des activit&#xE9;s de vaccinations int&#xE9;gr&#xE9;s aux cliniques mobiles sont mises en ?uvre dans ces districts . de r&#xE9;cup&#xE9;ration et de vaccination des enfants cibles du PEV. En plus des districts identifi&#xE9;s par le RSS3, les districts de Tchirozerine, If&#xE9;rouane, Ngourti, Tassara et Ingal ont b&#xE9;n&#xE9;fici&#xE9; du financement de l&apos;UNICEF pour la mise en ?uvre de ladite strat&#xE9;gie,</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% des districts urbains et semi-urbains identif&#xE9;s ont mis en oeuvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les 6 districts prioritaires RSS3 (B.Konni, Maradi Ville, Niamey5, Niamey3,Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">100% des districts urbains et semi-urbains identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie urbaine de vaccination. Trois (3 ) consultants sont d&#xE9;ploy&#xE9;s dans les 3 r&#xE9;gions couvrant les 6 districts et apportent un appui technique continue dans l&apos;organisation des activit&#xE9;s de vaccination de routine et de masse, la gestion des vaccins , la maintenance des &#xE9;quipements de Chaine de froid et l&apos;analyse des donn&#xE9;es (DVD MT, SMT, Niger Vaccine Stock). Aussi, l&apos;UNICEF apporte un financement dans la mise en ?uvre des strat&#xE9;gies urbaines et semi urbaines dans les districts de Agadez Commune, Diffa Commune, Zinder Ville , Niamey 1, 2 et 4. Ce qui porte un total de 12 le nombre de districts du Niger mettant en ?uvre les strat&#xE9;gies urbaines</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The LGAs are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to Lagos State in all LGAs in the NSIPSS implmentation and improving RI coverage, identification of missed communities,urban slums, zero dose children, conducting successful NPSIAs, and introducition of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? .OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The states are supported in conducting OIRIS visits.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provide technical support to the states in the NSIPSS implmentation and improving RI coverage, identification of missed communities and zero dose children,conducting successful NPSIAs, and introduction of new vaccines">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">? States RIWG in the FO developed annual work plan for RI activities and established SERICC in Ebonyi state.
? .OIRIS Strategy strengthened in the five (5) states in SEZ in conduct of RI service at the secondary and tertiary health facility. and optimized quality RISS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les documents pour l&apos;&#xE9;laboration de la strat&#xE9;gie sont collect&#xE9;s et analys&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour l&apos;&#xE9;laboration de la strategie de vaccination dans les 8 DS situ&#xE9;s en zone d?ins&#xE9;curit&#xE9; (Abala, Main&#xE9; soroa, Bankilar&#xE9;, Bosso, Tera, Ayerou, Tillia, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">L&apos;idenfication des acteurs et des personnes ressources (ECD, societ&#xE9; civile, ONG intervenants) est r&#xE9;aliis&#xE9;e. La collecte de la documentation est en cours. Un atelier d&apos;elaboration est pr&#xE9;vu pour le dernier trimestre 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des districts identifi&#xE9;s ont mis en ?uvre la strat&#xE9;gie de vaccination en milieu nomade</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strategie nomade dans 9 DS situ&#xE9;s dans les r&#xE9;gions de Maradi et Tahoua (Dakoro,,Abalak, Bermo,Malbaza,Tessaoua, G. Roumdji,Madaoua, Tahoua D&#xE9;partement,,Bouza,)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en ?uvre de la strat&#xE9;gie nomade est effective dans les 9 districts &#xE0; travers les strat&#xE9;gies avanc&#xE9;e et mobile. Ces districts ont r&#xE9;alis&#xE9; la cartographie des mouvements des nomades selon les p&#xE9;riodes de l?ann&#xE9;e et les &#xE9;venements socio-culturels. Les activit&#xE9;s de microplanification semestrielle pour l&apos;identification et l&apos;adressage de differents goulots sont en cours. Ces activit&#xE9;s ont &#xE9;t&#xE9; financ&#xE9;es par le Fond Commun RSS3 au 1er trimestre.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La strat&#xE9;gie de vaccination en zone d&apos;ins&#xE9;curit&#xE9; est &#xE9;labor&#xE9;e</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour l&apos;&#xE9;laboration de la strategie de vaccination dans les 8 DS situ&#xE9;s en zone d?ins&#xE9;curit&#xE9; (Abala, Main&#xE9; soroa, Bankilar&#xE9;, Bosso, Tera, Ayerou, Tillia, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les termes de r&#xE9;f&#xE9;rence pour l&apos;&#xE9;laboration de la strat&#xE9;gie de vaccination en zone d&apos;ins&#xE9;curit&#xE9; sont finalis&#xE9;s en attende de l&apos;atelier pr&#xE9;vue courant d&#xE9;cembre 2021. En attendant, l&apos;&#xE9;laboration du document de strat&#xE9;gie, les activit&#xE9;s de vaccination se poursuivent dans les 8 districts sanitaires avec un financement Gavi et un compl&#xE9;ment de l&apos;UNICEF dans les districts d&apos;Ayerou, Main&#xE9; Soroa, Tillia.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">40% des districts urbains et semi-urbains identif&#xE9;s ont mis en oeuvre la strat&#xE9;gie urbaine de vaccination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI pour la mise en oeuvre de la strat&#xE9;gie urbaine dans les 6 districts prioritaires RSS3 (B.Konni, Maradi Ville, Niamey5, Niamey3,Tahoua Commune, Madarounfa)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Tous les 6 districts ont mis en ?uvre la strat&#xE9;gie urbaine de vaccination gr&#xE2;ce au financement du Fond commun /RSS3</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. DHIS2 Server optimization analysis done
d</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct Data Quality Analysis, Reviews and Feedback to monitor the level of improvement of Data Quality in line with the DQIP. 
 2. Conduct HMIS/DHIS2 server utilitity and response gaps and make recommendations for improvement 
 3. Develop guidelines for the implementation and scale up of the RI SMS projects and eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Support data quality analysis of routine immunization data on DHIS2 and feedback provided on a monthly. 2. Plans underway to incorporate DQIP indicators on NERICC dashboard. 3. WHO provides regular feedback on the performance on the DHIS2 platform. 4. Supporting NERICCs plan to scale up real-time reporting of RI through a mobile App through Gavi support (NERICC is yet to receive Gavi&apos;s commitment to this).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine Feedback on RISS, AEFI, RI services updated and shared</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop, complie and share monthly RI, Supportive Supervision and AEFI feedback.
 Develop and implement dashboards to monitor quality of preparedness and outputs of service delivery strategies for routine immunisation
 Identify and develop data management related protocols for PAPA LQAS, MICS/NICS, EVMA etc.
 Compile data elements for the eJRF; and Joint Appraisals">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported in the preparation and dissemination of monthly feedback on routine immunization performance which includes supportive supervision and AEFI. 2. Supported the development of protocols for PAPA LQAS, MICs/NICs that is currently being used for data collection and analysis. 3. WHO supported NPHCDA to prepare and submitted the eJRF for 2020. 4. WHO is providing coordination and technical functions to ensure review of AEFI &amp; AESI cases by the NPEC.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Developed platform for electronic immunisation registry</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Conduct Data Quality Analysis, Reviews and Feedback to monitor the level of improvement of Data Quality in line with the DQIP. 
 2. Conduct HMIS/DHIS2 server utilitity and response gaps and make recommendations for improvement 
 3. Develop guidelines for the implementation and scale up of the RI SMS projects and eLMIS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported in the preparation of RI Data quality feedback 2. Support DQIP review and implementation tracking 3. Supported development of electronic checklists for real-time field data collection and transmission as part data quality improvement activities 4. Supported review of DHIS2 server infrastructure, server downtime monitoring and NHMIS Ver 2019 dataset utilization and recommend way forward 5. Supported development of assessment guide and criteria for eLMIS solution and operationalization of EMID system.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All NERICC data team trained on routine data analysis template</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Develop, complie and share monthly RI, Supportive Supervision and AEFI feedback.
 Develop and implement dashboards to monitor quality of preparedness and outputs of service delivery strategies for routine immunisation
 Identify and develop data management related protocols for PAPA LQAS, MICS/NICS, EVMA etc.
 Compile data elements for the eJRF; and Joint Appraisals">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO is supporting the development of monthly routine immunizaion and AEFI surveillance performance. The last monthly routine immunization performance was for April, 2021. 2. Provided technical support to the development of protocols for PAPA LQAS, MICS6/NICS2021, and EVMA. MICS6/NICs 2021 implementation is currently ongoing and now at the stage of national training of trainers and fieldwork proposed for 3rd quarter 2021. 3. Supported the compilation of e-JRF 2021 which has been submitted.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data desk review or triangulation analysis performed (coverage, surveillance, operational, others)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation des reunions mensuelles d&apos;analyse et de triangulation des donn&#xE9;es de vaccination dans les 33 districts prioritaires; trimestrielle au niveau regional et central y compris la production des bulletins trimestriels avec feedback (plan de resolution de probl&#xE8;me)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Au niveau central, des r&#xE9;unions d&apos;analyses des donn&#xE9;es sont r&#xE9;alis&#xE9;es y compris celles de la vaccination contre la covid-19 et de la gestion des vaccins. Cela a permsi notamment d&apos;alimenter le contenu des diff&#xE9;rentes faites avec le MSP et ses partenaires (Gavi, OMS-IST, AFRO, UNICEF WCARO...), les pr&#xE9;sentations lors des r&#xE9;unions de CCIA et la production de bulletin. Voir celui du S1 2021 en attendant la finalisation du bulletin T3.
Pour le niveau op&#xE9;rationnel, l&apos;OMS a positionn&#xE9; dans consultants gestionnaires de donn&#xE9;es dans les r&#xE9;gions afin d&apos;appuyer la culture d&apos;analyse et d&apos;utilisation des donn&#xE9;es. Ainsi ces &#xE9;quipes, en plus des appuis multiformes apport&#xE9;s aux &#xE9;quipes r&#xE9;gionales, identifient les districts qui ont besoin d&apos;appui sp&#xE9;ficiques et partent les aider.Cela a contribuer &#xE0; l&apos;am&#xE9;lioration des donn&#xE9;es notamment de vaccination (routine et covid-19) et l&apos;identification des centres de sant&#xE9; et localit&#xE9;s ayant plus d&apos;enfants 0-doses et insuffisamment vaccin&#xE9;s ayant permis de d&#xE9;finir les strat&#xE9;gies pour les atteindre.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils et modules DQS r&#xE9;vis&#xE9;s
50% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Compte tenu des charges de travail li&#xE9;es &#xE0; la gestion de la pend&#xE9;mie et autres &#xE9;pidemi&#xE9;es (campagnes polio, rougeole, m&#xE9;ningite, covid-19?), les acteurs n&apos;ont pas pu commencer cette importante activit&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30 agents des niveaux central et r&#xE9;gional sont capacit&#xE9;s sur la m&#xE9;thodologie d?&#xE9;laboration des projections</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Former 14 agents du niveau central et 16 soit 2 cadres par region provenant des 08 regions sur la m&#xE9;thodologie d?&#xE9;laboration des projections (y compris les cibles pour la vaccination) en lien avec la sant&#xE9; par l&apos;Institut National de la Statistique">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Compte tenu du nouveau recensement g&#xE9;n&#xE9;ral de la population et de l&apos;habitat en pr&#xE9;paration, l&apos;Institut de la Statistique de demand&#xE9; de report&#xE9; cette activit&#xE9; &#xE0; la fin du 5&#xE8;me RGPH</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La session de formation de formation suivie de la conduite du DQS dans les 72 districts est pr&#xE9;vue courant d&#xE9;cembre 2021. Une innovation a &#xE9;t&#xE9; introduite consistant &#xE0; coupler ces sessions de DQS &#xE0; une enqu&#xEA;te de type LQAS aupr&#xE8;s des m&#xE9;nages.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">La note conceptuelle de formation est &#xE9;labor&#xE9;e, les outils et mat&#xE9;riels divers de la formation sont developp&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Former 14 agents du niveau central et 16 soit 2 cadres par region provenant des 08 regions sur la m&#xE9;thodologie d?&#xE9;laboration des projections (y compris les cibles pour la vaccination) en lien avec la sant&#xE9; par l&apos;Institut National de la Statistique">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La vaccination COVID-19 en cours ne permet pas d organiser cette formation du fait de l;implication de la majorit&#xE9; de restaires dans cette activit&#xE9;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Documents des r&#xE9;sultats de recherche disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de 02 recherches op&#xE9;rationnelles sur l&apos;introduction du vaccin contre la COVID-19 et son impact sur le programme de vaccination (Enqu&#xEA;te Innocuit&#xE9; - Etude Cas-temoin)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Le protocole d&apos;&#xE9;tude sur l&apos;efficacit&#xE9; vaccinale (COVID-19) a &#xE9;t&#xE9; finalis&#xE9;e et est en attente de validation par le Comit&#xE9; Ethique du pays.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Outils et modules DQS r&#xE9;vis&#xE9;s 50% des acteurs &#xE0; former &#xE0; chaque niveau sont form&#xE9;s sur les outils r&#xE9;vis&#xE9;s et la conduite du DQS</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="R&#xE9;viser les outils DQS et former 180 acteurs (2 cadres par districts relevant des 72 districts, 3 cadres par region provenant des 8 regions et 12 cadres du niveau central) sur les outils r&#xE9;vis&#xE9;s et la conduite de DQS">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les outils revis&#xE9;s sont disponibles et les sessions de formation pr&#xE9;vues au mois de decembre 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 60% des activit&#xE9;s cibl&#xE9;es pour 2021 dans le PAQD sont mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre et le suivi des activit&#xE9;s du plan strat&#xE9;gique d&apos;am&#xE9;lioration des donn&#xE9;es (PAQD 2020-2022)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Malgr&#xE9; l&apos;orientation des acteurs de mise en ?uvre du PAQD dans la r&#xE9;ponse &#xE0; la pend&#xE9;mie de la COVID-19 et autres ripostes (Campagnes de vaccination, ripostes CVDPV2, riposte chol&#xE9;ra?), le niveau de mise en oeuvre du plan &#xE0; ce statde de mis-parcours est de 36%.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Au moins 30% des activit&#xE9;s cibl&#xE9;es pour 2021 dans le PAQD sont mises en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre et le suivi des activit&#xE9;s du plan strat&#xE9;gique d&apos;am&#xE9;lioration des donn&#xE9;es (PAQD 2020-2022)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Malgr&#xE9; le contexte difficile caract&#xE9;ris&#xE9; par diff&#xE9;rentes urgences &#xE0; prendre en charge par les acteurs (gestion covid-19, &#xE9;pid&#xE9;mie polio, rougeole, m&#xE9;ningite, documents de proposals?), les activit&#xE9;s continuent d&apos;&#xEA;tre mise en ?uvre. Ainsi, les analyses r&#xE9;guli&#xE8;res des donn&#xE9;es, la r&#xE9;vision des outils SNIS, l&apos;am&#xE9;lioration du DHIS2, la coordination SNIS-DHIS2, l&apos;appui &#xE0; l&apos;Observatoire national de la Sant&#xE9;, le processus d&apos;&#xE9;valuation du Plan Strat&#xE9;gique SNIS, le processus de transition vers DHIS2, les pr&#xE9;paratifs aux param&#xE9;trages des module QUalit&#xE9; de donn&#xE9;es et modules EPI... avancent comme pr&#xE9;vu</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 Protocoles de recherche disponibles</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la conduite de 02 recherches op&#xE9;rationnelles sur l&apos;introduction du vaccin contre la COVID-19 et son impact sur le programme de vaccination (Enqu&#xEA;te Innocuit&#xE9; - Etude Cas-temoin)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Un protocol sur l&apos;efficacit&#xE9; vaccinal contre la COVID-19 a ete developp&#xE9; en collaboration avec IST, CERMES,DI et DSRE</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Data guidance / SOP developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer l&apos;organisation des reunions mensuelles d&apos;analyse et de triangulation des donn&#xE9;es de vaccination dans les 33 districts prioritaires; trimestrielle au niveau regional et central y compris la production des bulletins trimestriels avec feedback (plan de resolution de probl&#xE8;me)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;Une r&#xE9;union d&apos;analyse des donn&#xE9;es du premier trimestre a &#xE9;t&#xE9; r&#xE9;alis&#xE9;e au niveau national avec l&apos;ensemble des parties prenantes. Les r&#xE9;sultats des travaux ont servi pour l&apos;&#xE9;laboration du premier bulletin trimestriel dont le draft est joint.
Les r&#xE9;gions, des r&#xE9;unions sont r&#xE9;alis&#xE9;es avec l&apos;appui des staffs OMS en r&#xE9;gion.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Approach for multi-data triangulation developed and approved by the NERICC and Core Group to identify zero dose populations and support targeted deployment of interventions to reduce number of zero dose children in Nigeria</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Draft approach developed and discussed by NERICC and the NPHCDA data team. The team is currently making additional refinements and will present the approach for approval in coming weeks.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Results of data triangulation presented monthly to the NERICC and Core Group
- State-level analysis shared with all states
- Action plans to address issues flagged by the analysis developed by the states and incorporated into state annual operational plans</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Multiple data analyses have been conducted to support NERICC&apos;s prioritization of interventions and focus areas. As the country eagerly awaits the results of the recent MICSNICS survey, the team is on ground to update the analyses using the new data.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. 50% of recommendation of HRH assessment implemented in selected states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Not done. Planned to be conducted before the year runs out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. HRS assessment implemented in 2 states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Provision of technical support to state to regularly map and optimally distribute health workers">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Not done. Planned to be conducted later in the year.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">John Snow, Inc. : Vaccine-Specific Support</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Pilot project plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the pilot implementation of RoverInk in one (1) district to facilitate data collection">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">RoverInk contract is in place (directly with WHO) and sites for RoverInk pilot have been selected (4 regions, 4 districts, 45 health centers). JSI has supported the identification of sites, together with WHO. JSI will help with training, facilitating, monitoring activities, and introducing RoverInk across the country. Health workers will use this device to transfer information into DHIS to initially demonstrate its use, particularly with stock information for better management. Additionally, there is potential to use RoverInk for cold chain equipment (CCE) and to update inventory as well.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Johns Hopkins University : Demand Promotion &amp; ACSM</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Online survey of socio-behavioural drivers of vaccine uptake conducted and analysis by state produced
? State communication plans that prioritizes demand generation strategies for zero dose children developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of state plans and strategies for behaviour change communication to address zero dose, informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake, stakeholder mapping and knowledge of key influencers.
? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi.">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Support the development of state plans and strategies for behaviour change communication to address zero dose (completed), informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake (major delays), stakeholder mapping and knowledge of key influencers. (on track)? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi. (minor delays)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Situational analysis report including drivers and correlates of zero dose, mapping of zero dose children produced
? States supported to implement planned funded communication strategies targeting zero-dose children
? Gavi CSO engagement framework adapted for the Nigerian context
? CSO mapping updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support the development of state plans and strategies for behaviour change communication to address zero dose, informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake, stakeholder mapping and knowledge of key influencers.
? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi.">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Support the development of state plans and strategies for behaviour change communication to address zero dose (completed), informed by state-specific analysis of socio-behavioural drivers of vaccine demand and uptake (major delays), stakeholder mapping and knowledge of key influencers. (on track)? Strengthen the basis for effective engagement and mobilization of CSOs for zero-dose and demand generation by supporting the adaptation to the Nigerian context, the forthcoming CSOs engagement framework by Gavi. (minor delays)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Training on adaptive management and use of HCD integrated into approved and funded training activities for national trainers</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management and human centred design approaches (HCD)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management (on track) and human centered design approaches (HCD) (major delays)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Produce how-to-do short training videos on various immunization skills (e.g. adaptive management processes like after action review, or organizing community listening exercises during HCD) for health workers disseminations</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management and human centred design approaches (HCD)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">TA to support the planning, coordination and conduct of innovative capacity building approaches to improve knowledge and skills of health workers, specifically use of adaptive management (on track) and human-centered design approaches (HCD) (major delays)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Supply Chain &amp; Procurement</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% completion of CCEOP PMT workplans across implementing states (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="11. Technical support for the CCEOP deployment and implementation">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. All activities related to CCEOP Tranche 1 process have completed including coordination meeting with States and signing of the MOUs, coordination with service provider, clearing of the equipment consignment, LSP&apos;s logistics facilities inspections, official launching of the CCEOP project
2. Revalidation of operational deployment plan before deployment. 
3. Coordination with states for the site readiness for the deployment and installation of the CCE
4. Quality management: 
a. Weekly report from service provider and feedback when needed procedure in place. Cross check of the update report from service provider with states
b. In-process monitoring: the detail planned physical site visit monitoring couldn&apos;t happen because of Covid pandemic. However, the PMT visited the initial installation in FCT and provided detail feedback to the service provider. 
c. Through Zonal and states stakeholders number of sites inspected using the PII monitoring checklist and shared feedback and discussed the issues with stake holders, especially service provider. 
d. 100% site installation validation of 1200 ties completed through desk review of the installations documents with pictures of different process of the installations. Through this process, number of installations were requested reinstall the solar panels correctly. 
5. Issue/Change management: 
a. Reviewed number of request from states for change of sites and provided advice to accept or not accept the request
b. Reviewed number of issues of storage condition of the CCE in number of states and coordinated proper action from service provider. 
c. Reviewed number of installation issues, such as solar panel not facing in correct direction, and resolved with service provider to reinstall those panels correctly. 
6. Results: as at 18 June, 57% (3,607out of 6,346) unit of CCE have been installed from tranche 2.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="11. Technical support for the CCEOP deployment and implementation">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. All activities related to CCEOP Tranche 1 process have completed including coordination meeting with States and signing of the MOUs, coordination with service provider, clearing of the equipment consignment, LSP&apos;s logistics facilities inspections, official launching of the CCEOP project
2. Revalidation of operational deployment plan before deployment. 
3. Coordination with states for the site readiness for the deployment and installation of the CCE
4. Quality management: 
a. Weekly report from service provider and feedback when needed procedure in place. Cross check of the update report from service provider with states
b. In-process monitoring: the detail planned physical site visit monitoring couldn&apos;t happen because of Covid pandemic. However, the PMT visited the initial installation in FCT and provided detail feedback to the service provider. 
c. Through Zonal and states stakeholders number of sites inspected using the PII monitoring checklist and shared feedback and discussed the issues with stake holders, especially service provider. 
d. 100% site installation validation of 1200 ties completed through desk review of the installations documents with pictures of different process of the installations. Through this process, number of installations were requested reinstall the solar panels correctly. 
5. Issue/Change management: 
a. Reviewed number of request from states for change of sites and provided advice to accept or not accept the request
b. Reviewed number of issues of storage condition of the CCE in number of states and coordinated proper action from service provider. 
c. Reviewed number of installation issues, such as solar panel not facing in correct direction, and resolved with service provider to reinstall those panels correctly. 
6. Results: as at 18 June, 57% (3,607out of 6,346) unit of CCE have been installed from tranche 2.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% des Coordonnateurs D&#xE9;partementaux  Immunisations et agents de sant&#xE9; sont form&#xE9;s sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT ) dans les 33 districts prioritaires</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Coordonnateurs D&#xE9;partementaux des Immunisations et des agents de sante offrant la vaccination sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT, outil de l &apos; inventaire et de l&apos;analyse des gaps ECF) dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">26 personnes dont 5 participants du niveau central, 4 des regions ,15 du niveau district et 2 OMS ont &#xE9;t&#xE9; form&#xE9;s sur le CCL du 16 au 27 novembre 2020 &#xE0; Dosso.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la formation des Coordonnateurs D&#xE9;partementaux des Immunisations et des agents de sante offrant la vaccination sur le CCL (chaine du froid, Gestion des vaccins, Tenue des outils SMT, outil de l &apos; inventaire et de l&apos;analyse des gaps ECF) dans les 33 districts prioritaires">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">26 personnes dont 5 participants du niveau central, 4 des regions ,15 du niveau district et 2 OMS ont &#xE9;t&#xE9; form&#xE9;s sur le CCL du 16 au 27 novembre 2020 &#xE0; Dosso.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">PSC Report submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="10. Physical Stock Counting Exercise">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Activity modified and physical stock data submitted monthly to regional office and not as one time outsourced activity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">SOPs disemminated and personnel trained on revised processes</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Both hubs yet to be completed. The discussion and coordination have commenced to develop the operationalization plan.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Lagos hub construction contract has just been awarded and site yet to be clear. Abuja upgrade is at the level of design review finalization. Procurement process of of Large cold rooms started. As part of the operationalization the human resource requirement, workflows and system design assessment will be conducted in Q3 and 4</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="14. Support operationalization of 3-hubs (focus on Kano and Abuja hubs)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Lagos hub construction contract has just been awarded and site yet to be clear. Abuja upgrade is at the level of design review finalization. Procurement process of of Large cold rooms started. As part of the operationalization the human resource requirement, workflows and system design assessment will be conducted in Q3 and 4</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% des activit&#xE9;s du plan d&apos;am&#xE9;lioration de la GEV ont &#xE9;t&#xE9; mises en ?uvre &#xE0; temps</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI au d&#xE9;veloppement et &#xE0; la mise en ?uvre du plan d&apos;am&#xE9;lioration de la gestion efficace des vaccins issu des r&#xE9;sultats de la GEV externe conduite en  2020">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Sur 55 activit&#xE9;s programm&#xE9;es : 35% des activit&#xE9;s sont r&#xE9;alis&#xE9;es (19) , 29% en cours (16) et 36% non r&#xE9;alis&#xE9;es (20)</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI au d&#xE9;veloppement et &#xE0; la mise en ?uvre du plan d&apos;am&#xE9;lioration de la gestion efficace des vaccins issu des r&#xE9;sultats de la GEV externe conduite en  2020">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Sur 55 activit&#xE9;s programm&#xE9;es : 35% des activit&#xE9;s sont r&#xE9;alis&#xE9;es (19) , 29% en cours (16) et 36% non r&#xE9;alis&#xE9;es (20)</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?25% completion of ISC systems redesign optimisation plan (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="13. Technical support for ISC systems redesign, including warehousing and distribution optimisation
 Other activities related to ISC2 mission">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">System design assessment completed in 8 states of Niger, Zamfara, Gombe, Kebbi, Katsina, Taraba, Bayelsa and Jigawa (80% of the 10 states targeted) with stakeholders workshops, landscape assessment, baseline scenario and prioritization completed. States of Kano and Lagos are at the stage of landscape scenario and data collection.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="13. Technical support for ISC systems redesign, including warehousing and distribution optimisation
 Other activities related to ISC2 mission">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">System design assessment completed in 8 states of Niger, Zamfara, Gombe, Kebbi, Katsina, Taraba, Bayelsa and Jigawa (80% of the 10 states targeted) with stakeholders workshops, landscape assessment, baseline scenario and prioritization completed. States of Kano and Lagos are at the stage of landscape scenario and data collection.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% completion of annualised NLWG projects to be implemented at the state level</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6. Technical liaisons between the NLWG and SLWGs, withinzonal catchment areas, for implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Technical support provided and immunization supply chain costed annual workplan available reflecting the iSC priorities. Support provided for the development of subnational immunization supply chain costed workplans through ZLWG and SLWG as well. NLWG, ZLWGs and SLWGs are meeting regularly in the past six month to operationalize workplans. Areas for zero dose intervention identified, vaccine delivery modalities to the implementing facilities are determined, cold chain availability was mapped in the zero dose affected areas in favor of coverage and equity</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="6. Technical liaisons between the NLWG and SLWGs, withinzonal catchment areas, for implementation of annualized NLWG work plan at state level">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Technical support provided and immunization supply chain costed annual workplan available reflecting the iSC priorities. Support provided for the development of subnational immunization supply chain costed workplans through ZLWG and SLWG as well. NLWG, ZLWGs and SLWGs are meeting regularly in the past six month to operationalize workplans. Areas for zero dose intervention identified, vaccine delivery modalities to the implementing facilities are determined, cold chain availability was mapped in the zero dose affected areas in favor of coverage and equity</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">iSC Roadmap finalized and 2021 annualized NLWG work plan developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="15. TA to support development of iSC Roadmap (Year 2)">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The draft road map is being finalized. A lockdown workshop has been planned in September 2021 to finalize the document.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% Procurement and distribution of vaccines and devices in line with 2020 forecast
100% Forecast accuracy monitoring and evaluation (quarterly)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5. Support  state specific forecasting  in line with the revised immunization coverage targets for states">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Vaccines and devices forecast for 2022 was done in line with the revised parameters (Wastage rate from wastage rate calculator, revised coverage rate and population). Procurement figures determined based on the current and expected balance adjustment</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="5. Support  state specific forecasting  in line with the revised immunization coverage targets for states">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Vaccines and devices forecast for 2022 was done in line with the revised parameters (Wastage rate from wastage rate calculator, revised coverage rate and population). Procurement figures determined based on the current and expected balance adjustment</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Les equipements de la chaine du froid de l&apos;ann&#xE9;e 2 du CCEOP sont receptionn&#xE9;s, distribu&#xE9;s, install&#xE9;s.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du CCEOP et le suivi de la gestion des equipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;248 (100%) &#xE9;quipements de la chaine du froid (133 r&#xE9;frig&#xE9;rateurs solaires , 64 r&#xE9;frig&#xE9;rateurs &#xE9;lectriques et 51 cong&#xE9;lateurs) ont &#xE9;t&#xE9; r&#xE9;ceptionn&#xE9;s, distribu&#xE9;s et install&#xE9;s. 
115 r&#xE9;gulateurs de tension et 526 Frigde Tag ont &#xE9;t&#xE9; r&#xE9;ceptionn&#xE9;es.&quot;</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la DI dans la mise en ?uvre du CCEOP et le suivi de la gestion des equipements de la chaine de froid a tous les niveaux">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;248 (100%) &#xE9;quipements de la chaine du froid (133 r&#xE9;frig&#xE9;rateurs solaires , 64 r&#xE9;frig&#xE9;rateurs &#xE9;lectriques et 51 cong&#xE9;lateurs) ont &#xE9;t&#xE9; r&#xE9;ceptionn&#xE9;s, distribu&#xE9;s et install&#xE9;s. 
115 r&#xE9;gulateurs de tension et 526 Frigde Tag ont &#xE9;t&#xE9; r&#xE9;ceptionn&#xE9;es.&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Independent Consultants (PEF) : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Update Gavi team on introduction and campaign planning and implementation. 
2.Provide written reports on work completed to Gavi Secretariat on a monthly basis.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Support the implementation of Gavi?s strategy of support to the Government of Nigeria (GoN) for strengthening immunisation and primary health care. 
2.	Provide technical support to the Federal Government of Nigeria (FGoN) through the National Primary Health Care Development Agency (NPHCDA) and state governments to assess the current needs in the primary health care system including immunisation and develop strategies to increase immunization coverage with special focus on reaching zero-dose children.  
3.	Participate in strategic meetings of the National Emergency Routine Immunization Coordination Centre (NERICC) and other technical working groups such as the Non-Polio SIA team (NPSIA) in line with the operationalization of the National Strategy for Immunization and PHC System Strategy (NSIPSS) and serve as a liaison to ensure linkage between routine immunisation, vaccine introduction and campaigns.
4.	Support the GoN to respond effectively and efficiently to any emerging vaccine preventable disease threat (this may include epi analyses and coordination of activities between GoN, partners and NGOs).
5.	Assist NPHCDA with developing proposals for Gavi support and addressing issues raised by the IRC.
6.	Monitor the implementation of wastage study findings on behalf of Gavi and represent Gavi at related critical meetings with the National Logistics Working Group (NLWG)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The 2021 dominant activities were focused on the Covid19 vaccine introduction and rolling-out the first 3phases. Despite conflicting activities on ground, we were able to cover 13 out of the 37 States for the non-polio SIAs. In addition, I contributed on the new NSIPSS 2.0 write-up. Activities are becoming more and more focused on the Gavi 5.0 strategy for reaching Zero-dose children. This has started being applied during the implementataon of the SIAs.
The CWG is giving a srtrong support for technical guidance for the country.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.	Support the implementation of Gavi?s strategy of support to the Government of Nigeria (GoN) for strengthening immunisation and primary health care. 
2.	Provide technical support to the Federal Government of Nigeria (FGoN) through the National Primary Health Care Development Agency (NPHCDA) and state governments to assess the current needs in the primary health care system including immunisation and develop strategies to increase immunization coverage with special focus on reaching zero-dose children.  
3.	Participate in strategic meetings of the National Emergency Routine Immunization Coordination Centre (NERICC) and other technical working groups such as the Non-Polio SIA team (NPSIA) in line with the operationalization of the National Strategy for Immunization and PHC System Strategy (NSIPSS) and serve as a liaison to ensure linkage between routine immunisation, vaccine introduction and campaigns.
4.	Support the GoN to respond effectively and efficiently to any emerging vaccine preventable disease threat (this may include epi analyses and coordination of activities between GoN, partners and NGOs).
5.	Assist NPHCDA with developing proposals for Gavi support and addressing issues raised by the IRC.
6.	Monitor the implementation of wastage study findings on behalf of Gavi and represent Gavi at related critical meetings with the National Logistics Working Group (NLWG)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">World Bank : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">WBG uses its convening power to regularly interact with parliamentarians, Ministry of FInance, Budget and National Planning to ensure that the GON maintains its commitment to PHC, including immunization, through the BHCPF.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Mobilizing more resources for primary health care and the immunisation programme, including vaccine procurement through coordinated high-level advocacy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">?	Through continuing high-level engagement, N25 billion (approx. U$61million) has been released to the national gateway accounts for BHCPF operations in 2022.
?	Facilitated at the Nigeria Health Commissioners forum, where priority action points for strengthening PHC and minimizing fragmentation in the health system were agreed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Trainings on BHCPF at the state level and ongoing technical support to ensure and track state readiness through the PHC readiness tracker.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">?	Through ongoing TA support, 34 of 37 states now disbursing funds to facilities through the NPHCDA gateway; and over 5000 PHCs now receive BHCPF funding across the country
?	Coordinated with the Auditor General?s office to initiate early nationwide audit of BHCPF operations, a critical preparatory step for funds release for Q1 2022
?	Facilitated the development and approval of an operations manual for the EMS gateway by the Ministerial Oversight Committee. Gateway ready to receive funding in the next national round</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Vaccine financing plan developed and agreed with stakeholders on an annual basis</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis; including the analysis of performance against vaccine financing targets in the Accountability Framework">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Draft Vaccine financing plan for 2022 developed and currently being reviewed by NPHCDA and other stakeholders. The current draft incorporates lessons from the 2021 planning process as well revised medium term outlook for vaccine financing in the country.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1.) Vaccine financing plan to transition from loans developed and agreed with stakeholders. 
 2.) Scenarios of vaccine financing in the medium term (based on the short-to-medium term economic outlook) developed and discussed with stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis; including the analysis of performance against vaccine financing targets in the Accountability Framework">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The 2022 Vaccine financing plan already developed is scheduled for presentation and endorsement at the meeting of the Interagency Coordinating Committee (ICC) chaired by Honorable Minister of Health (HMH), on December 14th, 2021. Vaccine financing review was completed as part of annual vaccine financing plan development. Next review planned for Q2 2022</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Framework for health financing strategy developed based on analytical work</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The PASA has been approved and is financed by GAVI, Bank budget and GFF. The fiscal space analysis report is being finalized. Health equity and financing protection report and PFM analysis outputs are scheduled for December 2021. In addition, at the request of GAVI, an immunization financing study is being developed and will be finalized by Q3 2021 (calendar year).</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The PASA has been approved and is financed by GAVI, Bank budget and GFF. The fiscal space analysis report is being finalized. Health equity and financing protection report and PFM analysis outputs are scheduled for December 2021. In addition, at the request of GAVI, an immunization financing study is being developed and will be finalized by Q3 2021 (calendar year).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Key analytics including the HFSA protocol completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="HFSA deep dive with immunization drill down that will inform the development of health financing strategy">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The PASA has been approved and is financed by GAVI, Bank budget and GFF. The fiscal space analysis report is being finalized. Health equity and financing protection report and PFM analysis outputs are scheduled for December 2021. In addition, at the request of GAVI, an immunization financing study is being developed and will be finalized by Q3 2021 (calendar year).</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">All states are disbursing BHCPF funds in line with operational manual</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The World Bank team conducted a training workshop and implementation review of the NPHCDA and NHIS implementation gateways of the BHCPF. The workshop was aimed at capacity building and implementation readiness for the expansion of BHCPF coverage at the state level. This activity together with continuing TA support contributed to notable improvements in availability and quality of services especially in Abia, Niger and Osun, the first pilot states. Across the three states, there is now one facility per ward which has been fully accredited by the NHIS and the NPHCDA and are receiving performance grants on the NHIS and NPHCDA gateways of the BHCPF for sustained improvement of primary healthcare services.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Provide technical support to the implementation of the BHCPF to improve readiness of states to accept funds for primary health care through trainings, and technical support to states.">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The World Bank team conducted a training workshop and implementation review of the NPHCDA and NHIS implementation gateways of the BHCPF. The workshop was aimed at capacity building and implementation readiness for the expansion of BHCPF coverage at the state level. This activity together with continuing TA support contributed to notable improvements in availability and quality of services especially in Abia, Niger and Osun, the first pilot states. Across the three states, there is now one facility per ward which has been fully accredited by the NHIS and the NPHCDA and are receiving performance grants on the NHIS and NPHCDA gateways of the BHCPF for sustained improvement of primary healthcare services.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Report on performance of health finance indicators of the acountability framework developed
 2. Progress report on strategic vaccine financing developed and discussed with stakeholders</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The development of the 2021 Vaccine Financing Plan initially delayed due to a prolonged process of forecasting and stakeholder engagement, has been finalized and is being processed by the National Primary Healthcare Development Agency for formal endorsement. The forecast formed the basis for Government budget for vaccine financing in 2021.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="3. Technical asssitance to the Vaccine Financing Working Group at NPHCDA for the development of the vaccine financing plan on an annual basis;">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The development of the 2021 Vaccine Financing Plan initially delayed due to a prolonged process of forecasting and stakeholder engagement, has been finalized and is being processed by the National Primary Healthcare Development Agency for formal endorsement. The forecast formed the basis for Government budget for vaccine financing in 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Financial management procedures document submitted</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started because the finance specialist not recruited.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">The finance specialist recruited.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist not recruited yet.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Prepare financial management system design document">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">This position was created to support the 8 Gavi supported states in financial management, however because of delay in the commencement of the state support, the specialist has not been recruited. it is expected to be recruited in the next 6 months.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">UNICEF : Programme Management - Financial Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of identified NPHCDA and SPHCDA finance staff trained on HACT and fiduciary risk control 50% Programme Monitoring Visits completion rate (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Major Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The activity has not started because the finance specialist not recruited.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">25% of identified NPHCDA and SPHCDA finance staff from prioriy states trained on HACT and fudiciary risk control 80% Programme Monitoring Visits (Financial) completion rate (anualized) in NERICC states</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile. Technical support for strategic management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited yet. This activity to be carried out by the specialist. This milestone has been reflected in new milestone for 2021.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">50% of identified NPHCDA and SPHCDA finance staff trained on HACT and fiduciary risk control
50%  Programme Monitoring Visits  completion rate  (annualized)</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile.                  Technical support for strategic  management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited yet. This activity to be carried out by the specialist.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="2. Design and implement financial management strengthening strategies at federal, state and sub-state levels to improve efficiency of fund distribution and availability at the last-mile.                  Technical support for strategic  management of immunization financing">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">The finance specialist has not been recruited yet. This activity to be carried out by the specialist.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">3 reunions de CCIA ordinaires tenues au niveau central et 1 reunion ordinaire tenue au niveau des regions d&apos;Agadez, de Tillabery et de Dosso avec rapport dsponibles et 80% des recommandations mise en ?uvre</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique au fonctionnement du CCIA au niveau central et dans les regions d&apos;Agadez, de Tillab&#xE9;ry et de Dosso">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">2 reunions ordinaires de CCIA sur 3 se sont tenues au niveau central (3 Mai et 1er Septembre). 
La r&#xE9;union du 3 Mai a abouti sur la n&#xE9;cessit&#xE9; de d&#xE9;caisser les fonds du Gouvernement pour l&apos;achat des vaccins et le paiement du cofinancement, la soumission dans le portail de GAVI de la demande du pays pour la campagne rougeole 2022 et la mobilisation des ressources pour soutenir la vaccination contre la COVID-19.
La r&#xE9;union du 1er Septembre a abouti &#xE0; la validation de la demande du pays &#xE0; Gavi pour la subvention de la vaccination contre la COVID-19 (CDS), &#xE0; la red&#xE9;finition des strat&#xE9;gies pour la vaccination contre la COVID-19 et &#xE0; l&apos;&#xE9;valuation de la mise en oeuvre du RSS3.
Au niveau des regions, les r&#xE9;uinons sont en cours de pr&#xE9;paration. Elles sont pr&#xE9;vues pour fin Novembre dans les r&#xE9;gions de Tillabery et Dosso (Tdrs valid&#xE9;s et ressources disponibles), et pour d&#xE9;but D&#xE9;cembre dans la r&#xE9;gion d&apos;Agadez (TDRs en cours d&apos;&#xE9;laboration).
Il est &#xE0; noter qu&apos;une r&#xE9;unions extraordinaire du CIIA s&apos;est tenue au niveau central, pour la validation du PNDV COVID-19, les pr&#xE9;paratifs du d&#xE9;marrage de la vaccination contre la COVID-19 au NIger, et sur l&apos;&#xE9;valuation du niveau de d&#xE9;caissement de la subvention RSS3.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 reunions du GTCV organis&#xE9;es avec au moins 2 avis (recommandations) emis pour orienter le programme de vaccination dans la mise en ?uvre des activit&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour le fonctionnement du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">3 reunions de GTCV ont eu lieu en Janvier,fevrier et mars 2021 et ont donn&#xE9; les avis sur l&apos;introduction du vaccin et de la cible de la vaccination contre la COVID-19, le vaccin nOPV2,</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">32 cadres de districts sanitaires prioritaires (2 cadres de 16 districts ) sont brief&#xE9;s sur la conduite des supervisions int&#xE9;gr&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 33 districts sanitaires prioritaires (Coaching par les pairs) dans la conduite de supervisions int&#xE9;gr&#xE9;es des formations sanitaires avec l&apos;appui du niveau central et regional">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Les TDRs deja &#xE9;labor&#xE9;s, les fonds est en cours de decaisssement et l&apos;activit&#xE9; est prevue etre r&#xE9;alis&#xE9;e du 19 au 24 juillet 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Mise en ?uvre d&apos;au moins 01 avis initi&#xE9;e; 

Au moins 3 r&#xE9;nions du GTCV avec au moins 3 avis (recommandations) emis pour orienter le programme de vaccination dans la mise en ?uvre des activit&#xE9;s</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter une assistance technique pour le fonctionnement du GTCV">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Trois r&#xE9;uions du GTCV se sont tenues, ayant abouti &#xE0; l&apos;&#xE9;mission de trois avis sur les types de vaccins contre la COVID-19 &#xE0; introduire au Niger, la cible de la vaccination contre la COVID-19 et l&apos;introduction du vaccin nOPV2.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2 reunions de CCIA statutaires sont tenues avec rapport disponibles au niveau central</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un appui technique au fonctionnement du CCIA au niveau central et dans les regions d&apos;Agadez, de Tillab&#xE9;ry et de Dosso">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Une reunion de CCIA a eu lieu le 3 mai 2021 et a trait&#xE9; les points ci-dessous:
EVALUATION DES RECOMMANDATIONS DU CCIA DU 25 NOVEMBRE 2020 
PRESENTATION SYNTHESE PAA 2021 MSP 
SITUATION DES INDICATEURS PEV DE ROUTINE ET SURVEILLANCE 
SITUATION DES STOCKS DE VACCINS DU PEV ET FINANCEMENT 
PREPARATIFS CAMPAGNE ROUGEOLE 2022
POINT SUR LA VACCINATION CONTRE LA COVID-19
RIPOSTE A L?EPIDEMIE DU PVDVc2
DIVERS
 :</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">01 supervision de qualit&#xE9; conduite par au moins 50% des districts brief&#xE9;s; 

34 cadres de districts sanitaires prioritaires (2 cadres de 17 districts ) sont brief&#xE9;s sur la conduite des supervisions int&#xE9;gr&#xE9;es</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer les 33 districts sanitaires prioritaires (Coaching par les pairs) dans la conduite de supervisions int&#xE9;gr&#xE9;es des formations sanitaires avec l&apos;appui du niveau central et regional">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Une supervision a &#xE9;t&#xE9; organis&#xE9;e sous le lead de la Direction des Immunisations vers les districts sanitaires des huits r&#xE9;gions en fin octobre 2021, avec l&apos;appui du niveau r&#xE9;gional et du niveau central. Le rapport de synth&#xE8;se national est en cours de r&#xE9;daction et sera partag&#xE9; d&apos;ici fin novembre 2021.
Rappelons qu&apos;&#xE9;galement les campagnes de vaccination contre la COVID-19 ont donn&#xE9; l&apos;opportunit&#xE9; au niveau central et r&#xE9;gional de suivre l&apos;&#xE9;volution des indicateurs de perfomance de la vaccination au niveau des districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">CDC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) All labs have applied for WHO certification 2)  Surveillance system revisions in place with standardized weekly epidemiology reports 3)Laboratroy information management system optimize with routine harmonizations with epi data 4) At least 2 outbreak investigated with reports completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2)  1 year Epidemiologist consultant to develop and refine protocols for surveillance, including  case investigation and classification and outbreak response for measles and yellow fever,  and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1) National reference lab and 5 regional labs are WHO Certified. NE regional lab in Gombe lost WHO certification and is not functioning. The country is in the process of assessing needs and feasibility of recertification or if not feasible, selecting and establishing another regional lab in another NE site(s) instead. Once selected and established, CDC will provide TA in support of certification applications. Training will then be planned and conducted for laboratorians at newly or re-established NE lab. 2) Standarardized weekly measles epidmiology reports now being produced, though COVID causes interuptions repeatedly. 3) Laboratory information managment system imporved with tracking of lab surveillance quality though optimizaton has been delayed due to COVID 4) Multiple measles outbreak investigations have been supported by this project with outbreak reports completed.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2)  1 year Epidemiologist consultant to develop and refine protocols for surveillance, including  case investigation and classification and outbreak response for measles and yellow fever,  and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1) National reference lab and 5 regional labs are WHO Certified. NE regional lab in Gombe lost WHO certification and is not functioning. The country is in the process of assessing needs and feasibility of recertification or if not feasible, selecting and establishing another regional lab in another NE site(s) instead. Once selected and established, CDC will provide TA in support of certification applications. Training will then be planned and conducted for laboratorians at newly or re-established NE lab. 2) Standarardized weekly measles epidmiology reports now being produced, though COVID causes interuptions repeatedly. 3) Laboratory information managment system imporved with tracking of lab surveillance quality though optimizaton has been delayed due to COVID 4) Multiple measles outbreak investigations have been supported by this project with outbreak reports completed.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) All labs have applied for WHO certification 2) Surveillance system revisions in place with standardized weekly epidemiology reports 3)Laboratroy information management system optimize with routine harmonizations with epi data 4) At least 2 outbreak investigated with reports completed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2) 1 year Epidemiologist consultant to develop and refine protocols for surveillance, including case investigation and classification and outbreak response for measles and yellow fever, and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Activities are either completed or delayed due to travel restrictions related to COVID19 and will be implemented once the restrictions are lifted. (1) The lab training for the testing of MRYF will be conducted next year, 2022. (2) Surveillance and outbreak response guidance is developed (3) Curriculum development is ongoing. (4) The system for the SORMAS surveillance is ongoing, a few more states are yet to implement (5) The outbreak investigation materials have been developed andimplementation will be done in line with government plans. (6) Measles rapid diagnostic testing not yet introduced as we await supplies.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) Lab training completed for 14 national staff 2) Epidemiologist consultant hired 3) Lab information consutlant hired 4) Outbreak response plans updated</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support NCDC in development of national surveillance and lab network for measles, rubella and yellow fever diagnostic testing to include: 1) Conduct lab training for lab staff to build their capacity on the testing for various vaccine preventable diseases to include measles, rubella, and yellow fever 2) 1 year Epidemiologist consultant to develop and refine protocols for surveillance, including case investigation and classification and outbreak response for measles and yellow fever, and laboratory/ epi data harmonization including data cleaning, data management, and summary/presentation of data 3) 1 year information strategy support for laboratory information management system 4) Outbreak investigation for measles, rubella and yellow fever including CDC support to conduct root cause analysis of outbreaks.">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">&quot;1.) YF lab training delayed due to Covid. Will be conducted as soon as travel to Nigeria for CDC lab trainers can be resumed/approved and training can be scheduled with NCDC laboratorians
2&amp;3) Terms of epidemiologist and lab consultants have been extended for a second year.
4) SOPs for outbreak investigation for measles, rubella, YF ongoing; major delay in integration with root cause analysis on outbreaks and conduct of training due to Covid (GoN staff reassigned to Covid activities). Development of training material is ongoing with CDC and AFENET. Training will be conducted once CDC trainers can be cleared to travel to Nigeria, and when NCDC and NPHCDA staff are freed from Covid-related duties to participate in training&quot;</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Sydani Initiative - Nigeria : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">?	Financial reports of utilization of Gavi funds across Gavi-supported programmes, including state budget, submitted every quarter (or as required)
?	Report on execution of activities and funds including the absorption rate per budget item
?	Request for reprogramming or reallocation submitted to Gavi in a timely manner
?	Timely submission of request for funding to WHO and UNICEF
?	Harmonization of HSS and NERICC workplans conducted 
?	Required budgets for NERICC, NLWG, Non-Polio SIAs and other programmes developed, agreed with WHO and UNICEF finance teams and submitted on time</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="?	Proactively monitor the execution of activities and utilization of Gavi funds by the RI and SIA teams, for NPHCDA and partners and provide weekly reports to the Gavi SCM and NPHCDA leadership
?	Support NERICC and other teams (where necessary) in the development of appropriate workplans and budgets for Gavi-funded activities
?	Track utilization of Gavi funds for the intended purposes and flag any potential issues related to execution of Gavi funds to Gavi teams.
?	Provide strategic efforts towards harmonisation, integration, when feasible, and ensure complementarities across the multiple programmes and/or projects funded by Gavi and by other partners.
?	Support identification and implementation of synergistic approaches that will deliver maximum impact and value for money in the roll-out of health system strengthening plans
?	Strengthen cross-communication and collaboration among Gavi-funded organizations (WHO, UNICEF, US-CDC, etc)
?	Provide systematic support in optimization of planned activities to eliminate/minimize wastage of resources
?	Proactively flag any delays in implementation or release of funds and provide options to address the bottlenecks and improve the absorption of funds.
?	Support NERICC and the NPSIA teams to report on execution of activities, Gavi grants and fund utilization and absorption to the Core Group, the Inter Agency Coordinating Committee (ICC) and the Gavi Secretariat.
?	Support the development of state-specific plans for improving RI and PHC, in line with the NSIPSS as well as support states to develop LGA-specific plans to improve RI and PHCMonthly reporting to Gavi and proactive reporting on specific issues and/or identified risks">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Detailed progress description contained in attached report</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">At least 50% of mapped non-immunization and under-used health sector partners at the national level engaged in the multi-sectoral approach to reaching zero dose populations and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="- Conduct mapping of non-immunization and other under-used health sector stakeholders in Nigeria that are relevant in rolling out an integrated multisectoral approach for reaching zero dose and missed communities
- Support the NERICC and EPI team in the design, development and deployment of multi-sectoral interventions targeted at reaching zero dose children and missed communities, in collaboration with other partners">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">This has been completed as part of NERICC&apos;s engagement activities with poor performing states to ensure multi-stakeholder engagement towards improvements in RI across states</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">#NAME?</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="#NAME?">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Health Financing/Sustainability</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.1.b. Immunization
funding sensitization
workshops for
National Assembly
and key stakeholders
completed
2.2.b. Secured buy-in
from National
Assembly &amp;
Presidency to
commence process
for First line Charge
for Vaccines
3.1.c. Funds
released for 2021 Q1
&amp; Q2 Vaccines
4. Roadmap to
firstline charge
advocacy concluded</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial
commitments in Nigeria&apos;s Gavi
transition plan (national &amp; state
level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial
commitments in Nigeria&apos;s Gavi
transition plan (national &amp; state
level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Clinton Health Access Initiative : Financial/General Management</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">2.1.b. Immunization funding sensitization workshops for National Assembly and key stakeholders completed
2.2.b. Secured buy-in from National Assembly &amp; Presidency to commence process for First line Charge for Vaccines
3.1.c. Funds released for 2021 Q1 &amp; Q2 Vaccines
4. Roadmap to firstline charge advocacy concluded.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Implementation of financial commitments in Nigeria&apos;s Gavi transition plan (national &amp; state level)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Evidence driven and efficiently coordinated campaigns and introductions
2. Data collected, collated, reviewed and triangulated before, during and after campaigns. -</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Providing data support for supplemental immunisation activities (SIAs)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">WHO : Service Delivery</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Updated Guidelines on PAPA LQAS.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Develop guidelines for the development and monitoring of States RI operational plans 
 2. Assess the quality of REW microplans and its implementation in addressing the burden of zero dose.
 3. Provide support for planning and technical coordination for the introduction of New vaccines as IPV2, Rota, HPV. 
 4. Develop and implement guidlines for the identification of RI human resource gaps and training of RI managers focusing on underserved areas. 
  5. Develop/update technical guidelines for conduct of PAPA/LQAS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Provided technical guide to states to develop plan to conduct routine immunization services in the context of COVID-19 outbreaks. 2. Conduct review of states operational plans during high level supportive supervision (as COVID-19 vaccination rollout) to the states. 3. Coversation currently ongoing between NERICC and GRID3 on how to use Geo-spatial technology to conduct REW microplans to identify where the zero dose children are. 4. Provided technical support planning &amp; coordination through NERICC, COVID-19 TWG &amp; Strategic Group, NG-TAG for the introduction of IPV2, Rota &amp; HPV. 5. Provided technical guide to the update concept note, training of trainers for PAPA/LQAS.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Atleast 30% of interventions to reach zero dose children on NERICC Annual Workplan containing are achieved. 
 2. Atleast 30% increase number of LGAs in the 18 priority states with acceptable LQAS results at &gt; 80%. 
 3. M&amp;E Framework to track the status of implementation of recommendations from EPI review and Multi-Stakeholder Dialogue (MSD).
 4. PAP/LQAS report.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Provide Technical support to development of costed NERICC workplan that include intervention (IMOP, RI Intensification, Urban vccination, OIRIS) to reach zero dose children. 
  2. Coordinate and develop M&amp;E framework to track implementation of action points from EPI Review/Multi-Stakeholders Dialogue. 
 3. Technical support for conduct of Post Introduction Coverage Survey for IPV, Men A, MCV2.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported NERICC to develop a 3-year strategic plan 2021-2024 to reduce high number of un-immunized children/zero dose. NERICC had extracted a 6 months plan to be implemented in coming months. The annual plan for 2022 will be extracted fro the strategic plan 2021-2024. 2. Post Introduction Evaluation (PIE) for IPV2, Men A &amp; MCV2 planned for 2021 is rescheduled for 2022 due to competing activity as COVID-19 vaccination.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. At least 80% of Service delivery strategies in the plan Implemented. 2 Introduction of IPV2, Rota and COVID-19 vaccine 
 3.At least one one service delivery approach (PIRI activity) focused on zero dose children and missed communities implemented 
 4.Information on Health worker availability in underserved within 8 GAVI priority States available. 5. MICS/NICS report.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Develop guidelines for the development and monitoring of States RI operational plans 
 2. Assess the quality of REW microplans and its implementation in addressing the burden of zero dose.
 3. Provide support for planning and technical coordination for the introduction of New vaccines as IPV2, Rota, HPV. 
 4. Develop and implement guidlines for the identification of RI human resource gaps and training of RI managers focusing on underserved areas. 
  5. Develop/update technical guidelines for conduct of PAPA/LQAS.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported states to develop their annual operational pan for 2022. NERICC Operations team members have been assigned to monitor and track status of implementation of state AOP. 2. Government of Nigeria is using the geospatial technology to support states and LGAs to develop REW microplan starting in December, 2021. This will help to identify where the zero dose children are. 3. Provided technical support in the introduction IPV2, development and submission of Rota &amp; HPV vaccine introduction. 4. Revised the concept note for PAPA LQAS which is currently being used.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Atleast 15% increase number of LGAs in the 18 priority states with acceptable LQAS results at &gt; 80%. 
 3. M&amp;E Framework to track the status of implementation of recommendations from EPI review and Multi-Stakeholder Dialogue (MSD). 3. Concept Note of PIE for IPV, MenA &amp; MCV2.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1.Provide Technical support to development of costed NERICC workplan that include intervention (IMOP, RI Intensification, Urban vccination, OIRIS) to reach zero dose children. 
  2. Coordinate and develop M&amp;E framework to track implementation of action points from EPI Review/Multi-Stakeholders Dialogue. 
 3. Technical support for conduct of Post Introduction Coverage Survey for IPV, Men A, MCV2.">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Supported the development and revision of NERICC workplan in the context of COVID-19 outbreaks and with strategies to reach zero dose children (IMOP, OIRIS, RI Intensification and urban vaccination). We are currently prioritizing the workplan to identify activities that can be supported by Gavi while working on ToC to improve routine immunization performance. 2. Although action points from the last MSD are being implemented, the M&amp;E framework is not cosely monitored at NERICC because of priority activity as COVID-19 vaccination. This will be incorporated into the current NERICC dashboard that is being developed. 3. PIE for MenA &amp; MCV2 is yet to be conducted because of COVID-19 outbreaks and now COVID-19 vaccination. There is a plan to conduct PIE before the year runs out.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Immunisation programme information provided to support high level decisions including JAR, ICC, Core group to track progress on NSIPSS Accountability Framework</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide routine technical support to strengthen partnership, coordination and immunisation programme planning and implemenation at national and sub-national levels focusing on :
  - Development of recovery and catch-up stragegy for routine immunisation
  - strengthening functionality of ICC, NGI-TAG and others to strengthening broader monitoring of Immunisation performance.
  - coordinating and monitoring priority stratgies to reach zero-dose children and unreached communities in the 8 Gavi Focus states and other states
  - supporting the development of a roadmap for improved integration of EPI with other PHC services
  - coordinate the introduction of new vaccine introduction and vaccine specific support including nOPV and related PIE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. Technical support at all ICC meetings and NGI-TAG meetings in the first six months of 2021. 2. Provided technical support to NERICC in the development of strategies to reduce zero dose children called Integrated Medical Outreach Program (IMOP) in 409 LGAs across 36 states and FCT in October, November, December 2020 &amp; January 2021. 3. Technical support during coordination meetings of new vaccines as COVID-19, IPV2, Rota, HPV &amp; nOPV</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">State Annual Workplans Developed focusing on reaching zero dose and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support for integration of EPI and PHC services toward strenthening Health System in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa). 2. Techinical support to map Human Resouce providing routine immunization in high priority LGAs in (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa) so as to support government to develop mitigation plan. 3. Technical Support for introduction of new vaccines (IPV2, Rota).">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. The WHO National Immunization Officer in each of these 8 Gavi focus states is providing technical support to strengthen health systems in the Gavi focus states. 2. They supported the development of Program Support Rational (PSR) in their states. 3. The country is yet to introduce IPV2 and Rota. 4. NERICC is currently working on the development of strategies to reduce zero-dose children that should be finalized in the coming weeks. States are also being engaged to develop state-specific strategies.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1) 10% increase in LGAs with penta3 coverage of &gt;80%
 2) 80% of NGI-TAG Disease Working Group meeting held
 3) Annual workplan developed in line with reaching zero dose and missed communities</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Provide routine technical support to strengthen partnership, coordination and immunisation programme planning and implemenation at national and sub-national levels focusing on :
  - Development of recovery and catch-up stragegy for routine immunisation
  - strengthening functionality of ICC, NGI-TAG and others to strengthening broader monitoring of Immunisation performance.
  - coordinating and monitoring priority stratgies to reach zero-dose children and unreached communities in the 8 Gavi Focus states and other states
  - supporting the development of a roadmap for improved integration of EPI with other PHC services
  - coordinate the introduction of new vaccine introduction and vaccine specific support including nOPV and related PIE">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO convened the discussions on zero dose by facilitating the leadership of NPHCDA and inputs from ES, State Immunisation Teams, and other partners. THe engagement led to the development of the medium term strategy to address zero-dose in Nigeria from 2021 - 2024 2. WHO has been providing technical support to the coordination platform-ICC &amp; NG-TAG. As at November 2021, there has been 3 ICC meeting and 5 NGI-TAG meetings. 3. Conducted 12 rounds of nOPV vaccination reaching over 150million children. The lowest national coverage was 70% and the highest national coverage was 94%.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Routine Immunisation Performance Shared and Action Plans developed
State Specific AF framework for PSR developed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="1. Technical support for integration of EPI and PHC services toward strenthening Health System in the 8 Gavi Focus States (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa). 2. Techinical support to map Human Resouce providing routine immunization in high priority LGAs in (Kebbi, Zamfara, Katsina, Gombe, Jigawa, Taraba, Niger and Bayelsa) so as to support government to develop mitigation plan. 3. Technical Support for introduction of new vaccines (IPV2, Rota).">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">1. WHO has provide technical and coordination functions in the SERICCs and DCI in the Gavi 8 states focusing on providing operational and technical guidance on coverage improvements, data quality, surveillance, and demand generation. The team in the also supporting critical milestones required from the implementation of the PSR. 2 WHO supported the preparations, implementation and monitoring of the IPV2 introduction in Nigeria schedule. Supported NPHCDA to respond to Gavi IRC feedback on the country Rota application which has be re-submitted for Gavi approval.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">80% de districts ont reduit ce taux de de 50% &#xE0; 20%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strategies particuli&#xE8;res (nomade, desertique, urbaine et d&apos;insecurit&#xE9;) pour identifier et vacciner les enfants zero doses et insuffisaments vaccin&#xE9;s dans les districts prioritaires de 4 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass) en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">71% (10/14) district avec appui OMS ont atteint l&apos;objectif de reduire de plus de 50% le nombre d&apos;enfants ZD entre Septembre 2020 et 2021. Cependant des efforts sont entrain d&apos;etre fournis pour le rattrapage des EIV avec la mise en oeuvre des activit&#xE9;s acc&#xE9;l&#xE9;r&#xE9;es par les equipes du districts avec l&apos;appui de l&apos;AT OMS au niveau regions et Districts.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">30% de districts avec enfants non vaccin&#xE9;s ou des zero doses ont reduit le taux de zero doses ou d&apos;enfants non vaccin&#xE9;s de 50% &#xE0; 20%</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la mise en ?uvre des strategies particuli&#xE8;res (nomade, desertique, urbaine et d&apos;insecurit&#xE9;) pour identifier et vacciner les enfants zero doses et insuffisaments vaccin&#xE9;s dans les districts prioritaires de 4 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass) en 2021">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La mise en oeuvre des strategies est en cours avec l&apos;appui des consultants OMS dans les 14 districts sanitaire cibl&#xE9;s, ;evaluation de la reduction d;enfants Zero dose est pr&#xE9;vue &#xE0; la revue &#xE0; mis-parcours au mos de juillet 2021</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le guide de Microplanificaton 2021 ACD/CEA y compris les outils adapt&#xE9;s sont diffus&#xE9;s dans tous les districts sanitaires (prioritaires et non prioritaires) des 04 regions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">La vaccination contre la COVID-19 en cours au Niger, ne permet pas de demarrer avec la microplanification dans les districts cibl&#xE9;s.</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">le guide de microplan valid&#xE9; et les outils sont disponibles diffus&#xE9;s dans toutes les 8 regions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Le draft 0 de la strat&#xE9;gie nationale de vaccination des populations en zone d&#xE9;sertique est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer la strategie nationale d&apos;atteinte et de vaccination des populations situ&#xE9;es en zones desertiques">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Reprogramm&#xE9;, cette activit&#xE9; ;a pas ete mise en oeuvre faut de financement</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">100% districts sanitaires des 04 regions disposent de microplans selon le nouveau guide ACD/CEA</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Appuyer la microplanification 2022 des activit&#xE9;s de vaccination selon le nouveau guide ACD/CEA dans les districts sanitaires prioritaires de 04 regions: Agadez (Aderbissinat, Arlit, Ingall); Dosso (Gaya Dosso Boboye); Tilabery (Abala, Bankilar&#xE9;, Tera, Ayerou) et Zinder (Magaria, Gour&#xE9;, Takeita, Dungass)">
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Une microplanification a &#xE9;t&#xE9; faite en Septembre 2021 &#xE0; travers l&apos;exercice d&apos;identification des enfants zeros doses (ZD) et enfants insuffisement vaccin&#xE9;s (EIV) par districts et par CSI dans les 08 regions. Concernant les 04 regions beneficiant de l&apos;appui de proximit&#xE9; de l&apos;OMS (Agadez, Dosso, Tillabery et Zinder), on a denombr&#xE9; en Fin Ao&#xFB;t 2021, 6 346 enfants ZD et 23 930 EIV. L&apos;exercice de microplanification fait sur la base de cette analyse de situation a permis la mise en oeuvre des activit&#xE9;s pour les rattraper entre Octobre et Decembre 2021. Un autre exercice sera conduit en fin decembre pour dresser la situation des ZD et EIV et permettre la proposition des actions &#xE0; mener au cours de l&apos;exercice 2022. en attach&#xE9; exemple de microplan fait dans la region de Tillab&#xE9;ri</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">le document valid&#xE9; de la strat&#xE9;gie nationale de vaccination des populations en zone d&#xE9;sertique est disponible</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Elaborer la strategie nationale d&apos;atteinte et de vaccination des populations situ&#xE9;es en zones desertiques">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">ICA - Claire Sambou : Leadership, management, and coordination (LMC)</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Le plan annuel du pays est en cours de validation 2. R&#xE9;union sur les cadres de gestion des programmes 3. Soumission du plan de TCA 4. Soutien au parcours d&apos;am&#xE9;lioration de la qualit&#xE9; 5. Approvisionnement en vaccins Covid</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Le plan annuel du pays est en cours de validation
2. R&#xE9;union sur les cadres de gestion des programmes
3. Soumission du plan de TCA
4. Soutien au parcours d&apos;am&#xE9;lioration de la qualit&#xE9;
5. Approvisionnement en vaccins Covid</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Mise en ?uvre des subventions Gavi
2. &#xC9;valuation conjointe annuelle (MSD) de la subvention Gavi
3. Rapports sur le parcours d&apos;am&#xE9;lioration de la qualit&#xE9;</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien au minist&#xE8;re de la sant&#xE9; pour la planification, la mise en ?uvre. Suivi et rapports sur toutes les subventions de Gavi conform&#xE9;ment aux proc&#xE9;dures et directives">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Acquisition et d&#xE9;ploiement du vaccin Covid-19
2. La mise en ?uvre du plan de d&#xE9;ploiement dans le pays
3. Rapports sur le d&#xE9;ploiement du vaccin Covid-19</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Processus de soumission des demandes de vaccin contre la Covid-19, des ECF et de l?AT 2. Pr&#xE9;sentation du plan de d&#xE9;ploiement national 3. R&#xE9;unions de l&apos;&#xE9;quipe de coordination nationale Covid et cadres de coordination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. Processus de soumission des demandes de vaccin contre la Covid-19, des ECF et de l?AT
2. Pr&#xE9;sentation du plan de d&#xE9;ploiement national
3. R&#xE9;unions de l&apos;&#xE9;quipe de coordination nationale Covid et cadres de coordination</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Apporter un soutien &#xE0; la DI et &#xE0; l&apos;&#xE9;quipe du minist&#xE8;re de la Sant&#xE9; pour l&apos;application, la planification et la mise en ?uvre du d&#xE9;ploiement du vaccin Covid-19 au Niger conjointement avec les partenaires de l&apos;Alliance Gavi et d&apos;autres parties prenantes nationales">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">University of Oslo : Data</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Covid-19 digital package installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="NE"></location>
     </target>
     <actual value="Re-programmed">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Re-programmed in agreement with the country</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed
3. EPI legacy data migrated
4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">Rescheduling process ongoing after delays have occured notably due to Covid 19 dysruptions</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned)
8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual value="Minor Delays">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">5. EPI Legacy data migrated (if fully transitioned) 8. Scorecard app installed</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on planned digital data package or app and know how to use it
Costed scale up plan exist</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support activities enhancing data analysis and use">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Core team trained on COVID-19 digital data package and know how to use it.</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support planning, configuration and management of COVID-19 surveillance">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">1. EPI digital package installed 3. EPI legacy data migrated 4. Training given</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target value="Support transitioning to DHIS2 for EPI">
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
  <result type="1">
   <title>
    <narrative xml:lang="EN">Expertise France : Programme Management - LMC</narrative>
   </title>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of each training session for a total of 8 training sessions</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="On Track">
      <location ref="NE"></location>
      <comment>
       <narrative xml:lang="EN">2 training sessions have been organized. 1 training session has been canceled because of the covid.</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">Report evidencing the modification of the organizational structure and an adaptation of the job descriptions in line with the workplan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual value="Completed">
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of each guidance mission (for a total of 8) with the integrated distance assistance</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
   <indicator ascending="1" measure="5">
    <title>
     <narrative xml:lang="EN">A report of the functional and organizational diagnosis of the decentralized level of the PH Ministry including a capacities reinforcement plan</narrative>
    </title>
    <period>
     <period-start iso-date="2021-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <location ref="NE"></location>
     </target>
     <actual>
      <location ref="NE"></location>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
